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Analyse av manganforsterket MRI av
sentralnervesystemet til rotte med og
uten skade
Skader eller sykdom i sentralnervesystemet som f.eks. ved hjerneslag eller
Alzheimers sykdom kan ofte ikke helbredes, og pasienter med slike tilstander har
dårlige prognoser. To viktige faktorer ved denne typen skader og sykdom er
sentralneversystemets manglende evne til regenerering, samt endringer i trans-
port langs nervebanene. Blant ﬂere sykdommer i sentralnervesystemet er feil i
nervebanenes (aksonenes) transportmekanisme den underliggende årsaken til syk-
dommen. Selv om nerver i sentralnervesystemet ikke repareres etter skade slik
som i det perifere nervesystemet ﬁnnes det eksperimentelle metoder som frem-
mer regenerasjon. Det er viktig å studere disse mekanisme i dyremodeller før
man overfører behandlingsmetoder til mennesker.
MR-avbildning (MRI) er en teknikk som gjør det mulig å studere sentralnervesys-
temet over tid uten å gjøre operative inngrep, i motsetning til tradisjonelle
metoder hvor man i dyreforsøk ofte må avlive dyrene før man tar vevsprøver
som analyseres. Mangan (Mn2+) er et paramagnetisk ion som hovedsaklig re-
duserer T1-relaksasjonstiden i vev og dermed øker kontrasten i T1-vektede MR
bilder. I tillegg kan mangan komme inn i nerveceller gjennom nervecellenes kal-
siumkanaler og bli transportert langs aksonene. Dette gjør mangan velegnet til å
studere celler og nervebaner i sentralnervesystemet. Denne teknikken, hvor man
bruker mangan som et MR kontrastmiddel, er ofte omtalt som manganforsterket
MRI (MEMRI).
I dette PhD arbeidet er det utviklet metoder for å segmentere aksoner og hjern-
evev med mangan i MR bilder samt metoder for å kvantiﬁsere signal- og kon-
trastendringer langs nervebanene. Synsnerven og hjernen til rotte er brukt som
eksperimentmodell for sentralnervesystemet.
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I første del av arbeidet ble en metode for segmentering og beregning av MR-bilde-
kontrast langs den manganforsterkede synsnerven er utviklet. Metoden gjør det
mulig å se hvordan mangan fordeles langs nerven og hvor transporten av mangan
eventuelt stopper opp. Denne metoden ble brukt til å detektere regenerasjon
av aksoner i synsnerven etter skade ved hjelp av MRI og etter stimulering av
gjenvekst. Videre ble mekanismene for tilførsel og transport av mangan i aksonene
undersøkt. Resultatene tyder på at tilførselen er uavhengig av konsentrasjon
over et visst nivå samt at mangan transporteres med en rekke hastigheter i friske
aksoner. Studier av hvordan denne hastighetsfordelingen endres ved sykdom kan
gi verdifull informasjon om sykdomsutvikling og eventuell respons på behandling.
Til slutt i arbeidet ble en billedanalytisk metode for sammenligning av MEMRI og
korresponderende histologi av hjerneslag hos nyfødte rotter utviklet. Resultatene
fra denne studien tyder på at mangan akkumuleres i deler av hjernen etter slag
som en følge av aktiviserte glia celler.
Metodene som er utviklet i dette arbeidet har bidratt til å gi en dypere kunnskap
om hvordan mangan kommer inn i og transporteres langs nervebanene. I tillegg
har de forbedret teknikkene for å studere regenerasjon av nerver i sentralnervesys-
temet og tolke betydningen av akkumulasjon av mangan i hjernevev i forbindelse
med hjerneslag hos nyfødte rotter. Dette har betydning for videre studier i dyre-
modeller hvor det endelige målet er å utvikle behandling for mennesker.
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Summary
Injury or disease in the central nervous system (CNS) such as stroke or Alzheimer's
disease is often irreversible, thus patients suﬀering from such injuries or diseases
have poor prognosis. Important factors in CNS injury and disease are absence of
axonal regeneration and axonal transport disturbances. Axons in the mammalian
CNS do not regenerate after injury but few experimental procedures have shown
to promote CNS regeneration. In some neurodegenerative diseases failure in the
axonal transport system is the underlying cause of the disease. Studies of these
mechanisms in animal models are important before translating any treatments to
humans. Magnetic resonance imaging (MRI) is a non-invasive imaging technique
which allows in vivo longitudinal CNS studies in contrast to traditional meth-
ods which requires sacriﬁcing the animals before tissue sampling and microscopic
analysis of neurons. Manganese (Mn2+) is a paramagnetic ion which reduces the
T1-relaxation time, thus increases tissue contrast in T1-weighted MR images. In
addition, Mn2+ enters neurons through voltage gated calcium channels and is
transported along neural axons which make Mn2+ well suited as a contrast agent
in MRI studies of the CNS and neural pathways.
In this PhD-thesis methods for segmentation of axons and brain tissue with Mn2+
accumulation together with methods for quantiﬁcation of signal- and contrast
changes along axons related to Mn2+ accumulation and transport have been
established. The rat optic nerve (ON) and brain was chosen as experimental
models for the mammalian CNS. A method for semi-automatic segmentation of
the manganese enhanced rat ON and calculation of contrast variation along the
ON was developed in Paper I. In Paper II, this method was used to in vivo detect
ON axon regeneration after injury and axon re-growth stimulation. In Paper III,
the transport kinetics of Mn2+ in the healthy rat ON was investigated. The
results indicate that input of Mn2+ into axons is restricted and are transported
along the ON axons in a wide range of velocities. In Paper IV, a method for
comparison of manganese enhanced MRI and corresponding histology of stroke
in the perinatal period was developed. The methods have enabled more reliable
in vivo studies of axonal damage and repair in parts of the CNS and provided
more profound knowledge about axonal manganese transport kinetics, as well as
novel insight into the relationship between manganese enhancement and neural
death related to ischemic insult in the neonatal brain.
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α ﬂip angle
b diﬀusion weighting factor
Ca2+ calcium ion
CNR contrast-to-noise ratio
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d days
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MnCl2 manganese chloride
MnDPDP manganese dipyridoxyl diphosphate
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Chapter 1
Introduction
1.1 Clinical background
Injury in the central nervous system (CNS) often results in paralysis and per-
manent loss of function. CNS damage occurs in traumatic injuries such as brain
trauma, hypoxic-ischemic injury (HI) and neurodegenerative diseases such as
Alzheimer's disease and Parkinson's disease. Few clinical treatments are cur-
rently available which means that for those suﬀering from CNS injury or disease,
many will experience loss in quality of life and in many cases CNS injury or
disease will be the causative event for death.
Axonal damage may cause axons to be isolated from its cell body. Within few
days after injury, the distal part of the axon degenerates [8] in contrast to the
proximal part where the axon survives to a greater degree [42]. However, in the
CNS axons will not regenerate spontaneously [23, 74].
During HI in the perinatal period, necrotic cysts within the brain cellular tissue
are produced which is then followed by a delayed phase of tissue injury which is
characterized by apoptotic cell death [31]. In addition, an over-activation of the
brain inﬂammatory response worsen the primary neuronal injury [31].
A hallmark for many neurodegenerative diseases is accumulations of organelles
and other proteins in the cell body [25]. The pathogenic accumulation of or-
ganelles suggests that defective functioning of the axon, including damage to
axonal transport, contributes to disease and is now known to be true for several
neurodegenerative diseases [25, 56].
Histology and immunohistochemistry is the gold standard to study cellular and
axonal damage in the CNS. However, this requires tissue sampling and is often
done post mortem and thus unsuited for longitudinal real time in vivo stud-
ies. This is also true for axon transport studies which traditionally use viruses,
radioactive, or non-ﬂuorescent tracers [64, 47, 100, 114, 82].
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A versatile MRI technique is manganese-enhanced MRI (MEMRI) which com-
bines the strengths of MRI with the physical and biological properties of man-
ganese (Mn2+). This technique makes it possible to visualize the neuroarchitec-
ture [51, 4], neural pathways [71, 98, 70, 83, 113] and to map functional brain
activity [3, 116]. In addition, MEMRI has been used for detecting brain ischemia
[1, 2] and abnormal brain function associated with neurodegenerative disease
[91, 93, 57].
1.2 Animal models
1.2.1 Rat optic nerve
The rat optic nerve (ON) contains about 120 000 axons [14, 15] which arise from
retinal ganglion cells (RGC) in the eye and project towards the optic chiasm where
the ON from both eyes meet. From the optic chiasm, the ON project through
the contralateral optic tract to the thalamic lateral geniculate nucleus (LGN),
midbrain pretectum, and superior colliculus (SC) [42, 108]. Visual information is
processed in the LGN before it is relayed to the primary visual cortex while the
SC is involved in the coordination of head and eye movements [102, 108].
1.2.2 Neonatal rat brain
The neonatal brain diﬀers from the adult brain in several ways and normal mat-
uration of the mammalian brain is characterized by periods of limitations in
glucose transport capacity and increased use of alternative cerebral metabolic
fuels lactate and ketone bodies [106]. Rates of cerebral energy metabolism are
low in the immature brain and relate primarily to the level of neuronal matura-
tion and synaptic activity at the developmental stage [106]. In contrast to adult
stroke, the development of energy failure and subsequent neuron death because
of HI in the immature brain results in a prolonged evolution of injury days and
weeks after the primary insult [106, 30, 59].
1.3 Axonal transport
Neurons are highly polarized cells which consist of a cell body from where a single
axon and shorter multiple dendrites emerge. The axon transmits signals while the
dendrites are specialized to receive signals. Inside neurons and other eukaryotic
2
1.4 Manganese-enhanced MRI
cells, microtubules are part of the cytoskeleton and are formed by alpha- and
beta-tubulin into 24nm wide hollow tubes with a plus and minus end. Inside
axons, microtubules are uniformly oriented with plus end pointing towards the
synapse and the minus end towards the cell body [19].
Kinesin and Dynein are the major molecular motors responsible axonal transport
[78]. Kinesin walks along microtubules toward the plus ends, facilitating material
transport from the cell interior toward the synapse while dynein transports ma-
terial toward the microtubule minus ends and transport material the cell interior
[32, 78]. Kinesin has been shown to walk in 8-nm steps along a single microtubule
protoﬁlament [96, 121] and Dynein seems wander with steps that vary from 8 to
32 nm [53, 75, 112] including runs in the reverse (plus-end) direction [79]. Even
though Kinesin and Dynein have preferred directions of movement their cargos
can be moved bi-directionally as a result of a tug of war between Dynein and
Kinesin being attached to the same cargo [58].
The transport rates of various substances are independent of the electrical activity
within the axons [7, 65] and are traditionally grouped in fast and slow components
with speeds of approximately 4-16mm/h and 0.004-0.25 mm/h respectively in
the healthy axon, [11, 29, 65]. The same "fast" molecular motors are involved in
both fast and slow axonal transport, but during slow axonal transport there are
prolonged pauses between phases of movements [81, 110]. Dynein tends to tether
its cargo at microtubuli intersections, a tendency which increases with increasing
density of dynein [78]. Kinesin, which is smaller in size than dynein, tends to
transverse microtubule intersections without stopping or reversing its direction,
thus, kinesin may have a higher speed along the microtubule than Dyenin [78].
1.4 Manganese-enhanced MRI
1.4.1 Properties of manganese
Manganese is an essential trace metal found at low levels in food, water, and
the air, and is a co-factor in several biological processes [6]. Mn2+ is a calcium
(Ca2+) analogue and can enter cells through voltage gated Ca2+-channels [60, 62]
and also be transported along axons [44, 48]. By substituting Ca2+ with Mn2+ it
is also possible to get intracellular accumulation of Mn2+ in neurons undergoing
cell death [1, 2].
3
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1.4.2 Contrast agents
Paramagnetic materials (e.g. Mn2+, Gd3+, Fe3+ and Cu2+) have unpaired elec-
trons resulting in a net magnetic moment. The magnetic moments are randomly
distributed and will cancel each other out unless they are placed in an external
magnetic ﬁeld where they align with the external ﬁeld and produce an increase in
the local ﬁeld. In tissue, paramagnetic substances will interact with tissue pro-
tons through dipole-dipole interactions and create ﬂuctuations in the magnetic
ﬁeld. This can aﬀect both the longitudinal relaxation time T1 and transver-
sal relaxation time T2 of the protons, and result in increased tissue contrast in
T1-weighted images or reduced tissue contrast in T2-weighted images in regions
where the paramagnetic substances are present [36, 55]. In pure water, the re-
laxation rates are linearly dependent on the concentration of the paramagnetic
substance [50].
Mn2+ was early recognized as an MRI contrast agent and in vivo, Mn2+can
bind to a variety of materials which inﬂuence the magnetic properties in the sur-
rounding tissue leading to a reduction in T1 relaxation time and increased tissue
contrast in T1-weighted imaging [45, 63]. A widely used Mn2+ contrast agent in
animal research is manganese chloride (MnCl2). In water, MnCl2 dissolves into
Mn2+ and Cl2− and the solution can be injected intravenously, subcutaneously,
intraperitoneally or directly into the area of interest where Mn2+ will enter cells
through the Ca2+-channels. However, overexposure of Mn2+ may cause toxic re-
actions [6, 21, 80] and Parkinson-like symptoms [6, 21]. In addition, high Mn2+
concentrations may inactivate the voltage gated Ca2+-channels which leads to un-
restrained Ca2+entry [12, 62]. Mn2+ may also increase the production of reactive
oxygen species which can lead to apoptosis of neurons [27, 123].
Manganese dipyridoxyl diphosphate (MnDPDP) (Teslascan, GE Healthcare AS,
Oslo, Norway) is a chelated Mn2+-compound which is clinically approved for MRI
of the human liver and has also been used in imaging of the human myocardium
[92]. The chelate consists of Mn and the organic ligand dipyridoxyl diphosphate
(DPDP). In blood, MnDPDP is metabolised by dephosphorylation to manganese
dipyridoxyl monophosphate (MnDPMP) and manganese dipyridoxyl ethylendi-
amine diacetate (MnPLED). The MnDPDP and MnPLED metabolites are si-
multaneously transmetalled with zinc (Zn) releasing Mn2+ [101].
1.4.3 Image sequences
T1-weighed image sequences such as the fast low angle shot (FLASH) sequence are
characterized by short TR and TE [36]. The FLASH is an incoherent steady state
4
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sequence which uses small ﬂip angle excitations and spoiling of the transverse
magnetization before the next RF pulse [36]. In steady state the signal is given
by:
S = ρ sinα
1− e−TRT1
1− e−TRT1 cosα
e−
TE
T2∗ (1.1)
where ρ is the proton density, α is the ﬂip angle, TR is the repetition time, TE
is the echo time and T1 and T2* are the longitudinal and transversal relaxation
times, respectively.
The centric reordered saturation recovery turbo-FLASH sequence consists of a 90
degree inversion pulse followed by a saturation recovery delay and a turbo-FLASH
readout [67]. The approximated signal is given by :
S = S0
(
1− e−TDT1
)
(1.2)
where S0 is is the maximum available signal when the longitudinal magnetization
is fully relaxed, TD is the saturation recovery delay and T1 the longitudinal
relaxation time. Since the centre of k-space is read out ﬁrst (centric reordered)
the image contrast is mainly determined by the saturation recovery delay.
1.5 Image processing
1.5.1 Mathematical morphology
Developed during the 1960s and 1970s mathematical morphology has become a
powerful tool in signal and image processing applications [11]. Since its intro-
duction, mathematical morphology has been used in a wide range of applica-
tions including biomedical image processing [86, 89], shape analysis [37], coding
and compression [41, 122], automated industrial inspection [54], texture analysis
[5, 40] and radar imagery [39].
Mathematical morphology has a rigorous mathematical foundation based on set
theory where an image is regarded as set in the 2D integer space Z2 (binary
images), Z3 (gray scale images) or in higher dimensions which can include colour
images and time varying components [33]. An image is probed with a smaller
set called a structuring element which explores the image and modify the image
by one or a set of rules which constitute an operation. The basic operations
are erosion and dilation which "contracts" and "expands" the boundary of a set
5
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and is the basis for operations like opening, closing, boundary extraction and
top-hat transformation [33]. Openings can be used to remove small objects (e.g.
noise), protrusions and thin connections between objects while closing smoothes
contours, eliminates small holes and fuses narrow breaks. The top-hat transfor-
mation is deﬁned as the diﬀerence between the original image and its opening by
an structuring element and extracts small elements from the image [33, 124].
1.5.2 Image segmentation
Image segmentation is the process of extracting regions or objects from images
and numerous methods exists and where the choice of method often depend of
the a priori knowledge of the objects to be detected [73, 87, 99, 117]. In medical
imaging, segmentation using mathematical morphology has been used in various
studies including 3D MRI of the human skull [28], microscope images and MRI of
blood vessels [69, 77], MRI of the human ventricular system [85], MRI of multiple
sclerosis lesions [68], CT images of neuroblastoma [26] and fMRI data [52].
Central elements in mathematical morphological segmentation are pixel connec-
tivity and region growing. The connectivity deﬁnes which pixels in the image
meeting speciﬁc criteria are connected and forms objects or connected compo-
nents. A region growing procedure utilizes the connectivity and extract objects
by grouping pixels which are connected as deﬁned by the connectivity. The con-
nectivity can be deﬁned in various ways in order to extract objects with certain
shapes. To explain connectivity, the standard 3D connectivities 6-connected, 18-
connected and 26-connected can be used as examples. A 3D pixel (voxel) has
6 faces, 12 edges and 8 corners. If the connectivity is 6-connected, voxels are
connected if one of their faces touches. If the connectivity is 18-connected (6
faces + 12 edges), voxels are connected if faces or edges touch while 26-connected
(6 faces + 12 edges + 8 corners) connectivity connect voxels where either faces,
edges or corners touch [33].
Segmentation of colour images uses the same paradigms as gray scale images [18]
as for example in detection of exudates in colour images of the human retina
[109]. Colour images are usually stored and displayed in the RGB vector space
where the Euclidian distance between two colours not necessarily correspond to
the human perception of the colour diﬀerence [18] and can cause problems in
segmentations. This may be bypassed by transforming the image into the Luv
colour space which approximates the human perception of colour diﬀerences [88].
However, the transformation is non-linear and may signiﬁcantly increase noise in
the transformed image [88]. A way to segment images in the RGB vector space is
to use the Mahalanobis distance [24] as a threshold which include the covariance
6
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matrix of a sample (ROI) representative to the colour we want to segment [33].
In contrast to the Euclidian distance where all colours within a certain distance
from an "average" colour describes a solid 3D sphere, the locus of points using
the Mahalanobis distance describes a solid 3D elliptical body. This means that
the Mahalanobis distance, as opposed to the Euclidian distance, is sensitive to
diﬀerent spread in colours along the three colour axis and may therefore yield a
better segmentation.
1.5.3 Image registration
Image registration is the process of aligning two or more images of the same scene
and was actualized in the 1970s concerning problems of aligning satellite images
[94]. Image registration algorithms can use landmarks [13, 43, 66, 119], contours
[22, 115], surfaces [72, 97] or volumes [49, 118] to manually or automatically
deﬁne correspondence between images. Traditionally intra-subject images have
been registered using rigid body transformations while inter-subject images have
required non-rigid body transformation. Recently, it has been shown that intra-
subject data in fMRI studies improves by using non-rigid transformation [120].
A fundamental step in image registration is to determine the transfer function
which maps the points in one image into the other. The transformation should
be one-to-one, i.e., each point in one image is mapped to only one point in the
other and vice versa [16]. A method which obey this rule in addition to be
able to handle geometrical distortions between the images is the piecewise linear
mapping [34] using manually placed landmarks. Based on a set of manually
placed landmarks in the images an optimal triangulation of the convex hull is
calculated. For each pair of corresponding triangles a linear transfer function
is found which will overlay the triangles. Outside the convex hull, the transfer
function is based on extrapolated boundary triangles which may result in poor
alignment [34, 35]. The area of interest should therefore be situated within the
convex hull of the landmarks.
1.5.4 Model optimization
Optimization is the action of ﬁnding the best solution to a problem. Optimizing a
model to ﬁt observed data can be done by constructing a function which describe
the diﬀerence between the model and data and search for the model parameters
which minimizes the diﬀerence.
A mathematical model with a set of variables x1, ..., xn can be optimized to ﬁt a
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set of data by ﬁnding the set of variables which minimize the L-norm. Generally,
the Lp norm can be written as:
Lp =
(∑
|Model(x1, ..., xn)−Data(x1, ..., xn)|p
) 1
p
p > 1 (1.3)
where minimizing the L2 norm (p = 2) equals the least square ﬁt.
A simplex method for ﬁnding a local minimum of a function of n variables, e.g.
the L-nom, has been developed by Nelder and Mead [61]. The method is a
systematic search that compares function values at each vertex of a simplex, a
generalized triangle in n dimensions, and rejects the worst vertex (largest function
value), replaces it with a new and repeats the procedure. The process creates a
sequence of simplexes for which the function values of the vertices gradually get
smaller until a minimum has been found. Since the procedure terminates at any
local minimum several searches with diﬀerent initial conditions should be carried
out to increase the probability to ﬁnd the global minimum.
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Chapter 2
Aims of study
The main objective of this thesis were to develop and apply methods for analysing
MEMRI of the normal and injured rat central nervous system.
More speciﬁcally, the aims of this thesis were:
1. Develop and scientiﬁcally evaluate methods for segmentation of axons and
brain tissue with manganese accumulation (Paper I & IV).
2. Develop and scientiﬁcally evaluate methods for quantiﬁcation of signal/contrast
changes related to manganese accumulation and transport (Paper I & III).
3. Adapt these methods to scientiﬁc studies of:
a) Nerve damage and regeneration in CNS (Paper II).
b) Uptake and transport kinetics in brain neurons and axons (Paper III).
c) Tissue damage after ischemic insult in the neonatal brain (Paper IV).
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Materials and Methods
3.1 Animal models
3.1.1 Animal handling
Fisher (Paper I & II), Sprague Dowley (Paper III) and Wistar rats (Paper IV)
were used in the studies. The animals were kept in a 12:12h light:dark cycle
and allowed free access to food and water. All experimental procedures were
performed under anaesthesia and analgesia was provided afterwards if required.
Guidelines approved by the local ethics committee for animal research were fol-
lowed and all experiments were approved by the responsible governmental au-
thorities.
3.1.2 Contrast agent injections
Anesthetized animals were placed in a purpose-built head frame and a single
dose of MnCl2 (Paper I-III), MnDPDP (Paper I) and Gadodiamid (Paper I)
was injected through the sclera posterior to the ora serrata of the left eye us-
ing a purpose-built injection device consisting of a plastic syringe connected via
polyethylene tubing to a glass micropipette with a tip diameter of 50 µm. After
the injection the pipette was slowly withdrawn to minimize reﬂux. In Paper IV,
animals were given a single dose of MnCl2 intraperitoneally.
3.1.3 CNS injury
Optic nerve crush (ONC) was performed according to the method described by
Berry et al. [10]. In brief, the dural sheath of the ON was incised longitudinally
after intraorbital exposure through a superior palpebral incision, and the ON was
crushed for 10 seconds, 2 mm distal to the lamina cribrosa with microforceps,
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leading to a complete transaction of all axons. Hypoxic-ischemic injury (HI)
(Paper IV) was performed according to Vannucci-Rice model for HI brain damage
[76, 105]. Through a mid-neck incision, the right common carotid artery was
thermo-cauterized and severed. After surgery, the animals were exposed to pre-
heated air (36 deg C) with 8% O2 in 92% N2 for 75 minutes.
3.2 MRI
3.2.1 T1-weighted MRI
Paper I: 2.35 T Bruker Biospec Avance DBX-100 with water-cooled BGA-12
(200 mT/m) gradients (Bruker, Ettlingen, Germany). A 72-mm volume coil was
used for RF transmission and an actively decoupled quadrature rat head surface
coil for receive. Data acquisition: T1-weighted FLASH with TR/TE = 15/4.2
ms, and a ﬂip angle of 25 deg. Field of view (FOV) = 5x5x2 cm3. With an
acquisition matrix of 256x256x64, the voxel resolution was 195x195x312 µm3.
Paper II: 7 T Bruker Biospec Avance 70/20 with water-cooled BGA-12 (400
mT/m) gradients. A 72-mm volume coil was used for RF transmission and an
actively decoupled quadrature rat head surface coil for receive. Data acquisition:
T1-weighted FLASH with TR/TE = 12.5/3.7 ms, and a ﬂip angle of 20 deg. FOV
= 4x4x2.3 cm3. With an acquisition matrix of 192x192x112, the voxel resolution
was 208x208x205 µm3.
Paper III: 7 T Bruker Biospec Avance 70/20 with water-cooled BGA-12 (400
mT/m) gradients. A 72-mm volume coil was used for RF transmission and an
actively decoupled quadrature rat head surface coil for receive. Data acquisition:
3D centric recorded saturation recovery turbo-FLASH sequence, with saturation
delay=500ms, ﬂip angle = 15 deg. TR/TE = 9.25/2.7 ms, echo train length 445
ms and number of segments = 4. FOV = 3.5x3.5x2.64 cm3. With an acquisition
matrix of 192x192x66, the voxel resolution was 182x182x400 µm3.
Paper IV: 7 T Bruker Biospec Avance 70/20 with water-cooled BGA-12 (400
mT/m) gradients. A 72-mm volume coil was used for RF transmission and an
actively decoupled quadrature mouse head surface coil for receive. Data acquisi-
tion: T1-weighted FLASH with TR/TE = 12/3.0 ms, ﬂip-angle = 30 deg. FOV
= 20x20x17.5 mm. The acquisition matrix was 128x96x84 giving an acquired
resolution of 156x208x208 µm3. With zero-ﬁlling of the matrix to 128x128x112,
the interpolated resolution was 156 µm3 isotropic.
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3.2.2 T2-maps
Paper IV: 2D T2-maps were obtained with a spin-echo sequence (MSME) with
TR/TE = 2500/7.6 ms, 40 echoes, slice thickness 1 mm. FOV = 18x18 mm and
acquisition matrix 128x96 giving an in plane resolution of 140x187 µm2. With
zero-ﬁlling of the matrix to 128x128 the interpolated resolution was 140 µm2
isotropic.
3.2.3 Diﬀusion tensor imaging
Paper II: A 2D multishot (four segments) DTI-EPI scan with ﬁve oblique axial
slices containing the ON was obtained with TR/TE = 1500/ 32.6 ms, ∆ = 15
ms, δ = 6 ms. Diﬀusion sensitizing gradients along 12 non-collinear directions
and six b-values in the range of 0-3000 s/mm2 (ﬁve A0 images, and 300, 600,
1000, 1600, 2300, and 3000 s/mm2) were used. The slice thickness was 0.8 mm
(no gap), FOV = 5x5 cm2, and the acquisition matrix size = 160x160 (zero-ﬁlled
to 256x256).
3.3 Data analysis
3.3.1 Optic nerve segmentation
In Paper I, a technique for semiautomatic segmentation of the manganese-enhanced
ON was developed. In brief, the 3D image was binarised using a global threshold
close to the mean signal of the non-enhanced ON. Then morphological segmen-
tation of the manganese-enhanced ON was done by a 6-connected region growing
resulting in an image containing the manganese-enhanced eye, ON, and part of
the brain. The ON was separated from the eye and brain using a morphologi-
cal top-hat transformation with a spherical structuring element with a diameter
slightly largger than the ON diameter. Furthermore, a sliding box technique
was developed to ensure correct deﬁnitions of the ON co-ordinates. The ON
co-ordinates was re-sampled with 0.2 mm resolution and the signal in a 1 mm
diameter ROI centred on the ON in 2D planes perpendicular to the ON was
calculated every 0.2 mm.
Due to image distortions (Paper II) and low signal to noise ratio (SNR) (Paper
III), the segmentation procedure failed to segment the ON in the DTI datasets
(Paper II) and in the study of manganese kinetics (Paper III). In these cases
the co-ordinates of the centre were manually identiﬁed along the ON. The set of
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co-ordinates were re-sampled with 0.2mm resolution by either bi-linear (Paper
II) or tri-linear (Paper III) interpolation which gave an intensity curve of the ON
for each scan.
3.3.2 Axonal Mn2+ transport model optimization
In Paper III, approximated ON Mn2+ concentration curves at various time points
were constructed by subtracting a mean pre Mn2+ intensity curve from the post
Mn2+ injection curves. Three diﬀerent transport functions were evaluated; 1) a
single component anterograde convection together with random walk and clear-
ance as described in [20] and [57], 2); a pure anterograde convection with a ma-
jority of fast velocity components, and 3); a pure anterograde convection with a
majority of slow velocity components. The transport functions together with two
diﬀerent functions which described Mn2+ entrance into RGC axons were ﬁtted to
the concentration curves. The ﬁt was done by optimizing the model parameters
in order to minimize the L1 and L2 norm.
3.3.3 Segmentation of manganese enhanced areas in the
ischemic brain
In paper IV, a binary mask of the manganese-enhancement in the injured hemi-
sphere was deﬁned by signal intensities above a threshold set by the mean signal
intensity (SI) of a ROI placed in the thalamus of the contralateral non-injured
hemisphere + 1 SD of the image noise.
3.3.4 Histology
Histological counting of the RGC in retina (Paper II) was obtained after injection
of 1 µl FluroGold into the ON between the lamina cribrosa and ONC 20 days past
lesion (dpl). After preparation, the retina was whole mounted on a slide, deﬁning
the temporal, nasal, superior and inferior retinal quadrants with radial incisions.
A 349.0x440.4 µm2 counting grid was projected onto the mid radial point of
each retinal segment and the total number of FluroGold-ﬁlled RGC recorded
per grid. Details on the preparations are given in the Material and Methods
section in Paper II. The ON was dissected, straightened on a stiﬀ card, and dried
in room temperature for a couple of minutes. After preparation, the ON was
frozen at -80 deg. C and 5 µm thick frozen longitudinal sections were cut and
mounted onto dedicated microscope slides. After further preparation, sections
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were stained with anti-GAP43. After preparation, 8 µm coronal sections of the
HI brain corresponding to -3.25 mm from the bregma (Paxinos and Watson, 1998)
were cut and stained with among others anti-MAP2, anti-GFAP and anti-CD68
(Paper IV).
3.3.5 Segmentation of stained areas in the histology images
Images of whole histological slices stained for MAP-2, CD68 and GFAP (Paper
IV) were segmented in the RGB vector space using the Mahalanobis distance
from an average colour calculated from a ROI manually placed in an area with
uniform staining. The segmented colours were deﬁned to be in a distance equal
or less than 1 SD from the average colour, where the SD was selected from the
RGB component with the largest variance within the ROI. From this a binary
mask for the area of staining was created.
3.3.6 Image registration
The T1-weighted MR images and the histology images (Paper IV) were co-
registered using landmark based image registration. After manually selecting
approximately 15 pairs of anatomical points of reference in the two images, the
transformation was calculated using piecewise linear mapping. The transforma-
tion was applied to the segmented histology image which enabled comparison of
manganese-enhanced areas and segmented histology staining on a pixel-to-pixel
basis.
3.3.7 Statistical analysis
Statistical analyses were conducted using the statistical software package SPSS
(SPSS Inc., Chicago, IL, USA), with a signiﬁcance level of 5%. The statistical
analyses are described in detail in the Material and Methods sections of each
individual paper.
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Chapter 4
Summary of papers
Paper I
Axon tracing in the adult rat optic nerve and tract after intrav-
itreal injection of MnDPDP using a semi-automatic segmenta-
tion technique
Øystein Olsen, Marte Thuen, Martin Berry, Vassili Kovalev, Maria Petrou, Pål
Erik Goa, Axel Sandvig, Olav Haraldseth, and Christian Brekken.
Journal of Magnetic Resonance Imaging 27:3442, 2008
The aims of this study were to:
1. Develop and validate an objective technique for 3D segmentation of the
manganese enhanced optic nerve in adult rats and to improve CNR calcu-
lations.
2. Use the technique to ascertain if manganese dipyridoxyl diphosphate (MnD-
PDP) gives suﬃcient Mn2+ enhancement compared to MnCl2 when used
for functional imaging of the visual pathway.
Intravitreal MnDPDP injection resulted in signiﬁcant MRI contrast enhancement
of the retina and ON after 12-24 hours. The enhanced optic nerve was success-
fully segmented and CNR calculated accurately within 2 minutes on a standard
desktop PC in a representative 3D MR image volume using a semi-automated
procedure.
Mn2+ was found to be released from MnDPDP after intravitreal injection in
suﬃcient amounts to obtain functional tracing of the adult rat primary visual
pathway. This study also indicated that a slow release contrast agent formulation
might be useful to prevent the high initial Mn2+ concentration that follows from
MnCl2 injections for such tract-tracing studies.
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Paper II
Combination of Mn2+-enhanced and diﬀusion tensor MR imag-
ing gives complementary information about injury and regen-
eration in the adult rat optic nerve
Marte Thuen, Øystein Olsen, Martin Berry, Tina Bugge Pedersen, Anders Kristof-
fersen, Olav Haraldseth, Axel Sandvig, and Christian Brekken.
Journal of Magnetic Resonance Imaging 29(1):39-51, 2009
The aims of this study were to:
1. Evaluate manganese MEMRI and diﬀusion tensor imaging (DTI) as tools
for detection of axonal injury and regeneration after peripheral nerve graft
(PNG) implantation in the rat optic nerve.
2. Investigate retinal ganglon cell survival after optic nerve crush (ONC) and
PNG implantation.
This study showed that MEMRI and DTI enabled detection of functional and
structural degradation after rat ON injury, and there was correlation between
MEMRI and immunohistochemical measures of axon regeneration. The DTI-
derived parameters fractional anisotropy, mean diﬀusivity, axial diﬀusivity, and
radial diﬀusivity were unaﬀected by the presence of Mn2+ in the ON.
At 1 dpl, both CNR (MEMRI) and axial diﬀusivity were reduced at the injury
site, while at 21 dpl they were increased. ONC reduced RGC density in retina at
21 dpl compared to noninjured ON without MnCl2 injections. Both intravitreal
PNG and intravitreal MnCl2 injections improved RGC survival in retina after
ONC.
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Manganese transport in the rat optic nerve evaluated with
spatial- and time-resolved MRI
Øystein Olsen, Anders Kristoﬀersen, Marte Thuen, Axel Sandvig, Christian
Brekken, Olav Haraldseth, Pål Erik Goa.
Submitted to Journal of Magnetic Resonance Imaging
The aim of this study were to:
1. Utilize spatial- and time-resolved MEMRI and diﬀerent models of how
Mn2+ enters RGC axons and axonal transport of Mn2+ to evaluate Mn2+
RGC axon entrance, multiple transport rates, dispersion and clearance in
the healthy rat ON after intravitreal manganese injection.
2. Compare predictions from the new models with previously reported exper-
imental data.
The study showed that the rate of Mn2+ entrance into the RGC axon is not
proportional to the Mn2+ concentration in the vitreous body. Instead a model
with constant rate of Mn2+ inﬂux, termed rate limited axonal entrance, gave a
good ﬁt to the experimental data. In addition, the model simulations showed that
rate limited axonal entrance explains the semi-logarithmic relationship between
intravitreal Mn2+ dose and ON contrast enhancement seen in-vivo [98].
The study did not give any clear answers regarding the transport along the ON.
Both a random-walk like model with bi-directional transport and a convection-
like model with uni-directional transport gave similar ﬁt to the data. However,
what did seem clear, was that components of both fast and slow transport is
necessary in order to ﬁt the data, which might indicate that manganese does not
depict synaptic vesicle transport rates directly. Clearance of Mn2+ along the ON
is slow or non-existent. Two of the models gave an inﬁnite time constant for
exponential axonal clearance while one model gave a time constant of 100h.
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Paper IV
Manganese-enhanced magnetic resonance imaging of hypoxic-
ischemic brain injury in the neonatal rat
Marius Widerøe, Øystein Olsen, Tina Bugge Pedersen, Pål Erik Goa, Annemieke
Kavelaars, Cobi Heijnen, Jon Skranes, Ann-Mari Brubakk, Christian Brekken.
Neuroimage 45(3):880-90 2009
The aims of this study were to:
1. Depict delayed neuronal death by MEMRI up to several days after the
initial hypoxicischemic insult (HI) in the neonatal rat brain.
2. Evaluate the speciﬁcity of MEMRI in detection of cells related to injury by
comparison with histology and immunohistochemistry.
Seven days after HI, increased Mn enhancement was seen on T1-weighted im-
ages in parts of the injured cortex, hippocampus and thalamus among HI+Mn
pups, but not among HI+Vehicle or Sham+Mn pups. Comparison with immuno-
histochemistry showed delayed neuronal death and inﬂammation in these areas
with late Mn enhancement. Areas with increased Mn enhancement corresponded
best with areas with high concentrations of activated microglia. Thus, late Mn
enhancement seems to be related to accumulation of manganese in activated mi-
croglia in areas of neuronal death rather than depicting neuronal death per se.
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General discussion
5.1 Main ﬁndings
The main objective of this thesis was to develop methods for segmentation of
manganese enhanced axons and brain tissue and apply the methods for studies
of axonal damage and repair, axon transport of Mn2+, and studies of ischemic
insult in the neonatal brain. The main ﬁnding of Paper I was that the manganese
enhanced ON could be segmented and CNR calculated along the ON using a
combination of global thresholding, region growing and a sliding box technique.
Furthermore we showed that a top hat transformation resulted in a consistent
separation of the ON from the manganese enhanced retina at lamina cribrosa
which deﬁned a reliable zero point for measuring distance along the ON. In Paper
II we applied MEMRI and the method developed in Paper I to detect blocking of
Mn2+transport in and beyond the site of a nerve crush 1 dpl and increased Mn2+
enhancement 21 dpl and implantation of a peripheral nerve graft. The increase
of Mn2+ enhancement 21 dpl corresponded well with histological ﬁndings which
showed axon re-generation at the lesion site and beyond.
In paper III, model ﬁtting to time- and spatial resolved ON MEMRI data indi-
cated that entrance of Mn2+ into RGC axons after intravitreal injection is rate
limited and independent of the Mn2+ concentration above a certain threshold.
Furthermore, the model optimization indicated that Mn2+ is loosely bound dur-
ing axonal transport which means that the apparent Mn2+ transport velocities
are diﬀerent from the genuine synaptic vesicle transport velocities.
In Paper IV, T1-weigthed images and T2-maps of hypoxic ischemic rat pup brains
were segmented using a global threshold and region growing while stained areas
in the histology images were segmented in the RGB vector space. Compari-
son of segmented Mn2+ enhanced areas and areas with reduced T2 showed a
53% match. Comparison of Mn2+ enhanced areas with segmented immunohis-
tochemical staining showed best spatial agreement between Mn2+ and activated
microglia/macrophages.
21
Chapter 5 General discussion
5.2 Methodological considerations
The initial process of segmentation of the Mn2+ enhanced volumes (Paper I and
II) and areas (Paper IV) was based on a threshold which binarised the image and
included voxels for further morphological image processing steps. The threshold
was based on the SI in the non-enhanced ON (Paper I and II) and SI in the
non-injured brain hemisphere (Paper IV). At least three factors inﬂuenced which
voxels were included for further analysis: 1) the threshold level, 2) the image
noise and 3), any gradient in the image which may change the overall signal level
from where the threshold level was determined to where it was applied.
In Paper I and Paper II the threshold was determined by the mean SI in a ROI
manually placed in the non-enhanced ON. Since the diameter of the rat ON is
about 1mm and the voxel size was 0.2mm the mean SI in a small ROI manually
placed on the ON is susceptible for both inherent partial volume eﬀect and an
artiﬁcial partial volume eﬀect caused by slight misplacement of the ROI. This
will cause an error in the estimate of the mean SI but as the validation of the
method showed (Paper I) the centre of nerve co-ordinates were not sensitive for
variation within 10% of the threshold level. In Paper IV, the threshold was
determined by the mean of a ROI placed in the corresponding non-injured hemi-
sphere. Enhanced areas (T1-weighted images) and reduced T2 areas (T2-maps)
were deﬁned to be above and below 1 SD of the mean, respectively. The use of
a large ROI made the determination of the threshold level less sensitive of the
exact positioning of the ROI.
During data acquisition, thermal noise enters the signal and ad to the intrinsic
object noise formed by the statistical behaviour of the spin populations [111]. The
noise is generally known to be characterized by a zero mean Gaussian probability
function which is transformed into a Rice probability function after reconstruc-
tion of the complex MR signal into a magnitude image [90]. Because of noise,
some voxels may wrongly be included in the binarised image after applying a
threshold. In Paper I and Paper II, 6-connected region growing was applied to
the binarised 3D image to segment theMn2+ enhanced ON. This included only
voxels where neighbouring voxel faces touched as expected in the ON which is
a heavily elongated object. Wrongly included voxels because of noise showed a
more random spatial distribution appearing either alone or in groups connected
by edges and corners in addition to faces. 6-connected region growing omitted
the corner- and edge-connected voxels and resulted in a smooth segmented nerve
(Figure 5, Paper I). In Paper II the method was applied to detect axon regen-
eration after ON nerve crush and intravitreal implantation of a peripheral nerve
graft (PNG). The use of PNG in this model results in few percent regeneration
of axons [9] and a small but signiﬁcant increase of CNR was detected beyond
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the crush 21 dpl (Paper II, Figure 7). Because of few regenerating axons the
MEMRI signal in the regenerating area was small and close to the noise. Low
signal MEMRI voxels wrongly omitted by 6-connected region growing may have
been included in the segmented nerve if 18- or 26-connected region growing had
been applied. However, the contrast was calculated based on re-sampled slices
perpendicular to the nerve which was independent of the choice of connectivity.
Higher degree of connectivity may have leaded to longer part of the ON being
segmented but also increased the risk for including noise voxels in the deﬁnition
of the segmented ON.
In Paper III, the dynamic changes in MEMRI signal along the ON was inves-
tigated which included the low MEMRI signal from the ﬁrst time points after
intravitreal Mn2+ injections. The weak MEMRI signal at these time points gave
unreliable segmentation results and the ON was therefore manually identiﬁed in
the image volume. This was also the case for the EPI-DTI data in Paper II
where the segmentation method also failed to give reliable results because of the
image artefacts. EPI is prone to several artefacts such as chemical shift and eddy
current in addition to distortions due to ﬁeld inhomogeneity and magnetic sus-
ceptibility variations. SE-DTI may have produced maps with suﬃcient quality
for the segmentation procedure to work but because of the long scan time [95]
this technique was diﬃcult to combine with the other MRI protocol in the study.
A surface coil was used for signal detection. The advantage of a small surface
coil is the high sensitivity close to the coil and the small volume form where noise
is received, both of which contribute to a good SNR. However, the sensitivity
is highly inhomogeneous and results in a gradually decreased tissue signal as
a function of distance form the coil [17]. This leads to gradients in the image
which may impact both segmentation and calculation of CNR. In Paper I, no
corrections of the image gradients before segmentation were made but this did
not aﬀect the segmentation of the ON because of the high MEMRI signal in the
enhanced nerve. In Paper II and Paper IV, low resolution correction scans were
used to correct for the image gradients. This was important in order to segment
the low MEMRI signal from the regenerating axons (Paper II) and areas with low
Mn2+ accumulation (Paper IV) which else may have been below the threshold and
not included for further analysis. The rat ON projects ventrally from the retina
towards the optic chiasm away from the dorsally located surface coil which result
in a gradually reduced signal along the ON. In Paper I, this was corrected for by
using a linear regression model based on non-enhanced ON data when calculating
CNR proﬁles. However, the signal do probably not vary linearly along the ON,
both because the surface coil ﬁeld does not vary linearly [107] and because the
ON curves from the retina towards the optic chiasm (Paper 1, Figure 5a). As
a result of the linear approximation, the CNR curves presented in Paper I may
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include variations caused by the surface coil. In Paper III, the signal variation
along the ON was corrected by subtracting the mean signal from the ON (n=5)
before intravitreal MnCl2 injection. Since these data were obtained almost in
the same positions as the Mn2+ enhanced data relative to the surface coil the
result was not susceptible spatial change in the coil ﬁeld as we could expect if
we used data from the contralateral non-enhanced ON. The use of low resolution
correction scans in Paper II and Paper IV removed the gradients in the images
caused by the coil.
In pure water, the relaxation rate 1T1 is a linear function of the concentration
of a contrast agent [50]. T1-mapping which gives the true T1 value in tissue
[17, 38] therefore yield a method for studying absolute Mn2+ tissue concentration.
However, a reliable 3D T1-maping sequence was not available for use in this
project. Instead, 3D T1-weighted imaging was used in the MEMRI studies where
CNR can be used to estimate Mn2+ temporospatial variations since it reﬂects the
diﬀerence between enhanced and non-enhanced tissue . In Paper I and Paper II,
ON CNR curves were made based the segmented Mn2+ enhanced ON and the
mean SI in a ROI manually placed in the non-enhanced ON. As discussed above,
manually placing a small ROI in the non-enhanced ON may induce errors in the
estimate of the non-enhanced ON signal. Correct calculation of CNR was crucial
in detecting nerve damage (Paper II) where a too high or too low CNR in and
beyond the ON crush could lead to opposite conclusions. However, the result
from the segmentation and CNR calculation was supported by both histology
and visual inspection, but the CNR sensitivity to errors in the estimation of the
enhanced and non-enhanced signal should be considered in these types of studies.
In Paper III, signal intensity (SI) was used to estimate Mn2+ temporospatial vari-
ations. There are two main issues to take into considerations when comparing
changes in SI between diﬀerent animals at diﬀerent time points and approxi-
mating SI to Mn2+ concentration: 1), SI is a dimensionless quantity resulting
from the number of spins which have been manipulated and their coupling to the
coil, and scaling during image reconstruction; and 2), in a T1-weighted sequence
change in SI is not linearly related to changes in Mn2+ concentration. Regarding
the ﬁrst point, diﬀerent sequence settings such as TR, TE and geometry, as well
as changes in subject shape, size, mass and positioning within the magnet will
alter the SI. SI is also sensitive to changes in tuning and matching of the coil,
receiver gain, inhomogeneities the excitation ﬁeld (B1) and reception coil sensi-
tivity, and is independently rescaled during reconstruction for each scan. In this
study all sequence settings were identical in each scan, and equally sized animals
were put in the same position within the magnet. Diﬀerences in receiver gain
and reconstruction scaling were corrected and tuning and matching performed
equally, but spatial variations in the local reception coil sensitivity were not cor-
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rected and the B1 ﬁeld was not mapped to check for B1 homogeneity. Those
parameters could aﬀect our results but, since we compare SI at the same posi-
tions relative to the magnet iso-centre, these eﬀects mainly represent a systematic
error and do not play an important role in the dynamic changes. Regarding the
second point, we assumed that changes in SI were proportional to changes in the
Mn2+ concentration. This approximation is only true for small variations but, for
larger variations, SI tends to underestimate Mn2+ variations. The approximation
probably holds for the changes we observe in the ON, but early time points of
the vitreous body data were probably in the non-linear regime and may have
inﬂuenced the estimation of the time constant for vitreal clearance used in the
input functions. However, our conclusions are based on the overall shape of the
input function rather than small changes the time constant for the exponential
decay.
In Paper IV, stained areas in histology images where segmented and compared
with Mn2+ enhanced areas in T1-weigted images after co-registration of the im-
ages. The segmented colours were based on the colours within a sample ROI rep-
resentative to the coloured areas of interest. Since the ROI was placed manually
the selected colour sample was sensitive to user errors and may have inﬂuenced
the results. The segmented area was aligned with the T1-weigted image using
a piecewise linear transform. Event though the transform can handle local geo-
metrical distortions [34], alignment of large distortions is sensitive to the number
and positioning of the landmarks. An example of large local distortion can be
seen in Paper IV Figure 7 where part of the cortex which in HI animals in vivo
was supported by cystic tissue, ex vivo have moved substantially. This eﬀect
might have contributed to misalignment of part of the images. However, a visual
inspection was carried out in every case to validate the result.
5.3 Intracellular manganese
Mn2+ enters the cells through voltage gated Ca2+-channels [60] and the use of
the Ca2+-channel blocker diltiazem has shown to reduce uptake of Mn2+ [70]. In
Paper I, the T1 contrast agents MnCl2, manganese dipyridoxcyl monophosphate
(MnDPDP) and gadodiamide (Gd3+) were injected intravitreally. Both MnCl2
and MnDPDP which probably released Mn2+ through transmetallization with
intraocular zinc (Zn) [46, 101] gave enhancement in the retina, ciliary body and
ON, while no enhancement in these areas was seen with Gd3+. This supported
the hypothesis on speciﬁc uptake rather than unspeciﬁc uptake like pinocytosis.
Ca2+-channels have an ion turnover rate of approximately 3 · 106 Ca2+ ions/s
[103] which means that there is a plateau of ion transport into the cell. In Pa-
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per III, model optimization of time and spatial resolved MEMRI data detected
a plateau of Mn2+ input into the ON after intravitreal injection. However, the
plateau could also be due to restricted input of Mn2+ into the axons, e.g. re-
stricted Mn2+ vesicle packing, or a combination of both. To our knowledge this
is the ﬁrst time such a plateau is detected.
The existence of a plateau was supported by simulations of dose-concentration
relationship in the ON which showed a semi-logarithmic relationship between the
doses of intravitreal injected Mn2+ and ON Mn2+ concentration when restricted
Mn2+ input was assumed, while the relationship was linear if we assumed a Mn2+
concentration dependent input (Paper III, Figure 8). A semi-logarithmic rela-
tionship between intravitreal Mn2+ dose and ON CNR has earlier been reported
from in-vivo MEMRI of the rat visual system by Thuen et al. [98]. The exis-
tence of a plateau of maximum Mn2+ input into the ON suggest that increased
ON signal enhancement observed with increased dose [98] is a consequence of a
greater duration of Mn2+ availability when large doses are used. As a conse-
quence, the Mn2+ exposure can be greatly reduced by using a slow release low
dose contrast agent with a release rate tuned to the uptake threshold, and ON
signal enhancement may even be improved if the contrast agent release time is
increased.
After entering the cell, Mn2+ complex with other molecules or enter subcellular
compartments for axonal transport [7] like mitochondria and vesicles. Mitochon-
dria travel slowly (0.18-1.08 mm/h) [84] while neural vesicles may travel as fast as
18 mm/h [104]. Mn2+ may enter several of these compartments, and thus travel
at various velocities in the same axon [7]. The transport model optimization in
Paper III forced the centre of all tested velocity distributions towards zero which
indicated a high density of slow transporters. This may indicate a high degree
of transport in mitochondria. However, the two transport models which ﬁtted
the data best both supported inﬁnitesimal velocity components which means
that even slower velocities than reported for mitochondria seemed to be involved.
This could include slow transport, but an alternative hypothesis is that Mn2+
is loosely bound during transport fall oﬀ and re-enter transporters which create
apparent velocities diﬀerent from the genuine transporter velocities, e.g. vesicle
and mitochondria transport velocities.
5.4 Conclusion
Methods for segmentation of axons and brain tissue with manganese accumu-
lation together with methods for quantiﬁcation of signal- and contrast changes
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along axons related to manganese accumulation and transport have been estab-
lished. The methods have enabled more reliable in vivo studies of axonal damage
and repair in parts of the CNS and provided more profound knowledge about ax-
onal manganese transport kinetics, as well as novel insight into the relationship
between manganese enhancement and neural death related to ischemic insult in
the neonatal brain.
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Abstract 
Purpose: 1) To evaluate a novel theoretical model for in vivo axonal Mn2+ transport with 
MRI data from the rat optic nerve (ON), and 2); to compare predictions from the new model 
with previously reported experimental data. 
Materials and Methods: Time resolved in vivo T1 weighted MRI of adult female Sprague 
Dowley rat (n=9) ON was obtained at different time points after intravitreal MnCl2-injection. 
A concentration dependent and a rate dependent function for the Mn2+ retinal ganglion cell 
(RGC) axon entrance were convolved with three different transport functions and each model 
system was optimized to fit the ON data. 
Results: The rate-limited input function gave a better fit to the data than the concentration-
limited input. Simulations showed that the rate-limited input leads to a semi-logarithmic 
relationship between injected dose and Mn2+ concentration in the ON, which is in agreement 
with previously reported in vivo experiments. A random walk transport model and an 
anterograde predominant slow model gave similar fit to the data, both better than an 
anterograde predominant fast model. 
Conclusion: The results indicate that Mn2+ input into RGC axons is limited by a maximum 
entrance rate into the axons. Also, a wide range of apparent Mn2+ transport rates seems to be 
involved, different from synaptic vesicles transport rates, meaning that manganese does not 
depict synaptic vesicle transport rates directly. 
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Introduction 
In neurons many proteins are synthesised in the cell body and transported along axons by 
molecular motors. Kinesin and dynein motor proteins generate force and move along 
microtubules carrying protein cargos; Kinesin travels from the cell body towards the synapse 
(anterograde direction) while dynein travels towards the cell body (retrograde direction) (1). 
In many major human neurodegenerative diseases such as Alzheimer’s and Parkinson’s 
disease disruption of the transport processes is an early significant event in the aetiology (2). 
 
Various substances move at different rates independently of the electrical activity within the 
axons (3,4) and are grouped in fast and slow components with speeds of approximately 4-
16mm/h and 4-250μm/h respectively in the healthy axon, (3,5). The same “fast” molecular 
motors are involved in both fast and slow axonal transport, but during slow axonal transport 
there are prolonged pauses between periods of movements (6,7). Axon transport of 
radioactive, fluorescent and non-fluorescent tracers is the basis of axon tracing and may be 
specific for either antero- or retrograde transport. However, most techniques require tissue 
sampling (8) and are therefore unsuited for longitudinal real time in vivo studies. 
 
Rat optic nerve (ON) axons arise from retinal ganglion cells (RGC) in the eye and project 
towards the optic chiasm and project through the contralateral optic tract to the superior 
colliculus (SC) in the mid brain. Hence, ON anterograde transport is from the eye and towards 
the SC while ON retrograde transport is directed towards the eye. The vitreous body makes a 
well defined and easily accessible chamber for tracer injection from where a tracer can access 
the RGC and be transported in their axons in the ON. The uniform orientation of the 
trajectory of RGC axons in the ON and optic tract makes the visual pathway well suited for 
axonal transport studies.  
 
Pautler et al. introduced manganese enhanced MRI (MEMRI)  as an in vivo anterograde 
central nervous system (CNS) tract tracing technique by injecting an unchelated manganese 
chloride (MnCl2) solution into the vitreous body of the mouse eye (9). Since then, MEMRI 
has become an established technique for in vivo anatomical CNS tract tracing in various 
animal models (9-13) and has recently been extended to dynamic tracing (14-16). MEMRI 
utilizes the paramagnetic property of the manganese ion (Mn2+) and takes advantage of Mn2+ 
being a calcium (Ca2+) analogue in biological systems. Mn2+ gives positive contrast on T1-
weigthed images and enters cells through voltage gated Ca2+ channels on the cell membrane 
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(17). A working hypothesis for Mn2+ transport is that Mn2+ is packaged into vesicles and 
transported anterogradely along axonal microtubules (18) and released into the synaptic cleft 
for thereafter to enter post synaptic neurons through voltage gated Ca2+ channels (11,19).  
 
One way to describe the Mn2+ transport processes is to use the analogy of vesicles being 
carried on transport belts running in anterograde and retrograde directions. If Mn2+ is bound to 
vesicles until it reaches the synapse, the transport will be described as convection-like with 
either 1) a single velocity if all transport belts run at the same speed or 2), a mean velocity 
with dispersion if the transport belts run in the same direction at different speeds. However, if 
Mn2+ are loosely bound to the vesicles, detach during transport and re-bind to cargo on the 
anterograde and/or retrograde running transport belts, the transport resembles that of random 
walk, also called Brownian motion or diffusion. However, note that the diffusion coefficient 
now is not that of the Brownian motion of free ions, but rather an apparent or effective 
transport coefficient.  
 
Even though Mn2+ CNS axonal transport rates have been reported in various studies (9-13,16) 
a more thorough investigation of Mn2+ transport which addresses issues like entering of Mn2+ 
into axons, multiple transport rates and axonal clearance are needed before MEMRI has 
application in in vivo studies of neurodegenerative diseases. The previous studies have used 
two time points and positions to estimate transport rates while several positions and time 
points are needed to reveal multiple transport rates. 
 
The response of ON contrast to various intravitreal Mn2+ doses has been investigated by 
Thuen et al (20) and a semi-logarithmic relationship between intravitreal Mn2+ dose and ON 
contrast to noise ratio (CNR) has been found. However, the transport mechanisms governing 
this semi-logarithmic relationship are unknown. 
 
The aims of the present study were to: 1) To evaluate a novel theoretical model for in vivo 
axonal Mn2+ transport with MRI data from the rat optic nerve, and 2); to compare predictions 
from the new model with previously reported experimental data. 
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Materials and Methods 
Animals 
Adult female Sprague Dowley rats (n=9) (~200g) were kept in a pathological-free 
environment on a 12:12 light:dark hours (h) cycle and allowed free access to food and water. 
All experimental procedures were performed using isoflurane gas anaesthesia (3.5% induction 
and 1.5% maintenance). Animal experiments were conducted in accordance to the National 
Ethics Committee for Animal Research approved by the responsible governmental authority. 
Intravitreal Mn2+ injections 
Anesthetized animals were placed in a purpose-built head frame and 3µl of a non-toxic dose 
of 150nmol MnCl2 was injected through the sclera posterior to the ora serrata of the left eye 
using a purpose-built injection device consisting of a plastic syringe connected via 
polyethylene tubing to a glass micropipette with a tip diameter of ~50μm. After the injection 
the pipette was slowly withdrawn to minimize reflux (21). 
Experimental design 
Time resolved (15min resolution) in vivo MRI was obtained before MnCl2-injection and in 
the periods 0-6h, 12-30h, 42-44h and 46-48h after MnCl2-injection. Each animal was in the 
scanner for 2h and eyes were lubricated with Simplex (Ophtha AS, Copenhagen, Denmark) to 
counteract corneal dehydration. In order to cover the time spans, each animal was scanned 2-4 
times throughout the 48h period. For the time period 0-6h 2-4 animals were used to increase 
the signal to noise ratio (SNR) at each time point while for all other time points one animal 
was used. More details of the experimental design are given in Figure 1. 
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Figure 1: a: The ON was sampled with 0.4 mm resolution from the retina to the optic chiasm every 
15min. Data from 3.5mm to 9.5 mm were used in the analysis. b: To cover the first 6h of Mn2+ 
transport 2-4 animals were used (0-2h: n=3, 2-4h: n=4 and 4-6h: n=2), while for the 12-30h period 
one animal was used for each time point with overlapping time slots.   
 
MEMRI 
MEMRI was performed at 7T using a Bruker Biospec Avance 70/20 (Bruker Biospin, 
Ettlingen, Germany) with Water-cooled BGA-12 (400mT/m) gradients. A 72mm volume coil 
was used for transmission and an actively decoupled quadrature rat head surface coil was used 
for receive-only. During scanning, the anesthetized rats lay prone in a dedicated animal bed 
heated with circulating water at 37°C. To plan a 3D data set, a gradient-echo pilot scan 
consisting of three orthogonal slice packages (five slices per package) was obtained using 
field of view (FOV) =5x5cm2, matrix =128x128, repetition time (TR) =200ms, and echo time 
(TE)=5ms.  
 
The 3D dataset was obtained using a centric reordered saturation recovery turbo-FLASH 
sequence, with saturation delay=500ms, flip angle=15°, TE/TR=2.7/9.25ms, echo train length 
445ms and number of segments=4. An oblique acquisition matrix of 192x192x66 voxels was 
placed 45° to the rostral-caudal direction. With a field of view of 3.5x3.5x2.64cm3, the 
resolution was 182x182x400μm2. The sequence was repeated every 15min over the 2h period 
the animal was in the scanner. 
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Image processing 
The co-ordinates of the centre of the left ON were manually identified in each slice 
perpendicular to the nerve from the retina to the optic chiasm. The set of co-ordinates were re-
sampled with 0.2mm resolution by tri-linear interpolation which gave an intensity curve of the 
ON for each scan. The intensities were normalized to the signal from a ROI placed in tissue in 
the same anatomical position in each animal and integrated in 1mm steps. Data from the 12-
48h period were averaged along the time dimension (45min window size) to increase signal to 
noise ratio. To construct approximated Mn2+ concentration curves, SIc(x), a mean intensity 
curve of ON data before Mn2+ injection was calculated and subtracted from the post Mn2+ 
injection curves.  The approximated Mn2+ concentration curves were placed in a position-time 
matrix, SIc(x,t), for model fitting. In addition, the vitreous body intensity was extracted and 
normalized, and the time constant for vitreal clearance was calculated based on a mono-
exponential fit to the vitreous body data. The data were post processed using Matlab® (R14 
SP3, MathWorks Inc., Natick MA, USA). 
Description of the Mn2+ transport model system 
The model system we used consisted of three elements as shown in Figure 2: 1), the vitreous 
body and retina, where Mn2+ is initially injected and subsequently cleared through blood 
vessels and transport into the RGC axons; 2) The input function u(t) describing how Mn2+ 
enters the RGC axon as a function of time, and 3), the ON in which the Mn2+ is transported 
along RGC axons.  The ON is mathematically represented by a transport function p(x,t) 
describing how an input of Mn2+ at time zero is transported and distributed along the ON at all 
later time points. This transport function is analogous to what is often referred to as the 
impulse response or Green’s function of a system. The total Mn2+ concentration cmod(x,t) along 
the ON at any time point is then given by the mathematical convolution between the input 
function and the transport function, as shown in Eq.1: 
 
 mod
0
( , ) ( ) ( , )
t
c x t a u p x t dτ τ τ= −∫  (1) 
 
where a is a scaling factor which includes the dose of injected Mn2+ and the cross-sectional 
area of the ON. The scaling factor was included in the input function in the parameter 
optimization. For Eq.1 to be valid, one must assume that the biological system is both linear 
and time-invariant. 
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Figure 2: After injection of MnCl2 into the vitreous body, intravitreal Mn2+ concentration gradually 
decreases as Mn2+ enters the retina (retinal compartment) by diffusion and then passes through Ca2+ 
channels to enter RGC. Entering of Mn2+ into RGC axons is described by the input function u(t) where 
the input could either be Mn2+ concentration dependent, or uptake rate dependent. Inside RGC axons, 
the transport is described by the transport function p(x,t). ON clearance is described by an 
exponential decay function with time constant τClearance. The ON Mn2+ concentration is given by the 
mathematical convolution of the input function and the transport function. 
Vitreal clearance 
A mono-exponential fit was made to the vitreous body time-intensity curve to obtain the 
vitreous body clearance rate. Data points in the interval 0 – 30min were excluded to allow 
Mn2+ to distribute in the vitreous body.  
Input functions 
Two input functions were evaluated. 1): The concentration-dependent input function which 
equalled the Mn2+ concentration time-curve in the vitreous body as found from the above 
mono-exponential fit. This describes the case where the entrance of Mn2+ is determined by the 
available amount of Mn2+, i.e. the Mn2+ concentration. 2): The rate-dependent input function 
which is constant for a given time followed by a mono-exponential decay. This describes the 
case when the uptake of Mn2+ into the RGC axons is limited by a maximum rate. The same 
time-constant as for vitreal clearance of Mn2+ was used to describe the mono-exponential 
decay part of this input function.  
Transport functions 
Three different transport functions were tested: A), Single component anterograde convection 
together with random walk and clearance as described in (15) and (16); B) Pure anterograde 
convection with a majority of fast velocity components, and C) Pure anterograde convection 
with a majority of slow velocity components. Transport function A was recently used in 
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studies of age-related axonal transport rates (16) and Alzheimer’s disease (15) and describes 
loosely bound Mn2 in a uniform translation with a single velocity in one direction and random 
walk transport in both directions. For functions B and C a distribution of velocities was 
assumed instead of single components. As transport function B the Rice distribution was used 
(Figure 3a), which has very few components close to zero even for the minimum average 
velocity. For higher average velocity it resembles a Gaussian distribution. As transport 
function C an exponential velocity distribution was used, which has the majority of velocity 
components towards zero (Figure 3a). See Appendix A for more details. 
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Figure 3: a: Velocity distributions of transport functions B and C with mean velocity 2mm/h. 
Transport model B has very few components close to zero while transport function C has the majority 
of velocity components towards zero. Transport function A consisted of a single velocity with bi-
directional random walk and as such, did not have a specific distribution of velocities b: Plot of 
transport functions A, B and C with comparable model parameters. The curves describe the 
concentration as a function of time at a given position x1 in the ON after an instantaneous injection of 
Mn2+. c: The concentration dependent input function. d: The rate dependent input function. e: 
Simulated concentration curves from the convolution of transport functions (b) and the concentration 
limited input function (c). f: Simulated concentration curves from the convolution of transport models 
(b) and the rate limited input function (d). 
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Model prediction of two-point velocity and dose-concentration relationship 
The injected dose of Mn2+, the input function and the transport function determine how the 
Mn2+ concentration in the ON develops (Eq.1). Figure 3 b-f show a simulation of how the 
convolution of the transport functions A, B and C with the concentration dependent and the 
rate dependent input functions generates different concentration curves after an arbitrary dose 
of Mn2+. We simulated ON Mn2+ concentration for eight different intravitreal Mn2+ doses to 
investigate the model predictions of dose-concentration relationship in the ON 3mm from the 
retina 24h after intravitreal Mn2+ injection.  
 
The two-point method used in previous studies to estimate apparent transport velocity was 
based on measurements of the time taken for the MEMRI signal to reach a specific level (e.g. 
detection level) at a given position from the Mn2+ injection site, or at two different positions. 
We applied the two-point method to the modelled ON concentration curves at three different 
positions and levels of Mn2+ concentrations to compare our models with previous data and to 
investigate if choice of detection level and spacing of measurements would impact the results. 
Model fitting 
Data from the first part of the ON (0-3.5mm) and beyond 9.5mm were excluded from the fit 
because of motion artefacts close to the eye and to avoid the optic chiasm (~10mm) where the 
ON from both eyes meet and the axon density within each voxel probably change.  
 
The models (Appendix A: Eq.6 - Eq.8) were fitted to the ON data SIc(x,t) by optimizing the 
model parameters in order to minimize the L1 and L2 norm. Generally, the Lp norm is given 
by: 
 
1
mod
,
[ ( , ) ( , )] 1
p
p
p i j c i j
i j
L abs c x t SI x t p
⎛ ⎞= − ≥⎜ ⎟⎝ ⎠∑  (2) 
The norm described the difference between the observed data and a model, and the optimized 
model which gave the smallest norm (difference) fitted the data best. The L2 norm (p=2) 
equals the least square fit but is more sensitive to outliers than the L1 norm. Both norms were 
used to evaluate the impact of choice of norm on the optimized model parameters. The 
optimizing was done using a build-in Matlab routine which utilizes the Nelder-Mead simplex 
method (22). The search was repeated 50 times for each model with randomly selected initial 
conditions to increase the probability of finding the global minimum. The mean and standard 
deviation (SD) of the seven best sets of model parameters (smallest L1/L2 norms) were 
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calculated. The SD reflects the variation of estimated model parameters as a function of initial 
conditions and SD = 0 indicates that the global minimum has been found while a large SD 
indicates one or several local minima among the seven best fits. The fits were also inspected 
visually since even though a small norm indicates a good overall fit, parts of the fit may not 
describe the data well. 
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Figure 4: MRI of left eye and ON before (a) 
and 30min (b), 3h (c) and 5h (d) after 
intravitreal injection of 3µl 50nM MnCl2. The 
enhancement in the vitreous body (1) gradually 
decreased as Mn2+ enhancement increased 
along the ON (2-4). 
Figure 5: Mono-exponential fit to the vitreous 
body data time intensity curve. 
Results 
 
Figure 4 shows example MR images of the 
eye and ON before, and at different time 
points after intravitreal injection of MnCl2 
into the vitreous body. While the 
intravitreal Mn2+ concentration gradually 
decreased, Mn2+ entered the RGC axons 
and were transported along the ON. 
Vitreal clearance 
The vitreous body data are plotted as 
function of time in Figure 5. The mono-
exponential fit to the vitreous body data 
gave a time constant for vitreous body Mn2+ 
clearance of 2.46h. 
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Input functions 
Figure 6 shows the best fit of model to data for transport function A convolved with the 
concentration-dependent and the rate-dependent input functions. For the concentration 
dependent input function, the model (solid line) overestimated the Mn2+ concentration close to 
the retina (Figure 6b) while underestimating the Mn2+ concentration further away from the 
retina (Figure 6d) over the first 10h after MnCl2 injection. For the rate dependent input 
function, the model gave a better fit along the whole ON (3.5mm-9.5mm) (Figure 6f-h) at 
early time points. The results were similar when using transport functions B and C. 
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Figure 6: b-d: Best fit for transport function A with the concentration dependent input function (a). 
Note how the model (solid line) rises too fast compared to the data (open dots) 3.5mm from the retina 
(b) while it rises too slow at 8.5mm from the retina (d) over the first 10h after MnCl2 injection. At 
5.5mm from the retina, the model fits the data well (c). f-h: Best fit of transport function A together 
with the rate dependent input function (e). 
 
Transport functions 
The convolution of three different transport functions with to different input functions 
generated six transport models. Transport function A, B and C convolved with the rate 
dependent input function constituted transport model A, B and C, respectively, while 
convolved with the concentration dependent input function, transport model A, B and C 
constituted transport model D, E and F. Table 1 gives the L1 and L2 optimized model 
parameters for the different models and Figure 7 shows the best fit of model A, B and C at 
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3.5, 5.5, 7.5 and 9.5mm from the retina. Table 2 gives apparent transport velocities for the L2 
optimized models A, B and C based on the two-point method used in previous studies. 
 
Table 1 Summary of the results from model fitting with the rate dependent and concentration 
dependent input function. The numbers indicate the mean of the seven best sets of model parameters 
with standard deviations in brackets. 
v b ( % SD)  D c (% SD)  σ d (%SD) τclearancee (%SD)  tadmission
f 
(%SD)  
Input 
function 
Transport 
function 
Transport 
model 
Norm a 
(% SD) 
(mm/h) (mm2/h) (mm/h) (h) (h) 
   L1 L2 L1 L2 L1 L2 L1 L2 L1 L2 L1 L2 
A A 
21.7 
(0.3) 
1.67 
(0.4) 
0.01 
(264) 
0.00 
(185) 
57.8 
(33) 
30.5 
(21.5) 
- - 
86.1 
(19.5) 
110 
(36.4) 
13.2 
(9.6) 
11.2 
(5.8) 
B B 
27.2 
(0.9) 
2.02 
(1.1) 
0.15 
(246) 
0.28 
(154) 
- - 
2.78 
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b Mean velocity except for the convection random walk model which includes only a single velocity 
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d Velocity dispersion parameter 
e Time constant for exponential clearance of Mn2+ from the ON 
f Time of constant entry of Mn2+ into RGC axons 
 
The model fitting resulted in the smallest L1 norm for model C (L1=21.5) which was only 
slightly better than model A (L1=21.7). The L2 norm optimization gave the smallest norm for 
model A (L2=1.67) while model B had larger norms than both model A and C (L1=27.2/ 
L2=2.02). The L1 and L2 norms for model D, E and F were larger than any of the 
corresponding norms of model A, B or C. The mean transport velocity was ~11mm/h for 
model C while both model A and B gave a velocity parameter close to zero. Note that this 
does not indicate zero transport but the centre of the velocity distributions. L1 and L2 
optimization resulted in similar model parameters except for the apparent diffusion coefficient 
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D (random walk transport coefficient) where L1 and L2 -optimization differed almost by a 
factor of two (D=57.8mm2/h and D=30.5mm2/h, respectively).  
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Figure 7: Best fit for transport models A, B and C at 3.5, 5.5, 7.5 and 9.5mm from the retina based on 
L2 optimization. 
 
Table 2 Apparent transport velocities based on the time to reach various optic nerve Mn2+ 
concentrations at 3.5mm, 5.5mm and 7.5mm from the retina (L2 optimized data). 
Optic nerve Mn2+ 
concentration 
Time (t) to reach Mn2+ concentration at a 
given positiona (h) 
Apparent velocity  
(mm/h) 
Apparent Velocity 
(mm/h) 
Transport 
model 
(arbitrary units) a=3.5 mm b=5.5mm c=7.5mm a/t b/t c/t (b-a)/Δt (c-b)/ Δt 
0,2 1,33 1,93 2,59 2,6 2,8 2,9 3,3 3,0 
0,4 3,53 4,61 5,77 1,0 1,2 1,3 1,9 1,7 A 
0,5 5,02 6,35 7,77 0,7 0,9 1,0 1,5 1,4 
0,2 1,11 1,74 2,38 3,2 3,2 3,2 3,2 3,2 
0,4 2,05 3,22 4,41 1,7 1,7 1,7 1,7 1,7 B 
0,5 3,10 4,88 6,66 1,1 1,1 1,1 1,1 1,1 
0,2 1,05 1,66 2,26 3,3 3,3 3,3 3,3 3,3 
0,4 3,40 5,33 7,27 1,0 1,0 1,0 1,0 1,0 C 
0,5 5,78 9,08 12,38 0,6 0,6 0,6 0,6 0,6 
 
a Positions along the optic nerve measured from the retina 
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Model prediction of dose-concentration relationship 
Figure 8 show the simulated Mn2+ concentrations in the ON 3mm from the retina 24h after 
intravitreal Mn2+ injection for a given set of comparable model parameters. The simulations 
showed a linear relationship between intravitreal Mn2+ dose and ON Mn2+ concentration 24h 
after intravitreal injection when the concentration dependent input function was used. The rate 
dependent input function resulted in near semi-logarithmic relationship between intravitreal 
dose and ON Mn2+ concentration. 
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Figure 8: Simulated Mn2+ concentrations in the ON 3mm from the retina 24h after intravitreal Mn2+ 
injection using doses 1, 2, 10, 20, 30, 40, 50 and 60 times an arbitrary reference dose and comparable 
model parameters. Simulations with the rate dependent input function and transport function A, B and 
C gave a semi-logarithmic relationship (R2=0.99,  R2=0.98 and R2=0.97 for transport function A, B 
and C, respectively), while simulations with the concentration dependent input function showed a 
linear relationship between intravitreal Mn2+ dose and ON Mn2+ concentration (R2=1.00 for all 
transport functions). Similar results were obtained within a range of model parameters, including the 
optimized parameters from the model fitting. 
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Discussion 
The main result from this study is that the input of Mn2+ into RGC axons seems to be limited 
by a maximum entrance rate rather than the vitreal concentration of Mn2+. This conclusion is 
supported both by the model fitting to the experimental data in this study and the simulations 
of the dose-concentration relationship. A semi-logarithmic relationship between intravitreal 
Mn2+ dose and ON contrast to noise ratio (CNR) has earlier been reported from in vivo 
MEMRI of the rat visual system by Thuen et al. (20) and correspond well with our 
simulations with a rate dependent input function (Figure 8). The L1 and L2 norm from the 
model optimization clearly indicated that the rate limited input function gave best fit (Table 
1).  
 
The input of Mn2+ into RGC is through voltage gated Ca2+ channels, but little is known about 
transit time of Mn2+ in RGC somata before axon transportation. Neither is it known if Mn2+ 
accumulates in RGC somata before/while it is transported in axons nor if it is a linear 
relationship between Mn2+ entering RGC and the transport of Mn2+ away from the cell body 
by anterograde axonal transport. The limited input of Mn2+ into the ON could be caused either 
by restricted Mn2+ vesicle packing in RGC somata, or by restricted Mn2+ transport through the 
voltage gated Ca2+ channels, or a combination of the two. Ca2+ channels have an ion turnover 
rate of approximately 3⋅106 Ca2+ ions/s (23) which means that there is a plateau of ion 
transport into the cell which could account for the observed restricted input. The time of 
which the retina is enhanced after vitreal clearance may indicate intracellular retinal storage of 
Mn2+ which could mean that the rate limited input we observe is caused by restricted Mn2+ 
vesicle packing. Future work should include a more comprehensive and detailed analysis of 
these mechanisms.  
 
An interesting and important observation from the above finding is that is not the injected 
dose as such that determines the degree of manganese enhancement in the ON, but the 
duration of which Mn2+ is available from the vitreous body. The toxicity of Manganese is well 
known and limits the dose used in MEMRI (21). If indeed the manganese enhancement is 
uptake rate limited, one should be able to achieve increased manganese enhancement by using 
a slow release contrast agent with a release rate tuned to the uptake threshold, and at the same 
time maintain the local concentration safely below toxic levels. Moreover, this result suggests 
that changes in dose-contrast relationship can be used to reveal information on how 
neurodegenerative diseases affect the entering mechanisms of Mn2+ into RGC axons. 
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For the three different transport functions the results are less conclusive  For model A, which 
consisted of a single velocity convective component together with random walk and a 
clearance factor, the best fit was found when the convection velocity was set to zero and the 
clearance time constant was set to around 100 h. In practice this means that model A was 
reduced to a pure random-walk model with an effective diffusion constant in the range 30-60 
mm2/h. Model A had the smallest L2-norm but the large SD for the optimized parameters 
which indicated several local minima among the seven best fits.  For model B, which 
consisted of pure anterograde convection with a rician distribution of velocities, the best fit 
was found for a mean and dispersion velocity of 0.15-0.28 mm/h and 2.78-2.85 mm/h 
respectively. Also here, large SD of the optimized mean velocity indicates that there was not a 
stable global minimum for this model. For model C, which consisted of pure anterograde 
convection with an exponential distribution of velocities, the best fit was found for a mean 
velocity of 10-12 mm/h. Model C had the smallest L1-norm (Table 1) and explained the data 
with only one transport parameter (mean velocity) which is one parameter less than Model A 
and B. From a modelling viewpoint this is an attractive feature. Overall, model A and model 
C both described the data reasonably well, although they are based on different transport 
functions. We interpret this as being a result of limited temporal and spatial extent in the 
experimental data.  
 
The optimized versions of both model A and model C involves a combination of slow and fast 
transport, although the detailed velocities and mechanisms involved cannot be extracted from 
this study. Furthermore, model B which involved a mean velocity with a gaussian spread was 
forced into a regime where it had a broad distribution of velocities. Hence none of the 
optimized models supports an interpretation where the transport velocity is well defined, as it 
would be if Mn2+ is tightly bound to its cargo. On the other hand, the observed  wide range of 
effective velocities is in agreement with a transport process where Mn2+ are loosely bound 
during transport, fall off, and then re-bind to either anterograde only moving cargos (model C) 
or both anterograde and retrograde moving cargos (model A).  
 
The apparent transport velocities for model A, B and C estimated with the two-point method 
(Table 2) showed that the reference level was an important factor as the apparent transport 
velocity increased as the reference level decreased. This could account for some of the spread 
  18 
of reported apparent Mn+2 transport velocities in CNS axons estimated as 2.8mm/h in rat ON 
(13), 2mm/h in the mouse ON  (9), 2.1-2.6mm/h and 4.6-6.1mm/h in the rat (sub)cortical 
structures and corticofugal pathways (10), 4mm/h in the rat olfactory bulb (16), 0.64-
1.42mm/h in the Macaque monkey striatum (11) and 2-6mm/h in a songbird brain (12). 
Furthermore, the apparent transport velocity did not seem to reflect the mean of the velocity 
distributions. For model B and C the apparent transport velocity was 3.2mm/h and 3.3mm/h at 
a given reference level whereas the mean of their velocity distributions was ~0.2mm/h and 
~10mm/h, respectively. Another interesting observation from the apparent transport velocity 
estimation is the behaviour of random walk transport. Generally, with random walk like 
transport, the apparent velocity will depend upon the selected spatial spacing of 
measurements, with the apparent velocity becoming lower as the spacing of the two 
measurement points is increased. However, in the case with a rate limited input function, a 
random walk model may show the opposite behaviour (Table 2, model A). A thorough 
investigation of apparent velocities was outside the scope of this study but this behaviour 
seems to be connected to the rate limited input function. 
 
In conclusion, RGC axonal entrance of Mn2+ is rate dependent and not directly proportional to 
the vitreal concentration, suggesting that increased Manganese enhancement could be 
achieved using a slow-release contrast agent without reaching toxic levels of local 
concentrations. Also, a wide range of apparent Mn2+ transport rates seems to be involved, 
different from synaptic vesicles transport rates, meaning that manganese does not depict 
synaptic vesicle transport rates directly. Furthermore, our study illustrates that with spatial- 
and time resolved in vivo MEMRI it is possible to assess different aspects of axonal transport 
kinetics, and this suggests that changes in axonal Mn2+ entrance and transport rate 
distributions can be used to reveal new information about how white matter disease affects 
axonal transport. 
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Appendix A 
Generally, a transport function, p, with only one velocity can be written:  
 
 ( , ; ) ( )p x t v x vt= δ −  (3) 
 
where δ is delta function, x position, v velocity and t time. If the transport function contains 
several velocities described by a velocity distribution function ρ(v;s) where s is a set of 
parameters, the averaged transport function can be written: 
 
 ( , ; ) ( , ; ) ( ; )p x t s p x t v v s dv= ρ∫  (4) 
 
Function (4) describes the transport of a tracer based on a spectrum of transport velocities. To 
further model the transport, we included exponential clearance of the tracer: 
 
 ( , ) exp( / ) ( , ; ) ( )clearancep x t t p x t v v dv= − τ ρ∫  (5) 
 
where τclearance is the time-constant for exponential clearance of the tracer from the ON. 
 
The following velocity distributions were used to test convection-like transport:  
 
1. The exponential distribution 
 
0 0
1( ) exp 0vv v
v v
ρ ⎛ ⎞= − ≥⎜ ⎟⎝ ⎠  (6) 
where v0 is the mean velocity. 
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2. The Rice distribution  
 
2 2
02 2 2
( )( ) exp 0
2
v v vv I vμ μρ σ σ σ
⎛ ⎞− + ⎛ ⎞= >⎜ ⎟ ⎜ ⎟⎝ ⎠⎝ ⎠
 (7) 
where σ and μ are distribution parameters, and I0 is the modified Bessel function of the first 
kind with order zero.  
 
In addition to these velocity distributions, a one dimensional convection-diffusion transport 
function recently used in studies of age-related axonal transport rates (16) and Alzheimer’s 
disease (15) was tested. The transport function can be written: 
 
2
0( )1 exp exp 0
( , ) 44
0 0
clearance
x v t t x
p x t DtDt
x
τπ
⎧ ⎛ ⎞⎛ ⎞−− ⋅ − ≥⎪ ⎜ ⎟⎜ ⎟= ⎨ ⎝ ⎠ ⎝ ⎠⎪ <⎩
 (8) 
where v0 is the transport velocity, D is the diffusion coefficient and τclearance is the time-
constant for exponential clearance of tracer from the ON. The model describes an overall 
transport with a single velocity in one direction with diffusion like transport in both 
directions.  
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Available online 24 December 2008I) to the neonatal brain results in delayed neuronal death with accompanying
inﬂammation for days after the initial insult. The aim of this study was to depict delayed neuronal death after
HI using Manganese-enhanced MRI (MEMRI) and to evaluate the speciﬁcity of MEMRI in detection of cells
related to injury by comparison with histology and immunohistochemistry. 7-day-old Wistar rat pups were
subjected to HI (occlusion of right carotid artery and 8% O2 for 75 min). 16 HI (HI+Mn) and 6 sham operated
(Sham+Mn) pups were injected with MnCl2 (100 mM, 40 mg/kg) and 10 HI-pups (HI+Vehicle) received NaCl
i.p. 6 h after HI. 3D T1-weighted images (FLASH) and 2D T2-maps (MSME) were acquired at 7 T 1, 3 and 7 days
after HI. Pups were sacriﬁced after MR-scanning and brain slices were cut and stained for CD68, GFAP, MAP-2,
Caspase-3 and Fluorojade B. No increased manganese-enhancement (ME) was detectable in the injured
hemisphere on day 1 or 3 when immunohistochemistry showed massive ongoing neuronal death. 7 days
after HI, increased ME was seen on T1-w images in parts of the injured cortex, hippocampus and thalamus
among HI+Mn pups, but not among HI+Vehicle or Sham+Mn pups. Comparison with immunohistochem-
istry showed delayed neuronal death and inﬂammation in these areas with late ME. Areas with increased ME
corresponded best with areas with high concentrations of activated microglia. Thus, late manganese-
enhancement seems to be related to accumulation of manganese in activated microglia in areas of neuronal
death rather than depicting neuronal death per se.
© 2008 Elsevier Inc. All rights reserved.Introduction
Hypoxic–ischemic brain injury in the perinatal period results in
high mortality and morbidity among infants and children (Ferriero,
2004; Vannucci and Perlman, 1997; Vannucci and Hagberg, 2004). In
contrast to adult stroke, hypoxia–ischemia in the neonatal brain
results in a prolonged evolution of injury with neurons dying days and
weeks after the primary insult. This has presented a possible window
of opportunity for therapeutic intervention (Nakajima et al., 2000;
Geddes et al., 2001; Vannucci and Hagberg, 2004; Northington et al.,
2005), but in order to develop effective treatment strategies the
complexity of the underlying injury mechanisms and evolution of
injury has to be further investigated. One of the injury mechanisms
that we are just beginning to elucidate the consequences and
signiﬁcance of is the inﬂammatory response after hypoxia–ischemiaNU, MTFS, 7489 Trondheim,
øe).
rights reserved.in the neonatal brain. Inﬂammatory cytokines have been shown to
potentiate excitotoxic injury, and microglia, the resident macrophage
of CNS, has been shown to be activated both acutely and delayed in the
brain after hypoxia–ischemia. Although microglia by many means are
considered a renovation cell through its phagocytosis of dead cells and
debris, it is increasingly viewed as a possible cause of cell death
through its release of glutamate, free radicals and nitric oxide (McRae
et al., 1995; McLean and Ferriero, 2004; Ferriero, 2004).
The advances during the past decade in revealing the pathogenesis
of neonatal hypoxic–ischemic brain injury are in part due to new
neuroimaging techniques and a focus on mapping the cellular and
molecular mechanisms of injury through animal models (Ferriero,
2004; Vannucci and Vannucci, 2005). Combining the strengths of MRI
with neonatal animal models give the opportunity of longitudinal
studies of brain injury in vivo where mechanisms of the evolution of
injury can be investigated on a structural and cellular level. One novel
versatile MRI technique is manganese-enhanced MRI (MEMRI).
Manganese (Mn2+) gives positive contrast on T1-weighted images
due to its paramagnetic properties that primarily shortens T1 in solid
881M. Widerøe et al. / NeuroImage 45 (2009) 880–890tissue (Koretsky and Silva, 2004; Silva et al., 2004). The divalent
manganese ion (Mn2+) functions as an analogue for Ca2+ in biological
systems and is known to enter neurons and glial cells through voltage-
gated Ca2+-channels. During normal homeostasis systemic adminis-
tration of Mn2+ gives signal enhancement on T1-weighted images of
brain areas with high neuronal activity (Watanabe et al., 2002;
Wadghiri et al., 2004; Kuo et al., 2005). Under pathological conditions
the properties of Mn2+ give MEMRI other potentials for use. Calcium
plays an important role in neuronal death during brain ischemia
either through rapid Ca2+-inﬂux as a result of depolarisation caused by
energy failure or excitatory glutamate release or as a result of slow
continued accumulation of intracellular Ca2+ associated with neuronal
apoptosis (Ankarcrona et al., 1995; Kristián and Siesjö, 1998; Won et
al., 2002; Aoki et al., 2003; Koretsky and Silva, 2004). Substituting Ca2+
with Mn2+ may lead to intracellular accumulation of Mn2+ in neurons
undergoing cell death. Aoki et al. has demonstrated this during early
neuronal death in the adult rat stroke model (Aoki et al., 2003, 2004).
However, using the same principles we hypothesised that MEMRImay
be utilised for imaging delayed neuronal death which would be
particularly valuable for better understanding neonatal hypoxic–
ischemic brain injury.
The main aim of the present study was to depict delayed neuronal
death by MEMRI up to several days after the initial hypoxic–ischemic
insult in the neonatal rat brain. In addition, we aimed to evaluate the
speciﬁcity of MEMRI in detection of cells related to injury by
comparison with histology and immunohistochemistry.
Materials and methods
Animals
Wistar rats (Scanbur, Norway AS) were bred in the animal facilities
at the St. Olav University Hospital in Trondheim. Time-mated rats
(n=5) and their offspring (n=35) were kept on a 12:12 h light:dark
cycle. They had water and food ad libitum. Animal experiments where
conducted in accordance with Guidelines set by the Norwegian Ethics
Committee for Animal Research and the experiments were approved
by the responsible governmental authority.
Hypoxia-ischemia (HI)
The Vannucci–Rice model for hypoxic–ischemic brain damage was
used (Rice et al., 1981; Vannucci and Vannucci, 2005): P7 rats (mean
weight: 15.1±1.6 g) were anaesthetized with isoﬂurane (Baxter
Medication Delivery, Oslo, Norway) (4% induction, 2% maintenance)
in O2. Through a mid-neck incision, the right common carotid artery
was identiﬁed, thermo-cauterized and severed. Wounds were closed
and sprayedwith Xylocaine (2%). Duration of operating procedurewas
5–10min. The pupswere then placed backwith their dam for recovery
and feeding for minimum 2 and maximum 4 h. Thereafter, pups wereFig. 1. Overview of the study design with study groups (HI+Mn, HI+Vehicle, Sham+Mn and
and timing of MR imaging (MR) and sacriﬁcing for histological examinations (Histo).put in a ﬁbreglass box inside an incubator. The temperature inside the
box was kept at 36±0.5 °C throughout the procedure. The box was
ﬂushedwith pre-heated humiﬁed air with 8% O2 (in 92% N2) (15 l/min)
for approximately 3min until the oxygen concentration in the boxwas
8%. Thereafter air ﬂowwas kept at 5 l/min and O2 was measured to 8%
throughout the procedure using an OxyQuant S® (EnviteC GmbH,
Wismar, Germany). After 75 min of hypoxia, the box was ﬂushed with
room air and the pups were allowed to recover for 5 min before being
placed back with their dam. This procedure resulted in a unilateral
hypoxic–ischemic insult (HI) to the right cerebral hemisphere. In
every litter pups were sham-operated; carotid artery was identiﬁed
under anaesthesia, but not damaged. Sham-operated animals were
not subjected to hypoxia.
Study groups and manganese administration
Six hours after the hypoxia one group of HI pups (HI+Mn) (n=16)
and the sham operated pups (Sham+Mn) (n=6) were given a single
dose of MnCl2 (# 7773-01-5, Sigma-Aldrich Inc., St. Louis, USA)
intraperitoneally. A dose of 40 mg MnCl2 per kg bodyweight
(∼318 μmol Mn2+/kg) at a concentration of 100 mM was mixed with
0.9% NaCl to make an isotonic injection volume of 0.1 ml. Another
group of pups (HI+Vehicle) (n=10) did not receive MnCl2, but were
instead injected with 0.1 ml of 0.9% NaCl to serve as controls (Fig. 1).
To evaluatewhether therewas active cellular uptake of manganese
7 days after hypoxia–ischemia (HI), one group of pups HI+Mn6 (n=3)
followed the described protocol for hypoxia–ischemia on day 0, but
received no injections until day 6 after HI. They were then injected
with 40 mg MnCl2 per kg at 100 mM mixed with 0.9% NaCl (total
volume 0.1 ml).
Magnetic resonance imaging
MRI was performed on days 1, 3 and 7 after HI (day 0) using a 7 T
magnet (Biospec 70/20 AS, Bruker Biospin MRI, Ettlingen, Germany)
with water-cooled (BGA-12, 400 mT/m) gradients. A 72 mm volume
resonator was used for RF transmission and an actively decoupled
mouse head surface coil was used for RF reception. Pups injected with
MnCl2 on day 6 (HI+Mn6) were also imaged on days 8, 10 and 14 after
HI. All animals were imaged longitudinally at all time-points until they
were sacriﬁced for histology. During scanning the anaesthetized (2%
isoﬂurane in 30% O2, 70% N2) pups lay prone in a dedicated water
heated mouse bed (Bruker Biospin MRI) and the head of every animal
was ﬁxed in the same position with inbuilt earplugs, tooth bar and
nose-mask. This assured the same placement of the head of the
animals within the magnet from scan to scan.
After a gradient echo FLASH pilot scan (acquisition time 1 min),
a 3D data set was obtained using a T1-weighted gradient echo
FLASH sequence with ﬂip-angle=30°, TR=12 ms, TE=3.0 ms.
FOV=20×20×17.5 mm and acquisition matrix was 128×96×84HI+Mn6). Timing of hypoxia–ischemia (HI) and injection with MnCl2 or Vehicle (NaCl2),
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zero-ﬁlling of the matrix to 128×128×112, the interpolated
resolution was 156 µm isotropic. Acquisition time was 25 min
with 16 averages. 2D T2-maps were obtained with a spin-echo
sequence (MSME) with TR=2500 ms, TE=7.6 ms, 40 echoes, slice
thickness 1 mm. FOV=18×18 mm and acquisition matrix 128×96
giving an in plane resolution of 140 μm×187 μm. With zero-ﬁlling
of the matrix to 128×128 the interpolated resolution was 140 μm
isotropic. Acquisition time was 16 min with 4 averages. The
receiver gain was held constant for all scans and the signal scaling
during reconstruction of the images was corrected for before
quantitative analysis of the data.
The B1-ﬁeld of the volume-coil was considered homogeneous
within the ﬁeld of view, while the spatially inhomogeneous
sensitivity of the surface-coil used in the 3D T1-weighted FLASH
acquisition was corrected for using two additional scans in coupled
and single coil operation: 3D T1-weighted FLASH sequences: Flip-
angle=30°, TR=12 ms, TE=3.0 ms, matrix size 32×32×32, acquisi-
tion-time was 2 min for each scan. FOVs were the same as those
used to obtain 3D data set. The correction-procedure was performed
in Matlab (MATLAB ver 2007a, MathWorks Inc.). The MRI signal
intensity in a voxel at location (x,y,z) was normalized using the
following relation:
ISC x; y; zð Þ = ICC x; y; zð Þ CSC x; y; zð ÞCCC x; y; zð Þ ð1Þ
where CCC and CSC is the coupled-coil and single-coil intensities in the
correction scan datasets respectively, ICC is the recorded couple-coil
signal intensity in the main 3D data set, and ISC is the resulting
normalized signal intensity.
Histology and immunohistochemistry
Animals were sacriﬁced after MRI acquisition on day 1 (HI+Mn,
n=2), day 3 (HI+Mn, n=2) and day 7 (HI+Mn, n=8; HI+Vehicle,
n=6; HI+Sham, n=3) following HI. They received an overdose
pentobarbital (300 mg/kg) and were perfused intracardially with 4%
paraformaldehyde (PAH) in phosphate-buffered saline (PBS). Brains
were removed and embedded in parafﬁn. Coronal sections (8 μm)
corresponding to −3.25 mm from the bregma (Paxinos and Watson,
1998) were cut and stained with either hematoxylin–eosin (Klini-
path, Duiven, the Netherlands), anti-MAP2 (Sigma-Aldrich, Stein-
heim, Germany), anti-cleaved-caspase3 (Cell Signaling) or anti-ED1-
ﬁtc (Serotec, Raleigh, NC) and slices from HI+Mn pups on days 1 and
3 and 4 HI+Mn pups on day 7 were stained with anti-GFAP (Cymbus
Biotechnology, Southampton, UK). Sections were then incubated
with rat-anti-FITC-biotin (Roche, Basel, Switzerland), goat-anti-
rabbit-biotin (Vector Laboratories, Burlingame, CA) or horse-anti-
mouse-biotin (Vector Laboratories, Burlingame, CA). Visualization
was performed using a Vectastain ABC kit (Vector Laboratories). Full
section images were captured with a Nikon D1 digital camera
(Nikon, Tokyo, Japan). Sections were also stained with Flourojade B
(Chemicon International, Temecula, CA, USA) after incubation in
0.06% potassium-permanganate, embedded in DEPEX and visualized
using a ﬂuorescence-microscope in the FITC channel.
MR image analysis
In-house developed software was used for MR image analysis
(MATLAB ver. R2007a, MathWorks Inc., Natick MA, USA). From the 3D
T1-weighted data set a coronal 2D image-slice (slice thickness
0.156 mm) approximately corresponding to the histological slice was
extracted by tri-linear interpolation and used for image analysis. Using
a rat brain atlas (Paxinos and Watson, 1998) for reference, regions of
interest (ROI) were manually placed in the cortex, hippocampus,External capsule and thalamus in both hemispheres and mean signal
intensity (SI) was calculated for each ROI.
To evaluate Manganese enhancement (ME), SI on T1-weighted
images in ROIs in the injured hemisphere (ipsilateral) was compared
to the contralateral (unaffected) hemisphere. To allow comparison
between animals and groups of animals, a measure of the relative
contrast (RC) was calculated for each structure (cortex, hippocampus,
external capsule and thalamus) in every animal using the 2D-image
slices acquired on days 1, 3 and 7. RC was calculated using the
following equation:
RC =
SIROIIpsilateral−SIROIContralateral
SIROIIpsilateral + SIROIContralateral
: ð2Þ
Comparison of histology and manganese enhancement
The histological slices with different staining were evaluated using
standard and ﬂuorescent microscopy. The extent and intensity of CD68
and GFAP staining and the number of stained cells in different areas of
the injured hemisphere were compared to the extent and intensity of
ME. The extent ofMAP-2 losswas compared to the extent ofME. For this
comparison2DT1-weighted imageswasviewedwith aRGB lookup table
where the threshold for the colour yellow was adjusted to right above
the highest level of signal intensity recorded in the contralateral
hemisphere for every animal. High signal areas in the injured hemi-
sphere, indicating increased ME, would hence appear yellow.
The following computer-based method for evaluating agreement
between increased ME on T1-weighted images and histological
staining was developed: manganese-enhancement in the injured
hemisphere was deﬁned by signal intensities above a threshold set by
mean SI of a ROI placed in the thalamus of the contralateral
hemisphere +1 SD of the image noise. A binary mask was created
for the area of ME in the injured hemisphere. Images of whole
histological slices stained for MAP-2, CD68 and GFAP were segmented
in the RGB vector space using the Mahalanobis distance from an
average colour calculated from a ROI manually placed in an area with
uniform staining (Gonzalez et al., 2004). The segmented colours were
deﬁned to be in a distance equal or less than 1 SD from the average
colour, where the SD was selected from the RGB component with the
largest variance within the ROI. From this a binary mask for the area of
staining was created. The T1 weighted MR images and the histology
images were then co-registered using landmark based image
registration. After manually selecting approximately 15 pairs of
anatomical points of reference in the two images, the transformation
was calculated using a piecewise linear model. The transformation
was applied to the segmented histology image which made us able to
compare the manganese-enhanced areas and segmented histology
staining on a pixel-to-pixel basis. The ﬁt of the transformation was
evaluated visually. The overlap between the area of histological
staining (AreaHistology) and the segmented manganese-enhanced area
(AreaME) was evaluated using three different parameters, where the
intersection of the areas of ME and histological staining was divided
by either the union of the two areas, area of histological staining or the
area of segmented ME:
Match =
AreaME \ AreaHistology
AreaME [ AreaHistology
ð3Þ
Sensitivity =
AreaME \ AreaHistology
AreaHistology
ð4Þ
Prediction =
AreaME \ AreaHistology
AreaME
: ð5Þ
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SPSS version 14.0 (SPSS Inc., Chicago, IL, USA) was used for all
statistical analysis and the level of signiﬁcance was set to 0.05.
Signal intensity data and relative contrast data are presented in
ﬁgures as mean with error-bars representing±2 SEM. Mann–
Whitney U-test was used to compare the mean signal intensities
in ROIs and the mean relative contrast (RC) in different structures
between groups. T2-values are presented as mean±1 SD. Paired t-
tests were used to analyze differences in T2-values of the ROIs
between the two hemispheres. Results from the pixel-wise
comparison of T1-weighted images with histology and T2-maps are
presented as mean±SEM.
Results
MR signal enhancement with manganese
T1-weighted MR images of HI pups injected with MnCl2 (HI+Mn)
showed high signal intensities in large parts of the dorsolateral
thalamus and in several animals also in parts of the hippocampus and
remaining cortex on day 7 (Fig. 2). In a few HI+Mn pups some small
spots were also seen in the thalamus on day 3, but no high signal
intensities was seen in the injured hemisphere among HI+Mn pups
prior to day 3. High signal changes were not seen in HI+Vehicle pups
in the injured hemisphere on day 3 or day 7 (Fig. 2).
ROI analysis of the injured hemisphere showed higher signal
intensities in cortex, hippocampus and external capsule amongHI+Mn
than HI+Vehicle pups on day 1. On days 3 and 7 signal intensities of
ROIs in cortex, hippocampus and thalamuswere higher amongHI+Mn
than HI+Vehicle pups (Fig. 3). Also, on day 7 signal intensity of ROIs in
the injured hemisphere's cortex and thalamus of HI+Mn pups was
signiﬁcantly higher than among Sham+Mn pups (Fig. 3).
Signal intensities in ROI in the contralateral hemisphere of HI+Mn
pups were similar to Sham+Mn at all times in all areas (data not
shown).Fig. 2. T1-weighted images of evolution of brain injury from day 1 till day 7 after hypoxia–isc
thalamus, and parts of the remaining cortex and hippocampus of the injured hemisphere of H
Sham+Mn pups.Contrast enhancement on T1-weighted MR images caused by manganese
on day 7
In order to identify areas of high or low signal intensities in the
injured hemisphere relative to the contralateral hemisphere and
compare these between animals, a normalized relative contrast (RC)
was calculated (see Materials and methods). In the dorsolateral
thalamus of the HI+Mn pups there was a mean negative RC on day 1
that increased to a highly positive RC (SI injured hemisphereNSI
contralateral hemisphere) on day 7. In cortex and hippocampus the
same trend was seen with RC increasing from negative (injur-
edbcontralateral) on day 3 to around zero (injured=contralateral)
on day 7. However, among HI+Vehicle pups the opposite trend was
observed going from positive RC in all areas on day 1 to negative on
day 3 and becoming more negative from day 3 till 7 (Fig. 4). This lead
to a large difference between HI+Mn and HI+Vehicle pups with far
more positive RC in cortex, hippocampus and thalamus among HI+Mn
than HI+Vehicle pups on day 7 (Fig. 4).
Increased manganese-enhancement after injection on day 6
T1-weighted MR images of animals injected with MnCl2 on day 6
(HI+Mn6) were also obtained on days 7, 8, 10 and 14 after HI. On day 7,
increased signal intensities were seen primarily in the borders
surrounding the area of the dorsolateral thalamus of the injured
hemisphere (Fig. 5). The area corresponded to that seen on day 7 in
pups injectedwithMnCl2 6 h after HI. A ROI placed in this area showed
signiﬁcantly higher mean signal intensities on day 7 among HI+Mn6
pups than among HI+Vehicle pups. From day 7 till day 14 the contrast
in this area increased with more uniformly high signal intensity in the
centre of the area evolving during the week (Fig. 5). However, signal
intensity of this ROI among HI+Mn6 pups never became as high as the
equivalent ROI among HI+Mn pups on day 7 (i.e. one week after their
MnCl2 injection). Among HI+Mn6 pups RC was negative in thalamus
and hippocampus on day 7, but steadily increased in both areas and
became positive on day 14.hemia in different groups. On day 7 high signal intensity is observed in the dorsolateral
I pups with injectedMnCl2 (arrows). These changes were not observed in HI+Vehicle or
Fig. 3.Mean signal intensity (SI) in ROIs in cortex, thalamus, hippocampus and external capsule of the injured/ipsilateral hemisphere of Sham+Mn, HI+Vehicle and HI+Mn pups at
different scan times. The graph shows how the mean SI of ROIs in cortex, hippocampus and thalamus increased over time among HI+Mn pups, with the most noticeable increase in
thalamus, whereas among HI+Vehicle the SI steadily decreased in all areas. On day 1 SI among HI+Mn was on the same level as in Sham+Mn, but it was higher than among HI+
Vehicles (thalamus p=0.93), indicating presence of manganese in these areas. SI in cortex and thalamus were signiﬁcantly higher than both Sham+Mn and HI+Vehicle pups on day 7,
indicating a pathological presence of manganese. SI in the external capsule ROI showed the same trend among HI+Mn and HI+Vehicle with decreasing values from day 1 till day 7.
However, SI in this areawas still higher among HI+Mnpups than HI+Vehicle on day 1 and 7. ⁎pb0.05 HI+Mn vs. HI+Vehicle, †pb0.05 HI+Mn vs. Sham, ‡pb0.05 HI+Vehicle vs. Sham.
(Error bars±2 SEM).
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HI+Mn vs HI+Vehicles
At all scans times; the mean T2 values measured in cortex,
hippocampus and thalamus were signiﬁcantly lower in HI+Mn than
in HI+Vehicle pups. Among HI+Mn and HI+Vehicle pups mean T2
values were elevated in cortex, hippocampus and thalamus in the
injured hemisphere compared to the contralateral hemisphere on
day 1. In HI+Vehicle, T2 values in cortex and hippocampus of the
injured hemisphere remained elevated, however slightly reduced
from day 1 till day 3. T2 in the same areas among HI+Mn pups were
gradually reduced from day 1 till day 7 and was on the same level
as in the contralateral hemisphere. In the dorsolateral thalamus,
mean T2 values were gradually reduced from day 1 till day 7 in both
groups with the largest reduction among the HI+Mn pups. The
mean T2 value in dorsolateral thalamus of the injured hemisphere
on day 7 was 24.5 ms±8.3 among HI+Mn pups vs. 54.3 ms±4.5
among HI+Vehicles (p=0.001) (Fig. 6). In the contralateral thalamus
there were also a tendency to lower mean T2 values among HI+Mn
than HI+Vehicle pups (mean 48.6 ms±14.8 vs. mean 61.3 ms±6.9;p=0.064). The differences in T2 values in thalamus between the
injured and the contralateral hemisphere on day 7 were signiﬁcant
for both groups.
HI+Mn vs Sham+Mn
Onday 1 therewere increasedmean T2 values in cortex, hippocampus
and thalamus of the injured hemisphere among HI+Mn pups compared
to Sham+Mn. On days 3 and 7, mean T2 values in these areas were
reduced, resulting in signiﬁcantly lower mean T2 values in dorsolateral
thalamus among HI+Mn pups than among Sham+Mn on day 7.
T2-mapping and manganese-enhancement
The area with reduced T2 in dorsolateral thalamus of the injured
hemisphere on day 7 in HI+Mn pups co-localized well with the
manganese-enhanced areas on T1-w images on visual analysis (Fig. 6).
Software-based pixel-wise comparison of the overlap between the
two segmented areas gave a mean match of 0.53±0.06, with a mean
probability of 0.69±0.08 for a manganese-enhanced pixel to have a
corresponding pixel with T2-reduction.
Fig. 4. Mean Relative Contrast (RC) in ROIs in cortex, thalamus, hippocampus and external capsule of Sham+Mn, HI+Vehicle and HI+Mn at different scan times. There was a
highly positive relative contrast in thalamus among HI+Mn pups on day 7, meaning higher signal intensity in the injured- than the contralateral hemisphere. Notice the
difference in development of RC between HI+Mn pups and HI+Vehicle in cortex, hippocampus and thalamus over time, with decreasing levels of RC among HI+Vehicle,
whereas HI+Mn pups showed increasing RC from day 3 till 7. RC was signiﬁcantly more positive in these areas on day 7 among HI+Mn than HI+Vehicle. External capsule
showed the same development among both HI groups. ⁎pb0.05 HI+Mn vs. HI+Vehicle, †pb0.05 HI+Mn vs. Sham, ‡pb0.05 HI+Vehicle vs. Sham. (Error bars±2SEM).
Fig. 5. T1-weighted images 7, 8, 10 and 14 days after HI in rat pup injected with MnCl2
day 6 after HI. Increasing signal intensity from day 7 till day 14 can be seen in an area of
thalamus in the ipsilateral hemisphere (arrows).
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Day 1
On day 1 there was neuronal loss (areas not stained for MAP-2) in
large parts of cortex, hippocampus and thalamus in the injured
hemisphere with accompanying high number of cleaved caspase 3
positive cells in cortex and hippocampus and some in thalamus.
Reactive astrocytes (staining positively for GFAP) and a few activated
microglial cells (CD68 positive cells) were seen in widespread areas of
the injured hemisphere.
Day 3
Histology on day 3 showed the same pattern of neuronal loss and
cleaved caspase 3 positive cells as on day 1. Reactive astrocytes with
intense GFAP staining were seen in all injured areas. Activated
microglia/macrophages were evenly spread out in cortex, hippocam-
pus and thalamus.
Day 7
Histological examination of brain sections showed no difference
in lesion size, morphology, or immunohistochemical staining
between HI +Mn and HI + Vehicle pups. The contralateral
Fig. 6. T1-weighted images and T2-maps 7 days after HI of pups with and without
injected MnCl2. An area with highly reduced T2 is seen in the dorsolateral thalamus of
HI+Mn pups, corresponding to the manganese-enhancement on T1-weighted image
(arrows). In HI+Vehicle a smaller reduction in T2 is observed in the same area, but with
no corresponding increased signal intensity on T1-weighted images (arrows).
886 M. Widerøe et al. / NeuroImage 45 (2009) 880–890hemisphere in these groups and among Sham+Mn pups showed no
injury or abnormal pattern of staining. Immunohistochemical
examination of the injured hemisphere in HI pups on day 7 showedFig. 7. T1-weighted image (A) acquired day 7 after HI in pup injected with MnCl2. Correspond
(F) are shown. Arrows points to areas with increased manganese-enhancement in the T1-we
neurons (not stained for MAP-2), activated microglia (CD68) and reactive astrocytes (GFAP) in
between manganese-enhancement and staining for activated microglia.widespread loss of tissue and cyst formation in the cortex and
external capsule of the injured hemisphere. In the remaining tissue,
neuronal loss was prominent and there were high numbers of
Flourojade B positive dying neurons in cortex, hippocampus and
dorsolateral thalamus in all HI animals (Fig. 7). Active caspase 3
positive cells were also present in all these areas, but in low
numbers. Activated microglia/macrophages with intense CD68
staining were numerous in all these areas with the highest
concentration in the dorsolateral thalamus. Numerous reactive
astrocytes with intense GFAP staining were seen in large parts of
the injured hemisphere with the highest concentration in hippo-
campus, cortex and dorsolateral thalamus.
Histology and manganese-enhancement on day 7
Areas with activated microglia (CD68 positive cells) had the best
agreement with the areas of increased ME on T1-weighted imaging.
In 7 out of 8 HI+Mn pups increased ME was seen in the same
areas that had high numbers of CD68 positive cells and vice versa.
Also, the areas with activated microglia/macrophages and the areas
of increased ME showed a similar morphological appearance,
especially in the dorsolateral thalamus (Fig. 7). Furthermore, in
two animals (HI+Mn) with very low density of activated microglia
in the thalamus, there was almost no detectable ME on MRI.
However, one animal had high density of CD68 positive cells, but
little ME.ing histological slices stained with HE (B) MAP-2 (C), Caspase-3 (D), CD68 (E) and GFAP
ighted image and corresponding areas on histology. Comparison shows areas with dead
areas with increased manganese-enhancement, but with best morphologic correlation
Fig. 8. Immunohistochemical staining with MAP-2, Caspase-3, CD68, GFAP and Flourojade B in different areas of varying intensity on T1-weighted MR Image acquired day 7 after HI in
pup injected with MnCl2. Intensity of increased manganese-enhancement correlates well with staining for reactive astrocytes (GFAP) and activated microglia (CD68) and less with
dying neurons (Flourojade B) and marker for apoptosis (Caspase-3).
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positive cells) as well as reactive astrocytes (GFAP positive cells) were
also found in the areas with increased ME on T1-weighted images
(Fig. 8). The morphological appearance of neuronal loss and the
distribution of dying neurons (Fluorojade B positive cells) corre-
sponded well with that of increased ME, but the degree of neuronal
loss and density of dying neurons did not always agree well with the
signal intensity of ME. The distribution of reactive astrocytes in the
injured hemisphere was far more extensive than the detectableTable 1
Overlap between manganese-enhancement and immunohistochemical staining
n Match Sensitivity Prediction
CD68 4 0.34 (±0.16) 0.44 (±0.23) 0.53 (±0.24)
GFAP 4 0.25 (±0.10) 0.27 (±0.12) 0.87 (±0.11)
MAP-2 loss 6 0.28 (±0.08) 0.31 (±0.09) 0.74 (±0.09)
Shows the results of a computer based comparison of immunohistochemical stainings
and manganese-enhancement in the thalamus. Match gives the degree of overlap
between the areas of manganese-enhancement and histological staining. Sensitivity
gives the probability of manganese-enhancement of a pixel, given positive histological
staining. Prediction gives the probability of positive staining on histologywhen a pixel is
manganese-enhanced. The relative small area of CD68 positive staining made the
predictive value very sensitive to errors in geometric overlap betweenMRI and histology.
(Mean±S.E.M).increased ME (Fig. 7). Also, the density of GFAP-staining in different
areas did not always correspond with the degree of ME.
Areas with GFAP-staining, CD68 staining and MAP-2 loss were
segmented and compared to areas of increased ME on a pixel-wise
basis. The uncertainty in co-registration of images, made the
comparison of ME and immunohistochemical staining in the small
areas of cortex and hippocampus unreliable. Results of the comparison
in the thalamus on day 7 are presented in Table 1 and suggest that the
best match was found between increasedME and CD68 positive areas,
in accordance with the results from the visual microscopic analysis.
Discussion
In the present study we have shown increased manganese-
enhancement (ME) on T1-weighted images in speciﬁc brain areas
seven days after hypoxic–ischemic injury in the neonatal rat. High
signal intensity on T1-weighted images as well as reduced T2-values
were seen in the dorsolateral thalamus and parts of hippocampus and
the remaining cortex of the injured hemisphere in pups that were
injected with MnCl2. Increased ME in these areas co-localized with
reactive astrocytes, dying neurons and activated microglia/macro-
phages on immunohistochemical analysis, with the best spatial
agreement with the activated microglia/macrophages.
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In order to study pathological processes with MEMRI, the
pathological ME always has to be compared to the normal physiolo-
gical enhancement of the brain tissue architecture as shown by several
studies (Wadghiri et al., 2004; Kuo et al., 2005; Watanabe et al., 2002;
de Sousa et al., 2007). The strength of the current animal model is that
only one hemisphere is injured, while the other is considered
physiologically normal. In this study we have calculated a relative
contrast parameter (RC) as a semi quantitative measure of the relative
signal intensity and manganese enhancement in the two hemi-
spheres. This also compensates for any variations in SI between days
and animals. Considering the fact that RC was consistent with zero in
Sham+Mn pups at all time points, any deviation of RC from zero in the
injured animals was most likely due to different tissue characteristics
and/or differences in manganese uptake in the two hemispheres and
not to any acquisition artefacts or inhomogeneity of the B1.
In the thalamus of the injured hemisphere, a speciﬁc increase inME
was observed on day 7 in the HI+Mn group (positive RC signiﬁcantly
different from shams). In hippocampus and cortex of the injured
hemisphere, the positive and signiﬁcantly higher RC among HI+Mn
than among HI+Vehicle on day 7 indicates the presence of manganese
in these structures, but is difﬁcult to distinguish from the normal
uptake in the uninjured hemisphere, as RC was not signiﬁcantly
different from shams.
The differences in RC between HI+Mn and HI+Vehicle pups on day
1 are interesting. The positive RC among HI+Vehicle pups indicates
reduction of T1 in the injured structures, compared to the uninjured
hemisphere, which contradicts a study that showed increased T1 (Qiao
et al., 2004). The increase in T2 in the same areas is more in accordance
with the previous study, but the simultaneous high signal on T1-
weighted images is somewhat puzzling. Increased proton density in
the injured hemisphere may be one explanation. Another may be that
paramagnetic effects of degraded haemoglobin gives hyperintensity
on T1-weighting, while oedema of the tissue gives a predominantly T2
increase. However, the exact cause of this ﬁnding remains unclear.
Furthermore, assuming the same underlying tissue-changes in HI+Mn
pups, the consistently lower RC among HI+Mn pups than among
HI+Vehicle pups at day 1 can actually be interpreted as a lower
Mn2+ uptake in the injured hemisphere compared to the uninjured
hemisphere among HI+Mn pups at this time-point. Considering this,
the temporal trends of RC in cortex, hippocampus and thalamus
among HI+Mn pups suggest increasing Mn2+ concentrations from
day 1 till day 7, which is also in accordance with the trends in signal
intensity.
No increased manganese-enhancement at time of maximum neuronal
death
Immunohistochemical analysis 1 and 3 days after HI showed
widespread cell death and apoptosis in the affected hemisphere, in
accordance with results from previous studies that cell death peaks
24–72 h after hypoxia–ischemia (Nakajima et al., 2000; Northington et
al., 2001; Vannucci and Vannucci, 2005). The lack of increased ME at
time of maximum neuronal death is in contrast with the results by
Aoki et al, who found increased ME immediately after ischemia in the
adult rat (Aoki et al., 2003, 2004). However, differences in animal
model and MEMRI methodology make it difﬁcult to compare the
studies. Intra-arterial injection of MnCl2 with disruption of the BBB
with mannitol shortly after ischemia in the study by Aoki et al. (2003,
2004) may lead to a much higher availability of Mn2+ in the ischemic
areas and less unspeciﬁc uptake in normal tissue compared to a slow
diffusion of Mn2+ over the choroid plexus. The intentional distribution
of Mn2+ to the brain tissue via choroid plexus in our model was
conﬁrmed on MRI on day 1 by better contrast of brain tissue
architecture and generally higher signal on T1-weighted imagesapproximately 18 h after IP injection of MnCl2. This is in accordance
with previous studies (Wadghiri et al., 2004; Kuo et al., 2005;
Watanabe et al., 2002; de Sousa et al., 2007). Some leakage of Mn2+
across the immature neonatal blood brain barrier (BBB) could also be
expected, and this may have been further potentiated by the effect of
hypoxia–ischemia (Takeda, 2003). Although caution must be exer-
cised when comparing signal intensity between animals, even when
the physical conditions during scanning are the same, the higher
signal intensity on T1-weighted images in the injured hemisphere on
day 1 among HI+Mn pups than among HI+Vehicle pups indicates the
presence of someMn2+ in the injured brain tissue amongHI+Mnpups.
However, any speciﬁc Mn2+ uptake into dying neurons on day 1 or 3
seems to have been too small to give any signiﬁcant T1 contrast
compared to normal tissue. One limitation of this study was that we
were not able to quantify the concentration of Mn2+ in tissue. For
future studies, quantiﬁcation of T1 could increase the sensitivity and
give more clarity to the present concentration of Mn2+in tissue.
Increased manganese-enhancement seven days after hypoxia–ischemia
relates to inﬂammation
A process of delayed neuronal cell death in the dorsolateral
thalamus several days after the initial injury has previously been
reported by others (Northington et al., 2001, 2005; Vannucci and
Hagberg, 2004; Ohno et al., 1994). Consistent with this, histology on
day 7 in our study showed high degree of neuronal loss and high
concentrations of dying neurons with some apoptotic cells especially
in the dorsolateral thalamus, but also in areas of the remaining cortex
and hippocampus. The increased ME found in the same areas
suggested that increased ME visualized brain tissue with neuronal
death. However, the increased ME was far better co-localized with
areas with glial cell activation and inﬂammation than with apoptotic
and dying neurons. The best co-localization was with activated
microglia/macrophages, which were largely conﬁned to the areas
with ME, whereas the reactive astrocytes were found in a larger area
than the increased ME. This co-localization and probable relation
between activated microglia/macrophages and ME has also been
reported in a MEMRI-study of cathepsin D-deﬁcient mice (Haapanen
et al., 2007). Moreover, the agreement between activated microglia
and increased ME in our study was further supported by two animals
that showed low density of activated microglia and almost no ME in
the thalamus. However, one animal showed little ME with a high
density of activated microglia, but this may be explained by reduced
absorption or distribution of MnCl2, for instance if the IP injection
went into the gut or bladder or by differences in slice thickness and
resolution between histology and MR-image slices or partial volume
effects on MRI. Furthermore, the increase in ME from day 1 till day 7
was paralleled by the increase in activated microglia/macrophages,
especially in the dorsolateral thalamus. This suggests that the
appearance of increased ME in injured areas 7 days after HI and
MnCl2 injection could be explained by accumulation of Mn2+ in
microglia/macrophages rather than speciﬁc uptake into dying
neurons.
Increased manganese-enhancement may represent accumulation in
phagocytes
Reactive astrocytes, activated microglia and macrophages all have
the capability of phagocytosis in the aftermath of brain injury (Ito et
al., 2007). A hypothesis that could explain our histological and MRI
results is that during the ﬁrst days after the hypoxic–ischemic insult
these cells phagocytose dead cells and cell debris containing small
amounts of Mn2+ in the large areas of early injury, resulting in an
accumulation of Mn2+ in the phagocytes with time. When the
phagocytosing cells are no longer needed in the areas with early
injury that have been cleared of dead cells and debris, they may
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dorsolateral thalamus. Arrival of numerous manganese-laden phago-
cytes to the injury areas of the thalamus would give high concentra-
tions of Mn2+ and a localized T1-shortening effect on MRI and may
hence explain the late increased ME and the high concentrations of
activated microglia we observe on day 7.
Circulating macrophages that are also stained by anti-CD68
antibody have a peak inﬁltration of the injury site between 3 and
6 days after brain ischemia (Schilling et al., 2003; Tanaka et al., 2003;
Ohno et al., 1994). These cells may have taken up Mn2+ while in the
blood stream and contributed to the increased ME on day 7 that
coincides well with their late inﬁltration. Since MnCl2 is rapidly
cleared from the circulating blood volume after a systemic injection,
at least in the adult rat (Zheng et al., 2000), such an accumulation of
Mn2+ in circulating macrophages must most likely have occurred
during the ﬁrst day after injection. Based on the estimates from Zheng
et al. and assuming the approximately same kinetics for an IP injection
of 40 mg/kg, the calculated time to return to baseline level of Mn2+ in
our rat pups could be approximately 16 h. However, whether the
pharmacokinetics of MnCl2 after systemic injection is the same in the
neonatal as the adult rat is unknown, and this needs further
investigation.
Possible active uptake of Mn2+ one week after hypoxia–ischemia
Rapid clearance of Mn2+ from the blood makes any active uptake
directly from the blood into the brain one week after the injection
seem unlikely. However, to investigate whether the ME we observed
on day 7 after HI and MnCl2 injection could be due to active uptake at
the time, we injected MnCl2 IP in 3 animals on day 6 after HI (not
previously injected with MnCl2) and imaged them repeatedly during
the following week. Increased signal around the edge of the injury
area of the dorsolateral thalamus was seen on day 7, progressing
towards a more uniformly increased signal in the whole injury area
during the following days (Fig. 5). Since free Mn2+ or protein bound
Mn2+ diffuses very rapidly across liquids, it is unlikely that the
increasing ME from the edge to the centre of the area could be
explained by passive diffusion of Mn2+. These results therefore
indicate that there may be a small active uptake in the area around
day 7 and during the following week.
In a study by Fujioka et al., high signal was found on T1-w-imaging
in stroke areas after 1 week. They related this to increased induction of
manganese superoxide dismutase (Mn-SOD) and glutamine synthe-
tase (GS) in reactive astrocytes in the injured area (Fujioka et al., 2003).
Increased induction of Mn-SOD occurring one week after a focal
cortical lesion has been reported by another study (Bidmon et al.,
1998). In our study, reactive astrocytes were found in the areas of ME
alongside the activatedmicroglia and could therefore be involved in an
active Mn2+ uptake around one week after hypoxia–ischemia. Induc-
tion of GS and Mn-SOD in astrocytes and neurons seen after hypoxia–
ischemia in the brain (Gunter et al., 2006; Takeda, 2003; Lindenau et
al., 2000;Wedler and Denman,1984) can be further potentiated by the
release of free-oxygen radicals and glutamate from activatedmicroglia
in these areas and hence contribute to the late ME seen in this study.
However, the increased signal intensity and theME in animals on day 6
(HI+Mn6) never reached the level observed in animals injected 6 h
after HI (HI+Mn). This suggests that the ME seen on day 7 in HI+Mn
pups is mostly due to a steady accumulation of Mn2+ during the 7 days
after injection, probably by activated microglia/macrophages, rather
than an active uptake around day 7.
Reduction of T2 is not only related to manganese
In both HI+Mn and HI+Vehicle pups there were reduced T2-values
in the thalamus of the injured hemisphere compared to the
contralateral hemisphere. This reduction is contrary to previousstudies which have found normal or increased T2-levels in ischemic
areas (Meng et al., 2006; Wegener et al., 2006). However, the results
might be explained by the large injury that our pups suffered, as large
injuries may lead to hemorrhagic infarctions and small bleeding in the
tissue with subsequent iron deposits in phagocytes giving a T2-
reduction and T2⁎-effect (Weber et al., 2005). Furthermore, the T2
among HI+Mn pups was more reduced compared to the HI+Vehicle
pups. Some of this reduction could be explained by a T2-effect caused
by the high concentration of Mn2+ in the area (Silva et al., 2004). There
was a good co-localization of T2-reduction and increased signal
intensity on T1-weighted images in the dorsolateral thalamus on
visual examination (Fig. 6),where the pixel-wise comparison showeda
quantiﬁed match of 53%. The lack of a complete match on pixel-wise
analysis may in part be accounted for by differences in geometric
distortions of the T1- and T2-sequences, partial volume effects and
uncertainty in the geometric co-localization of images. The over-
lapping areas of ME and T2-reduction are however interesting and
although it is outside the scope of this study, a possible interpretation is
that it may represent an interaction between iron andMn2+-uptake by
astrocytes through up-regulation of divalent metal transporter (DMT-
1) as previously reported in another setting (Erikson and Aschner,
2006).
Future and clinical implications
This study has shown that manganese-enhanced MRI (MEMRI)
may be a useful tool in future studies to follow the cellular
development of brain injury and detecting inﬂammatory processes
related to delayed neuronal death over time in the newborn animal.
Furthermore, MEMRImay also be utilised to evaluate the effect of anti-
inﬂammatory treatments of hypoxic–ischemic injury in the neonatal
brain in vivo. The results of this study suggest that late ME may be
related speciﬁcally to inﬂammatory processes rather than cell death.
Whether increased ME can be seen in relation to inﬂammation in
other disease models without massive cell death remains to be
investigated. However, MEMRI may prove to be a valuable tool to
detect and follow brain inﬂammation in other disease models as well.
It should be stressed that comparison of the MRI to histological
examinations is mandatory to be able to interpret the speciﬁcity of ME
in a given animal model.
Clinical use of MEMRI is still limited by safety issues concerning
cardio- and neurotoxic effects of high dose manganese. Although our
study was not designed for addressing this issue, no adverse effects of
MnCl2 were observed among the pups. In the future, use of low dose
Mn2+ or Mn2+-chelates as contrast agent for MEMRI of brain in human
patients may become a reality when the safety of such applications
has been established. In vivo high-resolution images of inﬂammation
in human brains would be extremely valuable in investigating a
number of different diseases including stroke and neurodegenerative
diseases such as Alzheimer's.
Conclusions
During the ﬁrst days after hypoxia–ischemia, there was no
increased manganese-enhancement detected on MRI in areas of
massive neuronal death in the injured hemisphere. Therefore, the
method of MEMRI used in this study does not seem applicable for
depiction of neuronal death per se. However, late increased manga-
nese-enhancement was shown in brain areas with delayed neuronal
death and inﬂammation seven days after hypoxia–ischemia. The areas
with latemanganese-enhancement correspondedbestwith areaswith
high concentrations of activated microglia on immunohistochemistry.
The late manganese-enhancement may therefore be related to
accumulation of manganese in activated microglia. However, other
cell typesmay be involved and further studies are needed to reveal the
speciﬁc mechanisms causing the late manganese-enhancement.
890 M. Widerøe et al. / NeuroImage 45 (2009) 880–890Acknowledgments
The authors would like to thank FUGE Molecular Imaging Center
for technical support and use of imaging facilities. We would also
thank Frank van Bel and Floris Groenendal at the University Medical
Center Utrecht for helpwith the animalmodel, planning the study and
valuable discussion of the results. This studywas ﬁnancially supported
by a grant from theMedical Faculty at Norwegian University of Science
and Technology.
References
Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A.,
Nicotera, P., 1995. Glutamate-induced neuronal death: a succession of necrosis or
apoptosis depending on mitochondrial function. Neuron 15, 961–973.
Aoki, I., Ebisu, T., Tanaka, C., Katsuta, K., Fujikawa, A., Umeda, M., Fukunaga, M.,
Takegami, T., Shapiro, E.M., Naruse, S., 2003. Detection of the anoxic depolarization
of focal ischemia using manganese enhanced MRI. Magn. Reson. Med. 50, 7–12.
Aoki, I., Naruse, S., Tanaka, C., 2004. Manganese-enhanced magnetic resonance imaging
(MEMRI) of brain activity and applications to early detection of brain ischemia.
NMR Biomed. 17, 569–580.
Bidmon, H.J., Kato, K., Schleicher, A., Witte, O.W., Zilles, K., Traystman, R.J., 1998.
Transient increase of manganese–superoxide dismutase in remote brain areas after
focal photothrombotic cortical lesion. Stroke 29, 203–211.
Erikson, K.M., Aschner, M., 2006. Increased manganese uptake by primary astrocyte
cultures with altered iron status is mediated primarily by divalent metal
transporter. Neurotoxicology 27, 125–130.
Ferriero, D.M., 2004. Neonatal brain injury. N. Engl. J. Med. 351, 1985–1995.
Fujioka, M., Taoka, T., Matsuo, Y., Mishima, K., Ogoshi, K., Kondo, Y., Tsuda, M., Fujiwara,
M., Asano, T., Sakaki, T., Miyasaki, A., Park, D., Siesjo, B.K., 2003. Magnetic resonance
imaging shows delayed ischemic striatal neurodegeneration. Ann. Neurol. 54,
732–747.
Geddes, R., Vannucci, R.C., Vannucci, S.J., 2001. Delayed cerebral atrophy following
moderate hypoxia–ischemia in the immature rat. Dev. Neurosci., 23, 180–185.
Gonzalez, R.C., Woods, R.E., Eddins, S.L., 2004. Digital Image Processing Using Matlab.
Pearson Education Inc., Pearson Prentice Hall, Upper Saddle River, New Jersey,
USA.
Gunter, T.E., Gavin, C.E., Aschner, M., Gunter, K.K., 2006. Speciation of manganese in cells
and mitochondria: a search for the proximal cause of manganese neurotoxicity.
Neurotoxocology 27, 765–776.
Haapanen, A., Ramadan, U.A., Autti, T., Joensuu, R., Tyynelä, J., 2007. In vivo MRI reveals
the dynamics of pathological changes in the brains of cathepsin D-deﬁcient mice
and correlates changes in manganese-enhanced MRI with microglial activation.
Magn. Reson. Imag. 25, 1024–1031.
Ito, U., Nagasao, J., Kawakami, E., Oyanagi, K., 2007. Fate of disseminated dead neurons in
the cortical ischemic penumbra. Ultrastructure indicating a novel scavenger
mechanism of microglia and astrocytes. Stroke 38, 2577–2583.
Kristián, T., Siesjö, B.K., 1998. Calcium in ischemic cell death. Stroke 29, 705–718.
Koretsky, A.P., Silva, A.C., 2004. Manganese-enhanced magnetic resonance imaging
(MEMRI). NMR Biomed. 17, 527–531.
Kuo, Y.T., Herlihy, A.H., So, P.W., Bhakoo, K.K., Bell, J.D., 2005. In vivo measurement of T1
relaxation times in mouse brain associated with different modes of systemic
administration of manganese chloride. J. Magn. Reson. Imag. 21, 334–339.
Lindenau, J., Noack, H., Possel, H., Asayama, K., Wolf, G., 2000. Cellular distribution of
superoxide dismutases in the rat CNS. Glia 29, 25–34.
McLean, C., Ferriero, D., 2004. Mechanisms of hypoxic–ischemic injury in the term
infant. Semin. Perinatol. 28, 425–432.
McRae, A., Gilland, E., Bona, E., Hagberg, H., 1995. Microglia activation after neonatal
hypoxic–ischemia. Dev. Brain Res. 84, 245–252.Meng, S., Qiao, M., Scobie, K., Tomanek, B., Tuor, U.I., 2006. Evolution of magnetic
resonance imaging changes associated with cerebral hypoxia–ischemia and a
relatively selective white matter injury in neonatal rats. Pediatr. Res. 59, 554–559.
Nakajima, W., Ishida, A., Lange, M.S., Gabrielson, K.L., Wilson, M.A., Martin, L.J., Blue, M.
E., Johnston, M.V., 2000. Apoptosis has a prolonged role in the neurodegeneration
after hypoxic ischemia in the newborn rat. J. Neurosci. 20, 7994–8004.
Northington, F.J., Ferriero, D.M., Graham, E.M., Traystman, R.J., Martin, L.J., 2001. Early
neurodegeneration after hypoxia–ischemia in neonatal rat is necrosis while
delayed neuronal death is apoptosis. Neurobiol. Dis. 8, 207–219.
Northington, F.J., Graham, E.M., Martin, L.J., 2005. Apoptosis in perinatal hypoxic–
ischemic brain injury: how important is it and should it be inhibited? Brain. Res.
Brain. Res. Rev. 50, 244–257.
Ohno, M., Aotani, H., Shimada, M., 1994. Glial responses to hypoxic/ischemic
encephalopathy in neonatal rat cerebrum. Dev. Brain. Res. 84, 294–298.
Paxinos, G., Watson, C., 1998. The Rat Brain in Stereotaxic Coordinates, 4th ed. Academic
Press, San Diego, CA.
Qiao, M., Latta, P., Meng, S., Tomanek, B., Tuor, U.I., 2004. Development of acute edema
following cerebral hypoxia–ischemia in neonatal compared with juvenile rats using
magnetic resonance imaging. Pediatr Res. 55, 101–106.
Rice, J.E., Vannucci, R.C., Brierley, J.B., 1981. The inﬂuence of immaturity on hypoxic–
ischemic brain damage in the rat. Ann. Neurol. 9, 131–141.
Schilling, M., Besselmann, M., Leonhard, C., Mueller, M., Ringelstein, E.B., Kiefer, R., 2003.
Microglial activation precedes and predominates over macrophage inﬁltration in
transient focal cerebral ischemia: a study in green ﬂuorescent protein transgenic
bone marrow chimeric mice. Exp. Neurol. 183, 25–33.
Silva, A.C., Lee, J.H., Aoki, I., Koretsky, A.P., 2004. Manganese-enhanced magnetic
resonance imaging (MEMRI): methodological and practical considerations. NMR
Biomed. 17, 532–543.
de Sousa, P.L., de Souza, S.L., Silva, A.C., de Souza, R.E., de Castro, R.M., 2007. Manganese-
enhanced magnetic resonance imaging (MEMRI) of rat brain after systemic
administration of MnCl2: changes in T1 relaxation times during postnatal
development. J. Magn. Reson. Imag. 25, 32–38.
Takeda, A., 2003. Manganese action in brain function. Brain. Res. Brain. Res. Rev. 41,
79–87.
Tanaka, R., Komine-Kobayashi, M., Mochizuki, H., et al., 2003.Migration of enhanced green
ﬂuorescent protein expressing bone marrow-derived microglia/macrophage into the
mouse brain following permanent focal ischemia. Neuroscience 117, 531–539.
Vannucci, S.J., Hagberg, H., 2004. Hypoxia–ischemia in the immature brain. J. Experim.
Biol. 207, 3149–3154.
Vannucci, R.C., Perlman, J.M., 1997. Interventions for perinatal hypoxic–ischemic
encephalopathy. Pediatrics 100, 1004–1014.
Vannucci, R.C., Vannucci, S.J., 2005. Perinatal hypoxic–ischemic brain damage:
evolution of an animal model. Dev. Neurosci. 27, 81–86.
Wadghiri, Y.Z., Blind, J.A., Duan, X., Moreno, C., Yu, X., Joyner, A.L., Turnbull, D.H., 2004.
Manganese-enhanced magnetic resonance imaging (MEMRI) of mouse brain
development. NMR Biomed. 17, 613–619.
Watanabe, T., Natt, O., Boretius, S., Frahm, J., Michaelis, T., 2002. In vivo 3D MRI staining
of mouse brain after subcutaneous application of MnCl2. Magn. Reson. Med. 48,
852–859.
Wedler, F., Denman, R., 1984. Glutamine synthetase: the major Mn(II) enzyme in
mammalian brain. Curr. Top. Cell. Regul. 24, 153–169.
Weber, R., Wegener, S., Ramos-Cabrer, P., Wiedermann, D., Hoehn, M., 2005. MRI
detection of macrophage activity after experimental stroke in rats: new indicators
for late appearance of vascular degradation? Magn. Reson. Med. 54, 59–66.
Wegener, S., Weber, R., Ramos-Cabrer, P., Uhlenkueken, U., Sprenger, C., Wiedermann,
D., Villringer, A., Hoehn, M., 2006. Temporal proﬁle of T2-weighted MRI
distinguishes between pannecrosis and selective neuronal death after transient
focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 26, 38–47.
Won, S.J., Kim, D.Y., Gwag, B.J., 2002. Cellular and molecular pathways of ischemic
neuronal death. J. Biochem. Mol. Biol. 35, 67–86.
Zheng, W., Kim, H., Zhao, Q., 2000. Comparative toxicokinetics of manganese chloride
and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague–Dawley
rats. Toxicol. Sci. 54, 295–301.
 
Dissertations at the Faculty of Medicine, NTNU 
 
1977 
1. Knut Joachim Berg: EFFECT OF ACETYLSALICYLIC ACID ON RENAL FUNCTION 
2. Karl Erik Viken and Arne Ødegaard: STUDIES ON HUMAN MONOCYTES CULTURED IN  
VITRO 
1978 
3. Karel Bjørn Cyvin: CONGENITAL DISLOCATION OF THE HIP JOINT. 
4. Alf O. Brubakk: METHODS FOR STUDYING FLOW DYNAMICS IN THE LEFT 
VENTRICLE  AND THE AORTA IN MAN. 
1979 
5. Geirmund Unsgaard: CYTOSTATIC AND IMMUNOREGULATORY ABILITIES OF 
HUMAN    BLOOD MONOCYTES CULTURED IN VITRO 
1980 
6. Størker Jørstad: URAEMIC TOXINS 
7. Arne Olav Jenssen: SOME RHEOLOGICAL, CHEMICAL AND STRUCTURAL 
PROPERTIES    OF MUCOID SPUTUM FROM PATIENTS WITH CHRONIC 
OBSTRUCTIVE BRONCHITIS 
1981 
8. Jens Hammerstrøm: CYTOSTATIC AND CYTOLYTIC ACTIVITY OF HUMAN 
MONOCYTES AND EFFUSION MACROPHAGES AGAINST TUMOR CELLS IN VITRO 
1983 
9. Tore Syversen: EFFECTS OF METHYLMERCURY ON RAT BRAIN PROTEIN. 
10. Torbjørn Iversen: SQUAMOUS CELL CARCINOMA OF THE VULVA. 
1984 
11. Tor-Erik Widerøe: ASPECTS OF CONTINUOUS AMBULATORY PERITONEAL 
DIALYSIS. 
12. Anton Hole: ALTERATIONS OF MONOCYTE AND LYMPHOCYTE FUNCTIONS IN 
REALTION TO SURGERY UNDER EPIDURAL OR GENERAL ANAESTHESIA. 
13. Terje Terjesen: FRACTURE HEALING AND STRESS-PROTECTION AFTER METAL 
PLATE FIXATION AND EXTERNAL FIXATION. 
14. Carsten Saunte: CLUSTER HEADACHE SYNDROME. 
15. Inggard Lereim: TRAFFIC ACCIDENTS AND THEIR CONSEQUENCES. 
16. Bjørn Magne Eggen: STUDIES IN CYTOTOXICITY IN HUMAN ADHERENT 
MONONUCLEAR BLOOD CELLS. 
17. Trond Haug: FACTORS REGULATING BEHAVIORAL EFFECTS OG DRUGS. 
1985 
18. Sven Erik Gisvold: RESUSCITATION AFTER COMPLETE GLOBAL BRAIN ISCHEMIA. 
19. Terje Espevik: THE CYTOSKELETON OF HUMAN MONOCYTES. 
20. Lars Bevanger: STUDIES OF THE Ibc (c) PROTEIN ANTIGENS OF GROUP B 
STREPTOCOCCI. 
21. Ole-Jan Iversen: RETROVIRUS-LIKE PARTICLES IN THE PATHOGENESIS OF 
PSORIASIS. 
22. Lasse Eriksen: EVALUATION AND TREATMENT OF ALCOHOL DEPENDENT 
BEHAVIOUR. 
23. Per I. Lundmo: ANDROGEN METABOLISM IN THE PROSTATE. 
1986 
24. Dagfinn Berntzen: ANALYSIS AND MANAGEMENT OF EXPERIMENTAL AND 
CLINICAL PAIN. 
25. Odd Arnold Kildahl-Andersen: PRODUCTION AND CHARACTERIZATION OF 
MONOCYTE-DERIVED CYTOTOXIN AND ITS ROLE IN MONOCYTE-MEDIATED 
CYTOTOXICITY. 
26. Ola Dale: VOLATILE ANAESTHETICS. 
1987 
27. Per Martin Kleveland: STUDIES ON GASTRIN. 
28. Audun N. Øksendal: THE CALCIUM PARADOX AND THE HEART. 
29. Vilhjalmur R. Finsen: HIP FRACTURES 
1988 
30. Rigmor Austgulen: TUMOR NECROSIS FACTOR: A MONOCYTE-DERIVED 
REGULATOR OF CELLULAR GROWTH. 
31. Tom-Harald Edna: HEAD INJURIES ADMITTED TO HOSPITAL. 
32. Joseph D. Borsi: NEW ASPECTS OF THE CLINICAL PHARMACOKINETICS OF 
METHOTREXATE. 
33. Olav F. M. Sellevold: GLUCOCORTICOIDS IN MYOCARDIAL PROTECTION. 
34. Terje Skjærpe: NONINVASIVE QUANTITATION OF GLOBAL PARAMETERS ON LEFT 
VENTRICULAR FUNCTION: THE SYSTOLIC PULMONARY ARTERY PRESSURE AND 
CARDIAC OUTPUT. 
35. Eyvind Rødahl: STUDIES OF IMMUNE COMPLEXES AND RETROVIRUS-LIKE 
ANTIGENS IN PATIENTS WITH ANKYLOSING SPONDYLITIS. 
36. Ketil Thorstensen: STUDIES ON THE MECHANISMS OF CELLULAR UPTAKE OF IRON 
FROM TRANSFERRIN. 
37. Anna Midelfart: STUDIES OF THE MECHANISMS OF ION AND FLUID TRANSPORT IN 
THE BOVINE CORNEA. 
38. Eirik Helseth: GROWTH AND PLASMINOGEN ACTIVATOR ACTIVITY OF HUMAN 
GLIOMAS AND BRAIN METASTASES - WITH SPECIAL REFERENCE TO 
TRANSFORMING GROWTH FACTOR BETA AND THE EPIDERMAL GROWTH 
FACTOR RECEPTOR. 
39. Petter C. Borchgrevink: MAGNESIUM AND THE ISCHEMIC HEART. 
40. Kjell-Arne Rein: THE EFFECT OF EXTRACORPOREAL CIRCULATION ON 
SUBCUTANEOUS TRANSCAPILLARY FLUID BALANCE. 
41. Arne Kristian Sandvik: RAT GASTRIC HISTAMINE. 
42. Carl Bredo Dahl: ANIMAL MODELS IN PSYCHIATRY. 
1989 
43. Torbjørn A. Fredriksen: CERVICOGENIC HEADACHE. 
44. Rolf A. Walstad: CEFTAZIDIME. 
45. Rolf Salvesen: THE PUPIL IN CLUSTER HEADACHE. 
46. Nils Petter Jørgensen: DRUG EXPOSURE IN EARLY PREGNANCY. 
47. Johan C. Ræder: PREMEDICATION AND GENERAL ANAESTHESIA IN OUTPATIENT 
GYNECOLOGICAL SURGERY. 
48. M. R. Shalaby: IMMUNOREGULATORY PROPERTIES OF TNF-α AND THE RELATED 
CYTOKINES. 
49. Anders Waage: THE COMPLEX PATTERN OF CYTOKINES IN SEPTIC SHOCK. 
50. Bjarne Christian Eriksen: ELECTROSTIMULATION OF THE PELVIC FLOOR IN FEMALE 
URINARY INCONTINENCE. 
51. Tore B. Halvorsen: PROGNOSTIC FACTORS IN COLORECTAL CANCER. 
1990 
52. Asbjørn Nordby: CELLULAR TOXICITY OF ROENTGEN CONTRAST MEDIA. 
53. Kåre E. Tvedt: X-RAY MICROANALYSIS OF BIOLOGICAL MATERIAL. 
54. Tore C. Stiles: COGNITIVE VULNERABILITY FACTORS IN THE DEVELOPMENT AND 
MAINTENANCE OF DEPRESSION. 
55. Eva Hofsli: TUMOR NECROSIS FACTOR AND MULTIDRUG RESISTANCE. 
56. Helge S. Haarstad: TROPHIC EFFECTS OF CHOLECYSTOKININ AND SECRETIN ON 
THE RAT PANCREAS. 
57. Lars Engebretsen: TREATMENT OF ACUTE ANTERIOR CRUCIATE LIGAMENT 
INJURIES. 
58. Tarjei Rygnestad: DELIBERATE SELF-POISONING IN TRONDHEIM. 
59. Arne Z. Henriksen: STUDIES ON CONSERVED ANTIGENIC DOMAINS ON MAJOR 
OUTER MEMBRANE PROTEINS FROM ENTEROBACTERIA. 
60. Steinar Westin: UNEMPLOYMENT AND HEALTH: Medical and social consequences of a 
factory closure in a ten-year controlled follow-up study. 
61. Ylva Sahlin: INJURY REGISTRATION, a tool for accident preventive work. 
62. Helge Bjørnstad Pettersen: BIOSYNTHESIS OF COMPLEMENT BY HUMAN ALVEOLAR 
MACROPHAGES WITH SPECIAL REFERENCE TO SARCOIDOSIS. 
63. Berit Schei: TRAPPED IN PAINFUL LOVE. 
64. Lars J. Vatten: PROSPECTIVE STUDIES OF THE RISK OF BREAST CANCER IN A 
COHORT OF NORWEGIAN WOMAN. 
1991 
65. Kåre Bergh: APPLICATIONS OF ANTI-C5a SPECIFIC MONOCLONAL ANTIBODIES FOR 
THE ASSESSMENT OF COMPLEMENT ACTIVATION. 
66. Svein Svenningsen: THE CLINICAL SIGNIFICANCE OF INCREASED FEMORAL 
ANTEVERSION. 
67. Olbjørn Klepp: NONSEMINOMATOUS GERM CELL TESTIS CANCER: THERAPEUTIC 
OUTCOME AND PROGNOSTIC FACTORS. 
68. Trond Sand: THE EFFECTS OF CLICK POLARITY ON BRAINSTEM AUDITORY 
EVOKED POTENTIALS AMPLITUDE, DISPERSION, AND LATENCY VARIABLES. 
69. Kjetil B. Åsbakk: STUDIES OF A PROTEIN FROM PSORIATIC SCALE, PSO P27, WITH 
RESPECT TO ITS POTENTIAL ROLE IN IMMUNE REACTIONS IN PSORIASIS. 
70. Arnulf Hestnes: STUDIES ON DOWN´S SYNDROME. 
71. Randi Nygaard: LONG-TERM SURVIVAL IN CHILDHOOD LEUKEMIA. 
72. Bjørn Hagen: THIO-TEPA. 
73. Svein Anda: EVALUATION OF THE HIP JOINT BY COMPUTED TOMOGRAMPHY AND 
ULTRASONOGRAPHY. 
1992 
74. Martin Svartberg: AN INVESTIGATION OF PROCESS AND OUTCOME OF SHORT-TERM 
PSYCHODYNAMIC PSYCHOTHERAPY. 
75. Stig Arild Slørdahl: AORTIC REGURGITATION. 
76. Harold C Sexton: STUDIES RELATING TO THE TREATMENT OF SYMPTOMATIC NON-
PSYCHOTIC PATIENTS. 
77. Maurice B. Vincent: VASOACTIVE PEPTIDES IN THE OCULAR/FOREHEAD AREA. 
78. Terje Johannessen: CONTROLLED TRIALS IN SINGLE SUBJECTS. 
79. Turid Nilsen: PYROPHOSPHATE IN HEPATOCYTE IRON METABOLISM. 
80. Olav Haraldseth: NMR SPECTROSCOPY OF CEREBRAL ISCHEMIA AND REPERFUSION 
IN RAT. 
81. Eiliv Brenna: REGULATION OF FUNCTION AND GROWTH OF THE OXYNTIC 
MUCOSA. 
1993 
82. Gunnar Bovim: CERVICOGENIC HEADACHE. 
83. Jarl Arne Kahn: ASSISTED PROCREATION. 
84. Bjørn Naume: IMMUNOREGULATORY EFFECTS OF CYTOKINES ON NK CELLS. 
85. Rune Wiseth: AORTIC VALVE REPLACEMENT. 
86. Jie Ming Shen: BLOOD FLOW VELOCITY AND RESPIRATORY STUDIES. 
87. Piotr Kruszewski: SUNCT SYNDROME WITH SPECIAL REFERENCE TO THE 
AUTONOMIC NERVOUS SYSTEM. 
88. Mette Haase Moen: ENDOMETRIOSIS. 
89. Anne Vik: VASCULAR GAS EMBOLISM DURING AIR INFUSION AND AFTER 
DECOMPRESSION IN PIGS. 
90. Lars Jacob Stovner: THE CHIARI TYPE I MALFORMATION. 
91. Kjell Å. Salvesen: ROUTINE ULTRASONOGRAPHY IN UTERO AND DEVELOPMENT IN 
CHILDHOOD. 
1994 
92. Nina-Beate Liabakk: DEVELOPMENT OF IMMUNOASSAYS FOR TNF AND ITS 
SOLUBLE RECEPTORS. 
93. Sverre Helge Torp: erbB ONCOGENES IN HUMAN GLIOMAS AND MENINGIOMAS. 
94. Olav M. Linaker: MENTAL RETARDATION AND PSYCHIATRY. Past and present. 
95. Per Oscar Feet: INCREASED ANTIDEPRESSANT AND ANTIPANIC EFFECT IN 
COMBINED TREATMENT WITH DIXYRAZINE AND TRICYCLIC ANTIDEPRESSANTS. 
96. Stein Olav Samstad: CROSS SECTIONAL FLOW VELOCITY PROFILES FROM TWO-
DIMENSIONAL DOPPLER ULTRASOUND: Studies on early mitral blood flow. 
97. Bjørn Backe: STUDIES IN ANTENATAL CARE. 
98. Gerd Inger Ringdal: QUALITY OF LIFE IN CANCER PATIENTS. 
99. Torvid Kiserud: THE DUCTUS VENOSUS IN THE HUMAN FETUS. 
100. Hans E. Fjøsne: HORMONAL REGULATION OF PROSTATIC METABOLISM. 
101. Eylert Brodtkorb: CLINICAL ASPECTS OF EPILEPSY IN THE MENTALLY RETARDED. 
102. Roar Juul: PEPTIDERGIC MECHANISMS IN HUMAN SUBARACHNOID HEMORRHAGE. 
103. Unni Syversen: CHROMOGRANIN A. Phsysiological and Clinical Role. 
1995 
104. Odd Gunnar Brakstad: THERMOSTABLE NUCLEASE AND THE nuc GENE IN THE 
DIAGNOSIS OF Staphylococcus aureus INFECTIONS. 
105. Terje Engan: NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY OF PLASMA 
IN MALIGNANT DISEASE. 
106. Kirsten Rasmussen: VIOLENCE IN THE MENTALLY DISORDERED. 
107. Finn Egil Skjeldestad: INDUCED ABORTION: Timetrends and Determinants. 
108. Roar Stenseth: THORACIC EPIDURAL ANALGESIA IN AORTOCORONARY BYPASS 
SURGERY. 
109. Arild Faxvaag: STUDIES OF IMMUNE CELL FUNCTION in mice infected with MURINE 
RETROVIRUS. 
1996 
110. Svend Aakhus: NONINVASIVE COMPUTERIZED ASSESSMENT OF LEFT 
VENTRICULAR FUNCTION AND SYSTEMIC ARTERIAL PROPERTIES. Methodology and 
some clinical applications. 
111. Klaus-Dieter Bolz: INTRAVASCULAR ULTRASONOGRAPHY. 
112. Petter Aadahl: CARDIOVASCULAR EFFECTS OF THORACIC AORTIC CROSS-
CLAMPING. 
113. Sigurd Steinshamn: CYTOKINE MEDIATORS DURING GRANULOCYTOPENIC 
INFECTIONS. 
114. Hans Stifoss-Hanssen: SEEKING MEANING OR HAPPINESS? 
115. Anne Kvikstad: LIFE CHANGE EVENTS AND MARITAL STATUS IN RELATION TO 
RISK AND PROGNOSIS OF CANCER. 
116. Torbjørn Grøntvedt: TREATMENT OF ACUTE AND CHRONIC ANTERIOR CRUCIATE 
LIGAMENT INJURIES. A clinical and biomechanical study. 
117. Sigrid Hørven Wigers: CLINICAL STUDIES OF FIBROMYALGIA WITH FOCUS ON 
ETIOLOGY, TREATMENT AND OUTCOME. 
118. Jan Schjøtt: MYOCARDIAL PROTECTION: Functional and Metabolic Characteristics of Two 
Endogenous Protective Principles. 
119. Marit Martinussen: STUDIES OF INTESTINAL BLOOD FLOW AND ITS RELATION TO 
TRANSITIONAL CIRCULATORY ADAPATION IN NEWBORN INFANTS. 
120. Tomm B. Müller: MAGNETIC RESONANCE IMAGING IN FOCAL CEREBRAL 
ISCHEMIA. 
121. Rune Haaverstad: OEDEMA FORMATION OF THE LOWER EXTREMITIES. 
122. Magne Børset: THE ROLE OF CYTOKINES IN MULTIPLE MYELOMA, WITH SPECIAL 
REFERENCE TO HEPATOCYTE GROWTH FACTOR. 
123. Geir Smedslund: A THEORETICAL AND EMPIRICAL INVESTIGATION OF SMOKING, 
STRESS AND DISEASE: RESULTS FROM A POPULATION SURVEY. 
1997 
124. Torstein Vik: GROWTH, MORBIDITY, AND PSYCHOMOTOR DEVELOPMENT IN 
INFANTS WHO WERE GROWTH RETARDED IN UTERO. 
125. Siri Forsmo: ASPECTS AND CONSEQUENCES OF OPPORTUNISTIC SCREENING FOR 
CERVICAL CANCER. Results based on data from three Norwegian counties. 
126. Jon S. Skranes: CEREBRAL MRI AND NEURODEVELOPMENTAL OUTCOME IN VERY 
LOW BIRTH WEIGHT (VLBW) CHILDREN. A follow-up study of a geographically based 
year cohort of VLBW children at ages one and six years. 
127. Knut Bjørnstad: COMPUTERIZED ECHOCARDIOGRAPHY FOR EVALUTION OF 
CORONARY ARTERY DISEASE. 
128. Grethe Elisabeth Borchgrevink: DIAGNOSIS AND TREATMENT OF WHIPLASH/NECK 
SPRAIN INJURIES CAUSED BY CAR ACCIDENTS. 
129. Tor Elsås: NEUROPEPTIDES AND NITRIC OXIDE SYNTHASE IN OCULAR 
AUTONOMIC AND SENSORY NERVES. 
130. Rolf W. Gråwe: EPIDEMIOLOGICAL AND NEUROPSYCHOLOGICAL PERSPECTIVES 
ON SCHIZOPHRENIA. 
131. Tonje Strømholm: CEREBRAL HAEMODYNAMICS DURING THORACIC AORTIC 
CROSSCLAMPING. An experimental study in pigs. 
1998 
132. Martinus Bråten: STUDIES ON SOME PROBLEMS REALTED TO INTRAMEDULLARY 
NAILING OF FEMORAL FRACTURES. 
133. Ståle Nordgård: PROLIFERATIVE ACTIVITY AND DNA CONTENT AS PROGNOSTIC 
INDICATORS IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK. 
134. Egil Lien: SOLUBLE RECEPTORS FOR TNF AND LPS: RELEASE PATTERN AND 
POSSIBLE SIGNIFICANCE IN DISEASE. 
135. Marit Bjørgaas: HYPOGLYCAEMIA IN CHILDREN WITH DIABETES MELLITUS 
136. Frank Skorpen: GENETIC AND FUNCTIONAL ANALYSES OF DNA REPAIR IN HUMAN 
CELLS. 
137. Juan A. Pareja: SUNCT SYNDROME. ON THE CLINICAL PICTURE. ITS DISTINCTION 
FROM OTHER, SIMILAR HEADACHES. 
138. Anders Angelsen: NEUROENDOCRINE CELLS IN HUMAN PROSTATIC CARCINOMAS 
AND THE PROSTATIC COMPLEX OF RAT, GUINEA PIG, CAT AND DOG. 
139. Fabio Antonaci: CHRONIC  PAROXYSMAL HEMICRANIA AND HEMICRANIA 
CONTINUA: TWO DIFFERENT ENTITIES? 
140. Sven M. Carlsen: ENDOCRINE AND METABOLIC EFFECTS OF METFORMIN WITH 
SPECIAL EMPHASIS ON CARDIOVASCULAR RISK FACTORES. 
1999 
141. Terje A. Murberg: DEPRESSIVE SYMPTOMS AND COPING AMONG PATIENTS WITH 
CONGESTIVE HEART FAILURE. 
142. Harm-Gerd Karl Blaas: THE EMBRYONIC EXAMINATION. Ultrasound studies on the 
development of the human embryo. 
143. Noèmi Becser Andersen:THE CEPHALIC SENSORY NERVES IN UNILATERAL 
HEADACHES. Anatomical background and neurophysiological evaluation. 
144. Eli-Janne Fiskerstrand: LASER TREATMENT OF PORT WINE STAINS. A study of the 
efficacy and limitations of the pulsed dye laser. Clinical and morfological analyses aimed at 
improving the therapeutic outcome. 
145. Bård Kulseng: A STUDY OF ALGINATE CAPSULE PROPERTIES AND CYTOKINES IN 
RELATION TO INSULIN DEPENDENT DIABETES MELLITUS. 
146. Terje Haug: STRUCTURE AND REGULATION OF THE HUMAN UNG GENE ENCODING 
URACIL-DNA GLYCOSYLASE. 
147. Heidi Brurok: MANGANESE AND THE HEART. A Magic Metal with Diagnostic and 
Therapeutic Possibilites. 
148. Agnes Kathrine Lie: DIAGNOSIS AND PREVALENCE OF HUMAN PAPILLOMAVIRUS 
INFECTION IN CERVICAL INTRAEPITELIAL NEOPLASIA. Relationship to Cell Cycle 
Regulatory Proteins and HLA DQBI Genes. 
149. Ronald Mårvik: PHARMACOLOGICAL, PHYSIOLOGICAL AND 
PATHOPHYSIOLOGICAL STUDIES ON ISOLATED STOMACS. 
150. Ketil Jarl Holen: THE ROLE OF ULTRASONOGRAPHY IN THE DIAGNOSIS AND 
TREATMENT OF HIP DYSPLASIA IN NEWBORNS. 
151. Irene Hetlevik:  THE ROLE OF CLINICAL GUIDELINES IN CARDIOVASCULAR RISK 
INTERVENTION IN GENERAL PRACTICE. 
152. Katarina Tunòn: ULTRASOUND AND PREDICTION OF GESTATIONAL AGE. 
153. Johannes Soma: INTERACTION BETWEEN THE LEFT VENTRICLE AND THE SYSTEMIC 
ARTERIES. 
154. Arild Aamodt: DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A CUSTOM-
MADE FEMORAL STEM. 
155. Agnar Tegnander: DIAGNOSIS AND FOLLOW-UP OF CHILDREN WITH SUSPECTED OR 
KNOWN HIP DYSPLASIA. 
156. Bent Indredavik: STROKE UNIT TREATMENT: SHORT AND LONG-TERM EFFECTS 
157. Jolanta Vanagaite Vingen: PHOTOPHOBIA AND PHONOPHOBIA IN PRIMARY 
HEADACHES 
2000 
158. Ola Dalsegg Sæther: PATHOPHYSIOLOGY DURING PROXIMAL AORTIC CROSS-
CLAMPING CLINICAL AND EXPERIMENTAL STUDIES 
159. xxxxxxxxx (blind number) 
160. Christina Vogt Isaksen: PRENATAL ULTRASOUND AND POSTMORTEM FINDINGS – A 
TEN YEAR CORRELATIVE STUDY OF FETUSES AND INFANTS WITH 
DEVELOPMENTAL ANOMALIES. 
161. Holger Seidel: HIGH-DOSE METHOTREXATE THERAPY IN CHILDREN WITH ACUTE 
LYMPHOCYTIC LEUKEMIA: DOSE, CONCENTRATION, AND EFFECT 
CONSIDERATIONS. 
162. Stein Hallan: IMPLEMENTATION OF MODERN MEDICAL DECISION ANALYSIS INTO 
CLINICAL DIAGNOSIS AND TREATMENT. 
163. Malcolm Sue-Chu: INVASIVE AND NON-INVASIVE STUDIES IN CROSS-COUNTRY 
SKIERS WITH ASTHMA-LIKE SYMPTOMS. 
164. Ole-Lars Brekke: EFFECTS OF ANTIOXIDANTS AND FATTY ACIDS ON TUMOR 
NECROSIS FACTOR-INDUCED CYTOTOXICITY. 
165. Jan Lundbom: AORTOCORONARY BYPASS SURGERY: CLINICAL ASPECTS, COST 
CONSIDERATIONS AND WORKING ABILITY. 
166. John-Anker Zwart: LUMBAR NERVE ROOT COMPRESSION, BIOCHEMICAL AND 
NEUROPHYSIOLOGICAL ASPECTS. 
167. Geir Falck: HYPEROSMOLALITY AND THE HEART. 
168. Eirik Skogvoll: CARDIAC ARREST Incidence, Intervention and Outcome. 
169. Dalius Bansevicius: SHOULDER-NECK REGION IN CERTAIN HEADACHES AND 
CHRONIC PAIN SYNDROMES. 
170. Bettina Kinge: REFRACTIVE ERRORS AND BIOMETRIC CHANGES AMONG 
UNIVERSITY STUDENTS IN NORWAY. 
171. Gunnar Qvigstad: CONSEQUENCES OF HYPERGASTRINEMIA IN MAN 
172. Hanne Ellekjær: EPIDEMIOLOGICAL STUDIES OF STROKE IN A NORWEGIAN 
POPULATION. INCIDENCE, RISK FACTORS AND PROGNOSIS 
173. Hilde Grimstad: VIOLENCE AGAINST WOMEN AND PREGNANCY OUTCOME. 
174. Astrid Hjelde: SURFACE TENSION AND COMPLEMENT ACTIVATION: Factors 
influencing bubble formation and bubble effects after decompression. 
175. Kjell A. Kvistad: MR IN BREAST CANCER – A CLINICAL STUDY. 
176. Ivar Rossvoll: ELECTIVE ORTHOPAEDIC SURGERY IN A DEFINED POPULATION. 
Studies on demand, waiting time for treatment and incapacity for work. 
177. Carina Seidel: PROGNOSTIC VALUE AND BIOLOGICAL EFFECTS OF HEPATOCYTE 
GROWTH FACTOR AND SYNDECAN-1 IN MULTIPLE MYELOMA. 
2001 
178. Alexander Wahba: THE INFLUENCE OF CARDIOPULMONARY BYPASS ON PLATELET 
FUNCTION AND BLOOD COAGULATION – DETERMINANTS AND CLINICAL 
CONSEQUENSES 
179. Marcus Schmitt-Egenolf: THE RELEVANCE OF THE MAJOR hISTOCOMPATIBILITY 
COMPLEX FOR THE GENETICS OF PSORIASIS 
180. Odrun Arna Gederaas: BIOLOGICAL MECHANISMS INVOLVED IN 5-AMINOLEVULINIC 
ACID BASED PHOTODYNAMIC THERAPY 
181. Pål Richard Romundstad: CANCER INCIDENCE AMONG NORWEGIAN ALUMINIUM 
WORKERS 
182. Henrik Hjorth-Hansen: NOVEL CYTOKINES IN GROWTH CONTROL AND BONE 
DISEASE OF MULTIPLE MYELOMA 
183. Gunnar Morken: SEASONAL VARIATION OF HUMAN MOOD AND BEHAVIOUR 
184. Bjørn Olav Haugen: MEASUREMENT OF CARDIAC OUTPUT AND STUDIES OF 
VELOCITY PROFILES IN AORTIC AND MITRAL FLOW USING TWO- AND THREE-
DIMENSIONAL COLOUR FLOW IMAGING 
185. Geir Bråthen: THE CLASSIFICATION AND CLINICAL DIAGNOSIS OF ALCOHOL-
RELATED SEIZURES 
186. Knut Ivar Aasarød: RENAL INVOLVEMENT IN INFLAMMATORY RHEUMATIC 
DISEASE. A Study of Renal Disease in Wegener’s Granulomatosis and in Primary Sjögren’s 
Syndrome  
187. Trude Helen Flo: RESEPTORS INVOLVED IN CELL ACTIVATION BY DEFINED URONIC 
ACID POLYMERS AND BACTERIAL COMPONENTS 
188. Bodil Kavli: HUMAN URACIL-DNA GLYCOSYLASES FROM THE UNG GENE: 
STRUCTRUAL BASIS FOR SUBSTRATE SPECIFICITY AND REPAIR 
189. Liv Thommesen: MOLECULAR MECHANISMS INVOLVED IN TNF- AND GASTRIN-
MEDIATED GENE REGULATION 
190. Turid Lingaas Holmen: SMOKING AND HEALTH IN ADOLESCENCE; THE NORD-
TRØNDELAG HEALTH STUDY, 1995-97 
191. Øyvind Hjertner: MULTIPLE MYELOMA: INTERACTIONS BETWEEN MALIGNANT 
PLASMA CELLS AND THE BONE MICROENVIRONMENT 
192. Asbjørn Støylen: STRAIN RATE IMAGING OF THE LEFT VENTRICLE BY 
ULTRASOUND. FEASIBILITY, CLINICAL VALIDATION AND PHYSIOLOGICAL 
ASPECTS 
193. Kristian Midthjell: DIABETES IN ADULTS IN NORD-TRØNDELAG. PUBLIC HEALTH 
ASPECTS OF DIABETES MELLITUS IN A LARGE, NON-SELECTED NORWEGIAN 
POPULATION. 
194. Guanglin Cui: FUNCTIONAL ASPECTS OF THE ECL CELL IN RODENTS 
195. Ulrik Wisløff: CARDIAC EFFECTS OF AEROBIC ENDURANCE TRAINING: 
HYPERTROPHY, CONTRACTILITY AND CALCUIM HANDLING IN NORMAL AND 
FAILING HEART 
196. Øyvind Halaas: MECHANISMS OF IMMUNOMODULATION AND CELL-MEDIATED 
CYTOTOXICITY INDUCED BY BACTERIAL PRODUCTS 
197. Tore Amundsen: PERFUSION MR IMAGING IN THE DIAGNOSIS OF PULMONARY 
EMBOLISM 
198. Nanna Kurtze: THE SIGNIFICANCE OF ANXIETY AND DEPRESSION IN FATIQUE AND 
PATTERNS OF PAIN AMONG INDIVIDUALS DIAGNOSED WITH FIBROMYALGIA: 
RELATIONS WITH QUALITY OF LIFE, FUNCTIONAL DISABILITY, LIFESTYLE, 
EMPLOYMENT STATUS, CO-MORBIDITY AND GENDER 
199. Tom Ivar Lund Nilsen: PROSPECTIVE STUDIES OF CANCER RISK IN NORD-
TRØNDELAG: THE HUNT STUDY. Associations with anthropometric, socioeconomic, and 
lifestyle risk factors 
200. Asta Kristine Håberg: A NEW APPROACH TO THE STUDY OF MIDDLE CEREBRAL 
ARTERY OCCLUSION IN THE RAT USING MAGNETIC RESONANCE TECHNIQUES 
2002 
201. Knut Jørgen Arntzen: PREGNANCY AND CYTOKINES 
202. Henrik Døllner: INFLAMMATORY MEDIATORS IN PERINATAL INFECTIONS 
203. Asta Bye: LOW FAT, LOW LACTOSE DIET USED AS PROPHYLACTIC TREATMENT OF 
ACUTE INTESTINAL REACTIONS DURING PELVIC RADIOTHERAPY. A 
PROSPECTIVE RANDOMISED STUDY. 
204. Sylvester Moyo: STUDIES ON STREPTOCOCCUS AGALACTIAE  (GROUP B 
STREPTOCOCCUS) SURFACE-ANCHORED MARKERS WITH EMPHASIS ON STRAINS 
AND HUMAN SERA FROM ZIMBABWE. 
205. Knut Hagen: HEAD-HUNT: THE EPIDEMIOLOGY OF HEADACHE IN NORD-
TRØNDELAG 
206. Li Lixin: ON THE REGULATION AND ROLE OF UNCOUPLING PROTEIN-2 IN INSULIN 
PRODUCING ß-CELLS 
207. Anne Hildur Henriksen: SYMPTOMS OF ALLERGY AND ASTHMA VERSUS MARKERS 
OF LOWER AIRWAY INFLAMMATION AMONG ADOLESCENTS 
208. Egil Andreas Fors: NON-MALIGNANT PAIN IN RELATION TO PSYCHOLOGICAL AND 
ENVIRONTENTAL FACTORS. EXPERIENTAL AND CLINICAL STUDES OF PAIN WITH 
FOCUS ON FIBROMYALGIA 
209. Pål Klepstad:  MORPHINE FOR CANCER PAIN 
210. Ingunn Bakke: MECHANISMS AND CONSEQUENCES OF PEROXISOME 
PROLIFERATOR-INDUCED HYPERFUNCTION OF THE RAT GASTRIN PRODUCING 
CELL 
211. Ingrid Susann Gribbestad: MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY OF 
BREAST CANCER 
212. Rønnaug Astri Ødegård: PREECLAMPSIA – MATERNAL RISK FACTORS AND FETAL 
GROWTH 
213. Johan Haux: STUDIES ON CYTOTOXICITY INDUCED BY HUMAN NATURAL KILLER 
CELLS AND DIGITOXIN 
214. Turid Suzanne Berg-Nielsen: PARENTING PRACTICES AND MENTALLY DISORDERED 
ADOLESCENTS 
215. Astrid Rydning: BLOOD FLOW AS A PROTECTIVE FACTOR FOR THE STOMACH 
MUCOSA. AN EXPERIMENTAL STUDY ON THE ROLE OF MAST CELLS AND 
SENSORY AFFERENT NEURONS 
2003 
216. Jan Pål Loennechen: HEART FAILURE AFTER MYOCARDIAL INFARCTION. Regional 
Differences, Myocyte Function, Gene Expression, and Response to Cariporide, Losartan, and 
Exercise Training. 
217. Elisabeth Qvigstad: EFFECTS OF FATTY ACIDS AND OVER-STIMULATION ON 
INSULIN SECRETION IN MAN 
218. Arne Åsberg: EPIDEMIOLOGICAL STUDIES IN HEREDITARY HEMOCHROMATOSIS: 
PREVALENCE, MORBIDITY AND BENEFIT OF SCREENING. 
219. Johan Fredrik Skomsvoll: REPRODUCTIVE OUTCOME IN WOMEN WITH RHEUMATIC 
DISEASE. A population registry based study of the effects of inflammatory rheumatic disease 
and connective tissue disease on reproductive outcome in Norwegian women in 1967-1995. 
220. Siv Mørkved: URINARY INCONTINENCE DURING PREGNANCY AND AFTER  
DELIVERY: EFFECT OF PELVIC FLOOR MUSCLE TRAINING IN PREVENTION AND 
TREATMENT 
221. Marit S. Jordhøy: THE IMPACT OF COMPREHENSIVE PALLIATIVE CARE 
222. Tom Christian Martinsen: HYPERGASTRINEMIA AND HYPOACIDITY IN RODENTS – 
CAUSES AND CONSEQUENCES  
223. Solveig Tingulstad: CENTRALIZATION OF PRIMARY SURGERY FOR OVARAIN 
CANCER. FEASIBILITY AND IMPACT ON SURVIVAL  
224. Haytham Eloqayli: METABOLIC CHANGES IN THE BRAIN CAUSED BY EPILEPTIC 
SEIZURES 
225. Torunn Bruland: STUDIES OF EARLY RETROVIRUS-HOST INTERACTIONS – VIRAL 
DETERMINANTS FOR PATHOGENESIS AND THE INFLUENCE OF SEX ON THE 
SUSCEPTIBILITY TO FRIEND MURINE LEUKAEMIA VIRUS INFECTION 
226. Torstein Hole: DOPPLER ECHOCARDIOGRAPHIC EVALUATION OF LEFT 
VENTRICULAR FUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION 
227. Vibeke Nossum: THE EFFECT OF VASCULAR BUBBLES ON ENDOTHELIAL FUNCTION 
228. Sigurd Fasting: ROUTINE BASED RECORDING OF ADVERSE EVENTS DURING 
ANAESTHESIA – APPLICATION IN QUALITY IMPROVEMENT AND SAFETY 
229. Solfrid Romundstad: EPIDEMIOLOGICAL STUDIES OF MICROALBUMINURIA. THE 
NORD-TRØNDELAG HEALTH STUDY 1995-97 (HUNT 2) 
230. Geir Torheim: PROCESSING OF DYNAMIC DATA SETS IN MAGNETIC RESONANCE 
IMAGING 
231. Catrine Ahlén: SKIN INFECTIONS IN OCCUPATIONAL SATURATION DIVERS IN THE 
NORTH SEA AND THE IMPACT OF THE ENVIRONMENT 
232. Arnulf Langhammer: RESPIRATORY SYMPTOMS, LUNG FUNCTION AND BONE 
MINERAL DENSITY IN A COMPREHENSIVE POPULATION SURVEY. THE NORD-
TRØNDELAG HEALTH STUDY 1995-97. THE BRONCHIAL OBSTRUCTION IN NORD-
TRØNDELAG STUDY 
233. Einar Kjelsås: EATING DISORDERS AND PHYSICAL ACTIVITY IN NON-CLINICAL 
SAMPLES 
234. Arne Wibe: RECTAL CANCER TREATMENT IN NORWAY – STANDARDISATION OF 
SURGERY AND QUALITY ASSURANCE 
2004 
235. Eivind Witsø: BONE GRAFT AS AN ANTIBIOTIC CARRIER 
236. Anne Mari Sund: DEVELOPMENT OF DEPRESSIVE SYMPTOMS IN EARLY 
ADOLESCENCE   
237. Hallvard Lærum: EVALUATION OF ELECTRONIC MEDICAL RECORDS – A CLINICAL 
TASK PERSPECTIVE  
238. Gustav Mikkelsen: ACCESSIBILITY OF INFORMATION IN ELECTRONIC PATIENT 
RECORDS; AN EVALUATION OF THE ROLE OF DATA QUALITY 
239. Steinar Krokstad: SOCIOECONOMIC INEQUALITIES IN HEALTH AND DISABILITY. 
SOCIAL EPIDEMIOLOGY IN THE NORD-TRØNDELAG HEALTH STUDY (HUNT), 
NORWAY 
240. Arne Kristian Myhre: NORMAL VARIATION IN ANOGENITAL ANATOMY AND 
MICROBIOLOGY IN NON-ABUSED PRESCHOOL CHILDREN 
241. Ingunn Dybedal: NEGATIVE REGULATORS OF HEMATOPOIETEC STEM AND 
PROGENITOR CELLS 
242. Beate Sitter: TISSUE CHARACTERIZATION BY HIGH RESOLUTION MAGIC ANGLE 
SPINNING MR SPECTROSCOPY 
243. Per Arne Aas: MACROMOLECULAR MAINTENANCE IN HUMAN CELLS – REPAIR OF 
URACIL IN DNA AND METHYLATIONS IN DNA AND RNA 
244. Anna Bofin:  FINE NEEDLE ASPIRATION CYTOLOGY IN THE PRIMARY 
INVESTIGATION OF BREAST TUMOURS AND IN THE DETERMINATION OF 
TREATMENT STRATEGIES 
245. Jim Aage Nøttestad: DEINSTITUTIONALIZATION AND MENTAL HEALTH CHANGES 
AMONG PEOPLE WITH MENTAL RETARDATION 
246. Reidar Fossmark:  GASTRIC CANCER IN JAPANESE COTTON RATS 
247. Wibeke Nordhøy:  MANGANESE AND THE HEART, INTRACELLULAR MR 
RELAXATION AND WATER EXCHANGE ACROSS THE CARDIAC CELL MEMBRANE 
2005 
248. Sturla Molden:  QUANTITATIVE ANALYSES OF SINGLE UNITS RECORDED FROM THE 
HIPPOCAMPUS AND ENTORHINAL CORTEX OF BEHAVING RATS 
249. Wenche Brenne Drøyvold:  EPIDEMIOLOGICAL STUDIES ON WEIGHT CHANGE AND 
HEALTH IN A LARGE POPULATION.  THE NORD-TRØNDELAG HEALTH STUDY 
(HUNT) 
250. Ragnhild Støen:  ENDOTHELIUM-DEPENDENT VASODILATION IN THE FEMORAL 
ARTERY OF DEVELOPING PIGLETS 
251. Aslak Steinsbekk:  HOMEOPATHY IN THE PREVENTION OF UPPER RESPIRATORY 
TRACT INFECTIONS IN CHILDREN 
252. Hill-Aina Steffenach:  MEMORY IN HIPPOCAMPAL AND CORTICO-HIPPOCAMPAL 
CIRCUITS 
253. Eystein Stordal:  ASPECTS OF THE EPIDEMIOLOGY OF DEPRESSIONS BASED ON 
SELF-RATING IN A LARGE GENERAL HEALTH STUDY (THE HUNT-2 STUDY) 
254. Viggo Pettersen:  FROM MUSCLES TO SINGING:  THE ACTIVITY OF ACCESSORY 
BREATHING MUSCLES AND THORAX  MOVEMENT IN CLASSICAL SINGING 
255. Marianne Fyhn:  SPATIAL MAPS IN THE HIPPOCAMPUS AND ENTORHINAL CORTEX 
256. Robert Valderhaug:  OBSESSIVE-COMPULSIVE DISORDER AMONG CHILDREN AND 
ADOLESCENTS:  CHARACTERISTICS AND PSYCHOLOGICAL MANAGEMENT OF 
PATIENTS IN OUTPATIENT PSYCHIATRIC CLINICS 
257. Erik Skaaheim Haug:  INFRARENAL ABDOMINAL  AORTIC ANEURYSMS – 
COMORBIDITY AND RESULTS FOLLOWING OPEN SURGERY 
258. Daniel Kondziella: GLIAL-NEURONAL INTERACTIONS IN EXPERIMENTAL BRAIN 
DISORDERS 
259. Vegard Heimly Brun:  ROUTES TO SPATIAL MEMORY IN HIPPOCAMPAL PLACE 
CELLS 
260. Kenneth McMillan:  PHYSIOLOGICAL ASSESSMENT AND TRAINING OF ENDURANCE 
AND STRENGTH IN PROFESSIONAL YOUTH SOCCER PLAYERS 
261. Marit Sæbø Indredavik:  MENTAL HEALTH AND CEREBRAL MAGNETIC RESONANCE 
IMAGING IN ADOLESCENTS WITH LOW BIRTH WEIGHT 
262. Ole Johan Kemi:  ON THE CELLULAR BASIS OF AEROBIC FITNESS, INTENSITY-
DEPENDENCE AND TIME-COURSE OF CARDIOMYOCYTE AND ENDOTHELIAL 
ADAPTATIONS TO EXERCISE TRAINING 
263. Eszter Vanky: POLYCYSTIC OVARY SYNDROME – METFORMIN TREATMENT IN 
PREGNANCY 
264. Hild Fjærtoft:  EXTENDED STROKE UNIT SERVICE AND EARLY SUPPORTED 
DISCHARGE.  SHORT AND LONG-TERM EFFECTS   
265. Grete Dyb:  POSTTRAUMATIC STRESS REACTIONS IN CHILDREN AND 
ADOLESCENTS 
266. Vidar Fykse: SOMATOSTATIN AND THE STOMACH 
267. Kirsti Berg: OXIDATIVE STRESS AND THE ISCHEMIC HEART:  A STUDY IN PATIENTS 
UNDERGOING CORONARY REVASCULARIZATION  
268. Björn Inge Gustafsson:  THE SEROTONIN PRODUCING ENTEROCHROMAFFIN CELL, 
AND EFFECTS OF HYPERSEROTONINEMIA ON HEART AND BONE 
2006 
269. Torstein Baade Rø:  EFFECTS OF BONE MORPHOGENETIC PROTEINS, HEPATOCYTE 
GROWTH FACTOR AND INTERLEUKIN-21 IN MULTIPLE MYELOMA 
270. May-Britt Tessem:  METABOLIC EFFECTS OF ULTRAVIOLET RADIATION ON THE 
ANTERIOR PART OF THE EYE 
271. Anne-Sofie Helvik:  COPING AND EVERYDAY LIFE IN A POPULATION OF ADULTS 
WITH HEARING IMPAIRMENT 
272. Therese Standal:  MULTIPLE MYELOMA:  THE INTERPLAY BETWEEN MALIGNANT 
PLASMA CELLS AND THE BONE MARROW MICROENVIRONMENT 
273. Ingvild Saltvedt:  TREATMENT OF ACUTELY SICK, FRAIL ELDERLY PATIENTS IN A 
GERIATRIC EVALUATION AND MANAGEMENT UNIT – RESULTS FROM A 
PROSPECTIVE RANDOMISED TRIAL 
274. Birger Henning Endreseth:  STRATEGIES IN RECTAL CANCER TREATMENT – FOCUS 
ON EARLY RECTAL CANCER AND THE INFLUENCE OF AGE ON PROGNOSIS 
275. Anne Mari Aukan Rokstad:  ALGINATE CAPSULES AS BIOREACTORS FOR CELL 
THERAPY 
276. Mansour Akbari: HUMAN BASE EXCISION REPAIR FOR PRESERVATION OF GENOMIC 
STABILITY 
277. Stein Sundstrøm:  IMPROVING TREATMENT IN PATIENTS WITH LUNG CANCER – 
RESULTS FROM TWO MULITCENTRE RANDOMISED STUDIES 
278. Hilde Pleym: BLEEDING AFTER CORONARY ARTERY BYPASS SURGERY -  STUDIES 
ON HEMOSTATIC MECHANISMS, PROPHYLACTIC DRUG TREATMENT AND 
EFFECTS OF AUTOTRANSFUSION 
279. Line Merethe Oldervoll:  PHYSICAL ACTIVITY AND EXERCISE INTERVENTIONS IN 
CANCER PATIENTS 
280. Boye Welde:  THE SIGNIFICANCE OF ENDURANCE TRAINING, RESISTANCE 
TRAINING AND MOTIVATIONAL STYLES IN ATHLETIC PERFORMANCE AMONG 
ELITE JUNIOR CROSS-COUNTRY SKIERS 
281. Per Olav Vandvik:  IRRITABLE BOWEL SYNDROME IN NORWAY,  STUDIES OF 
PREVALENCE, DIAGNOSIS AND CHARACTERISTICS IN GENERAL PRACTICE AND 
IN THE POPULATION 
282. Idar Kirkeby-Garstad:  CLINICAL PHYSIOLOGY OF EARLY MOBILIZATION AFTER 
CARDIAC SURGERY 
283. Linn Getz: SUSTAINABLE AND RESPONSIBLE PREVENTIVE MEDICINE.  
CONCEPTUALISING ETHICAL DILEMMAS ARISING FROM CLINICAL 
IMPLEMENTATION OF ADVANCING MEDICAL TECHNOLOGY  
284. Eva Tegnander: DETECTION OF CONGENITAL HEART DEFECTS  IN A NON-SELECTED 
POPULATION OF 42,381 FETUSES 
285. Kristin Gabestad Nørsett:  GENE EXPRESSION STUDIES IN GASTROINTESTINAL 
PATHOPHYSIOLOGY AND NEOPLASIA 
286. Per Magnus Haram:  GENETIC VS. AQUIRED FITNESS:  METABOLIC, VASCULAR AND 
CARDIOMYOCYTE  ADAPTATIONS 
287. Agneta Johansson:  GENERAL RISK FACTORS FOR GAMBLING PROBLEMS AND THE 
PREVALENCE OF PATHOLOGICAL GAMBLING IN NORWAY  
288. Svein Artur Jensen:  THE PREVALENCE OF SYMPTOMATIC ARTERIAL DISEASE OF 
THE LOWER LIMB 
289. Charlotte Björk Ingul:  QUANITIFICATION OF REGIONAL MYOCARDIAL FUNCTION 
BY STRAIN RATE AND STRAIN FOR EVALUATION OF CORONARY ARTERY 
DISEASE.  AUTOMATED VERSUS MANUAL ANALYSIS DURING ACUTE 
MYOCARDIAL INFARCTION AND DOBUTAMINE STRESS ECHOCARDIOGRAPHY 
290. Jakob Nakling:  RESULTS AND CONSEQUENCES OF ROUTINE ULTRASOUND 
SCREENING IN PREGNANCY – A GEOGRAPHIC BASED POPULATION STUDY 
291. Anne Engum:  DEPRESSION AND ANXIETY – THEIR RELATIONS TO THYROID 
DYSFUNCTION AND DIABETES IN A LARGE EPIDEMIOLOGICAL STUDY 
292. Ottar Bjerkeset: ANXIETY AND DEPRESSION IN THE GENERAL POPULATION:  RISK 
FACTORS, INTERVENTION AND OUTCOME – THE NORD-TRØNDELAG HEALTH 
STUDY (HUNT) 
293. Jon Olav Drogset:  RESULTS AFTER SURGICAL TREATMENT OF ANTERIOR 
CRUCIATE LIGAMENT INJURIES – A CLINICAL STUDY  
294. Lars Fosse: MECHANICAL BEHAVIOUR OF COMPACTED MORSELLISED BONE – AN 
EXPERIMENTAL IN VITRO STUDY 
295. Gunilla Klensmeden Fosse: MENTAL HEALTH OF PSYCHIATRIC OUTPATIENTS 
BULLIED IN CHILDHOOD 
296. Paul Jarle Mork:  MUSCLE ACTIVITY IN WORK  AND LEISURE AND ITS ASSOCIATION 
TO MUSCULOSKELETAL PAIN 
297. Björn Stenström:  LESSONS FROM RODENTS:  I: MECHANISMS OF OBESITY SURGERY 
– ROLE OF STOMACH.  II: CARCINOGENIC EFFECTS OF HELICOBACTER PYLORI 
AND SNUS IN THE STOMACH 
2007 
298. Haakon R. Skogseth:  INVASIVE PROPERTIES OF CANCER – A TREATMENT TARGET ?  
IN VITRO STUDIES IN HUMAN PROSTATE CANCER CELL LINES 
299. Janniche Hammer:  GLUTAMATE METABOLISM AND CYCLING IN MESIAL 
TEMPORAL LOBE EPILEPSY 
300. May Britt Drugli:  YOUNG CHILDREN TREATED BECAUSE OF ODD/CD:  CONDUCT 
PROBLEMS AND SOCIAL COMPETENCIES IN DAY-CARE AND SCHOOL SETTINGS 
301. Arne Skjold:  MAGNETIC RESONANCE KINETICS OF MANGANESE DIPYRIDOXYL 
DIPHOSPHATE (MnDPDP) IN HUMAN MYOCARDIUM.  STUDIES IN HEALTHY 
VOLUNTEERS AND IN PATIENTS WITH RECENT MYOCARDIAL INFARCTION 
302. Siri Malm:  LEFT VENTRICULAR SYSTOLIC FUNCTION AND MYOCARDIAL 
PERFUSION ASSESSED BY CONTRAST ECHOCARDIOGRAPHY 
303. Valentina Maria do Rosario Cabral Iversen:  MENTAL HEALTH AND PSYCHOLOGICAL 
ADAPTATION OF CLINICAL AND NON-CLINICAL MIGRANT GROUPS 
304. Lasse Løvstakken:  SIGNAL PROCESSING IN DIAGNOSTIC ULTRASOUND:  
ALGORITHMS FOR REAL-TIME ESTIMATION AND VISUALIZATION OF BLOOD 
FLOW VELOCITY 
305. Elisabeth Olstad:  GLUTAMATE AND GABA:  MAJOR PLAYERS IN NEURONAL 
METABOLISM  
306. Lilian Leistad:  THE ROLE OF CYTOKINES AND PHOSPHOLIPASE A2s  IN ARTICULAR 
CARTILAGE CHONDROCYTES IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS 
307. Arne Vaaler:  EFFECTS OF PSYCHIATRIC INTENSIVE CARE UNIT IN AN ACUTE 
PSYCIATHRIC WARD 
308. Mathias Toft:  GENETIC STUDIES OF LRRK2 AND PINK1 IN PARKINSON’S DISEASE 
309. Ingrid Løvold Mostad:  IMPACT OF DIETARY FAT QUANTITY AND QUALITY IN TYPE 
2 DIABETES WITH EMPHASIS ON MARINE N-3 FATTY ACIDS 
310. Torill Eidhammer Sjøbakk:  MR DETERMINED BRAIN METABOLIC PATTERN IN 
PATIENTS WITH BRAIN METASTASES AND ADOLESCENTS WITH LOW BIRTH 
WEIGHT 
311. Vidar Beisvåg:  PHYSIOLOGICAL GENOMICS OF HEART FAILURE:  FROM 
TECHNOLOGY TO PHYSIOLOGY 
312. Olav Magnus Søndenå Fredheim:  HEALTH RELATED QUALITY OF LIFE ASSESSMENT 
AND ASPECTS OF THE CLINICAL PHARMACOLOGY OF METHADONE IN PATIENTS 
WITH CHRONIC NON-MALIGNANT PAIN 
313. Anne Brantberg: FETAL AND PERINATAL IMPLICATIONS OF ANOMALIES IN THE 
GASTROINTESTINAL TRACT AND THE ABDOMINAL WALL 
314. Erik Solligård: GUT LUMINAL MICRODIALYSIS 
315. Elin Tollefsen: RESPIRATORY SYMPTOMS IN A COMPREHENSIVE POPULATION 
BASED STUDY AMONG ADOLESCENTS 13-19 YEARS. YOUNG-HUNT 1995-97 AND 
2000-01; THE NORD-TRØNDELAG HEALTH STUDIES (HUNT) 
316. Anne-Tove Brenne:  GROWTH REGULATION OF MYELOMA CELLS 
317. Heidi Knobel:  FATIGUE IN CANCER TREATMENT – ASSESSMENT, COURSE AND 
ETIOLOGY 
318. Torbjørn Dahl:  CAROTID ARTERY STENOSIS.  DIAGNOSTIC AND THERAPEUTIC 
ASPECTS 
319. Inge-Andre Rasmussen jr.:  FUNCTIONAL AND DIFFUSION TENSOR MAGNETIC 
RESONANCE IMAGING IN NEUROSURGICAL PATIENTS 
320. Grete Helen Bratberg:  PUBERTAL TIMING – ANTECEDENT TO RISK OR RESILIENCE ?  
EPIDEMIOLOGICAL STUDIES ON GROWTH, MATURATION AND HEALTH RISK 
BEHAVIOURS; THE YOUNG HUNT STUDY, NORD-TRØNDELAG, NORWAY 
321. Sveinung Sørhaug:  THE PULMONARY NEUROENDOCRINE SYSTEM.  
PHYSIOLOGICAL, PATHOLOGICAL AND TUMOURIGENIC ASPECTS 
322. Olav Sande Eftedal:  ULTRASONIC DETECTION OF DECOMPRESSION INDUCED 
VASCULAR MICROBUBBLES 
323. Rune Bang Leistad:  PAIN, AUTONOMIC ACTIVATION AND MUSCULAR ACTIVITY 
RELATED TO EXPERIMENTALLY-INDUCED COGNITIVE STRESS IN HEADACHE 
PATIENTS 
324. Svein Brekke:  TECHNIQUES FOR ENHANCEMENT OF TEMPORAL RESOLUTION IN 
THREE-DIMENSIONAL ECHOCARDIOGRAPHY 
325. Kristian Bernhard Nilsen:  AUTONOMIC ACTIVATION AND MUSCLE ACTIVITY IN 
RELATION TO MUSCULOSKELETAL PAIN 
326. Anne Irene Hagen:  HEREDITARY BREAST CANCER IN NORWAY.  DETECTION AND 
PROGNOSIS OF BREAST CANCER IN FAMILIES WITH BRCA1GENE MUTATION 
327. Ingebjørg S. Juel :  INTESTINAL INJURY AND RECOVERY AFTER ISCHEMIA.  AN 
EXPERIMENTAL STUDY ON RESTITUTION OF THE SURFACE EPITHELIUM, 
INTESTINAL PERMEABILITY, AND RELEASE OF BIOMARKERS FROM THE MUCOSA 
328. Runa Heimstad:  POST-TERM PREGNANCY 
329. Jan Egil Afset:  ROLE OF ENTEROPATHOGENIC ESCHERICHIA COLI  IN CHILDHOOD 
DIARRHOEA IN NORWAY 
330. Bent Håvard Hellum:  IN VITRO INTERACTIONS BETWEEN MEDICINAL DRUGS AND 
HERBS ON CYTOCHROME P-450 METABOLISM AND P-GLYCOPROTEIN TRANSPORT 
331. Morten André Høydal:  CARDIAC DYSFUNCTION AND MAXIMAL OXYGEN UPTAKE 
MYOCARDIAL ADAPTATION TO ENDURANCE TRAINING 
2008 
332. Andreas Møllerløkken:  REDUCTION OF VASCULAR BUBBLES:  METHODS TO 
PREVENT THE ADVERSE EFFECTS OF DECOMPRESSION 
333. Anne Hege Aamodt:  COMORBIDITY OF HEADACHE AND MIGRAINE IN THE NORD-
TRØNDELAG HEALTH STUDY 1995-97 
334. Brage Høyem Amundsen:  MYOCARDIAL FUNCTION QUANTIFIED BY SPECKLE 
TRACKING AND TISSUE DOPPLER ECHOCARDIOGRAPHY – VALIDATION AND 
APPLICATION IN EXERCISE TESTING AND TRAINING 
335. Inger Anne Næss:  INCIDENCE, MORTALITY AND RISK FACTORS OF FIRST VENOUS 
THROMBOSIS IN A GENERAL POPULATION.  RESULTS FROM THE SECOND NORD-
TRØNDELAG HEALTH STUDY (HUNT2) 
336. Vegard Bugten:  EFFECTS OF POSTOPERATIVE MEASURES AFTER FUNCTIONAL 
ENDOSCOPIC SINUS  SURGERY 
337. Morten Bruvold:  MANGANESE AND WATER IN CARDIAC MAGNETIC RESONANCE 
IMAGING  
338. Miroslav Fris:  THE EFFECT OF SINGLE AND REPEATED ULTRAVIOLET RADIATION 
ON THE ANTERIOR SEGMENT OF THE RABBIT EYE 
339. Svein Arne Aase:  METHODS FOR IMPROVING QUALITY AND EFFICIENCY IN 
QUANTITATIVE ECHOCARDIOGRAPHY – ASPECTS OF USING HIGH FRAME RATE 
340. Roger Almvik:  ASSESSING THE RISK OF VIOLENCE:  DEVELOPMENT AND 
VALIDATION OF THE BRØSET VIOLENCE CHECKLIST 
341. Ottar Sundheim:  STRUCTURE-FUNCTION ANALYSIS OF HUMAN ENZYMES 
INITIATING NUCLEOBASE REPAIR IN DNA AND RNA 
342. Anne Mari Undheim:  SHORT AND LONG-TERM OUTCOME OF EMOTIONAL AND 
BEHAVIOURAL PROBLEMS IN YOUNG ADOLESCENTS WITH AND WITHOUT 
READING DIFFICULTIES 
343. Helge Garåsen:  THE TRONDHEIM MODEL.  IMPROVING THE PROFESSIONAL 
COMMUNICATION BETWEEN THE VARIOUS LEVELS OF HEALTH CARE SERVICES 
AND IMPLEMENTATION OF INTERMEDIATE CARE AT A COMMUNITY HOSPITAL 
COULD PROVIDE BETTER CARE FOR OLDER PATIENTS.  SHORT AND LONG TERM 
EFFECTS  
344. Olav A. Foss:  “THE ROTATION RATIOS METHOD”.  A METHOD TO DESCRIBE 
ALTERED SPATIAL ORIENTATION IN SEQUENTIAL RADIOGRAPHS FROM ONE 
PELVIS 
345. Bjørn Olav Åsvold:  THYROID FUNCTION AND CARDIOVASCULAR HEALTH 
346. Torun Margareta Melø: NEURONAL GLIAL INTERACTIONS IN EPILEPSY 
347. Irina Poliakova Eide:  FETAL GROWTH RESTRICTION AND PRE-ECLAMPSIA:   SOME 
CHARACTERISTICS OF FETO-MATERNAL INTERACTIONS IN DECIDUA BASALIS 
348. Torunn Askim:  RECOVERY AFTER STROKE.  ASSESSMENT AND TREATMENT;  WITH 
FOCUS ON MOTOR FUNCTION 
349. Ann Elisabeth Åsberg:  NEUTROPHIL ACTIVATION IN A ROLLER PUMP MODEL OF 
CARDIOPULMONARY BYPASS.  INFLUENCE ON BIOMATERIAL, PLATELETS AND 
COMPLEMENT 
350. Lars Hagen:  REGULATION OF DNA BASE EXCISION REPAIR BY PROTEIN 
INTERACTIONS AND POST TRANSLATIONAL MODIFICATIONS 
351. Sigrun Beate Kjøtrød:  POLYCYSTIC OVARY SYNDROME – METFORMIN TREATMENT 
IN ASSISTED REPRODUCTION 
352. Steven Keita Nishiyama:  PERSPECTIVES ON LIMB-VASCULAR HETEROGENEITY:  
IMPLICATIONS FOR HUMAN AGING, SEX, AND EXERCISE 
353. Sven Peter Näsholm:  ULTRASOUND BEAMS FOR ENHANCED IMAGE QUALITY 
354. Jon Ståle Ritland:  PRIMARY OPEN-ANGLE GLAUCOMA & EXFOLIATIVE GLAUCOMA. 
SURVIVAL, COMORBIDITY AND GENETICS 
355. Sigrid Botne Sando:  ALZHEIMER’S DISEASE IN CENTRAL NORWAY.  GENETIC AND 
EDUCATIONAL ASPECTS 
356. Parvinder Kaur: CELLULAR AND MOLECULAR MECHANISMS BEHIND 
METHYLMERCURY-INDUCED NEUROTOXICITY 
357. Ismail Cüneyt Güzey:  DOPAMINE AND SEROTONIN RECEPTOR AND TRANSPORTER 
GENE POLYMORPHISMS AND EXTRAPYRAMIDAL SYMPTOMS. STUDIES IN 
PARKINSON’S DISEASE AND IN PATIENTS TREATED WITH ANTIPSYCHOTIC OR 
ANTIDEPRESSANT DRUGS 
358. Brit Dybdahl:  EXTRA-CELLULAR INDUCIBLE HEAT-SHOCK PROTEIN 70 (Hsp70) – A 
ROLE IN THE INFLAMMATORY RESPONSE ? 
359. Kristoffer Haugarvoll:  IDENTIFYING GENETIC CAUSES OF PARKINSON’S DISEASE IN 
NORWAY 
360. Nadra Nilsen: TOLL-LIKE RECEPTOR 2 –EXPRESSION, REGULATION AND SIGNALING 
361. Johan Håkon Bjørngaard: PATIENT SATISFACTION WITH OUTPATIENT MENTAL 
HEALTH SERVICES – THE INFLUENCE OF ORGANIZATIONAL FACTORS. 
362. Kjetil Høydal : EFFECTS OF HIGH INTENSITY AEROBIC TRAINING IN HEALTHY 
SUBJECTS AND CORONARY ARTERY DISEASE PATIENTS; THE IMPORTANCE OF 
INTENSITY,, DURATION AND FREQUENCY OF TRAINING. 
363. Trine Karlsen: TRAINING IS MEDICINE: ENDURANCE AND STRENGTH TRAINING IN 
CORONARY ARTERY DISEASE AND HEALTH. 
364. Marte Thuen: MANGANASE-ENHANCED AND DIFFUSION TENSOR MR IMAGING OF 
THE NORMAL, INJURED AND REGENERATING RAT VISUAL PATHWAY 
365. Cathrine Broberg Vågbø:  DIRECT REPAIR OF ALKYLATION DAMAGE IN DNA AND 
RNA BY 2-OXOGLUTARATE- AND IRON-DEPENDENT DIOXYGENASES 
366. Arnt Erik Tjønna:  AEROBIC EXERCISE AND CARDIOVASCULAR RISK FACTORS IN 
OVERWEIGHT AND OBESE ADOLESCENTS AND ADULTS 
367. Marianne W. Furnes:  FEEDING BEHAVIOR AND BODY WEIGHT DEVELOPMENT:  
LESSONS FROM RATS  
368. Lene N. Johannessen:  FUNGAL PRODUCTS AND INFLAMMATORY RESPONSES IN 
HUMAN MONOCYTES AND EPITHELIAL CELLS  
369. Anja Bye:  GENE EXPRESSION PROFILING OF INHERITED AND ACQUIRED MAXIMAL 
OXYGEN UPTAKE – RELATIONS TO THE METABOLIC SYNDROME. 
370. Oluf Dimitri Røe:  MALIGNANT MESOTHELIOMA:  VIRUS, BIOMARKERS AND GENES.  
A TRANSLATIONAL APPROACH 
371. Ane Cecilie Dale:  DIABETES MELLITUS AND FATAL ISCHEMIC HEART DISEASE. 
ANALYSES FROM THE HUNT1 AND 2 STUDIES 
372. Jacob Christian Hølen:  PAIN ASSESSMENT IN PALLIATIVE CARE:  VALIDATION OF 
METHODS FOR SELF-REPORT AND BEHAVIOURAL ASSESSMENT 
373. Erming Tian:  THE GENETIC IMPACTS IN THE ONCOGENESIS OF MULTIPLE 
MYELOMA 
374. Ole Bosnes:  KLINISK UTPRØVING AV NORSKE VERSJONER AV NOEN SENTRALE 
TESTER PÅ KOGNITIV FUNKSJON 
375. Ola M. Rygh:  3D ULTRASOUND BASED NEURONAVIGATION IN NEUROSURGERY.  A 
CLINICAL EVALUATION 
376. Astrid Kamilla Stunes:  ADIPOKINES, PEROXISOME PROFILERATOR ACTIVATED 
RECEPTOR (PPAR) AGONISTS AND SEROTONIN.  COMMON REGULATORS OF BONE 
AND FAT METABOLISM 
377. Silje Engdal:  HERBAL REMEDIES USED BY NORWEGIAN CANCER PATIENTS AND 
THEIR ROLE IN HERB-DRUG INTERACTIONS 
378. Kristin Offerdal:  IMPROVED ULTRASOUND IMAGING OF THE FETUS AND ITS 
CONSEQUENCES FOR SEVERE AND LESS SEVERE ANOMALIES 
379. Øivind Rognmo:  HIGH-INTENSITY AEROBIC EXERCISE AND CARDIOVASCULAR 
HEALTH 
380. Jo-Åsmund Lund:  RADIOTHERAPY IN ANAL CARCINOMA AND PROSTATE CANCER 
 
2009 
 
381. Tore Grüner Bjåstad:  HIGH FRAME RATE ULTRASOUND IMAGING USING PARALLEL 
BEAMFORMING 
382. Erik Søndenaa:  INTELLECTUAL DISABILITIES IN THE CRIMINAL JUSTICE SYSTEM 
383. Berit Rostad:  SOCIAL INEQUALITIES IN WOMEN’S HEALTH, HUNT 1984-86 AND 
1995-97, THE NORD-TRØNDELAG HEALTH STUDY (HUNT) 
384. Jonas Crosby:  ULTRASOUND-BASED QUANTIFICATION OF MYOCARDIAL 
DEFORMATION AND ROTATION 
385. Erling Tronvik:  MIGRAINE, BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN 
SYSTEM 
386. Tom Christensen:  BRINGING THE GP TO THE FOREFRONT OF EPR DEVELOPMENT 
387. Håkon Bergseng:  ASPECTS OF GROUP B STREPTOCOCCUS (GBS) DISEASE IN THE 
NEWBORN.  EPIDEMIOLOGY, CHARACTERISATION OF INVASIVE STRAINS AND 
EVALUATION OF INTRAPARTUM SCREENING  
388. Ronny Myhre: GENETIC STUDIES OF CANDIDATE TENE3S IN PARKINSON’S  
DISEASE 
389. Torbjørn Moe Eggebø:  ULTRASOUND AND LABOUR 
390. Eivind Wang:  TRAINING IS MEDICINE FOR PATIENTS WITH PERIPHERAL ARTERIAL 
DISEASE 
391. Thea Kristin Våtsveen: GENETIC ABERRATIONS IN MYELOMA CELLS 
392. Thomas Jozefiak:  QUALITY OF LIFE AND MENTAL HEALTH IN CHILDREN AND 
ADOLESCENTS:  CHILD AND PARENT PERSPECTIVES 
393. Jens Erik Slagsvold:  N-3 POLYUNSATURATED FATTY ACIDS IN HEALTH AND 
DISEASE – CLINICAL AND MOLECULAR ASPECTS 
394. Kristine Misund:  A STUDY OF THE TRANSCRIPTIONAL REPRESSOR ICER.  
REGULATORY NETWORKS IN GASTRIN-INDUCED GENE EXPRESSION 
395. Franco M. Impellizzeri:  HIGH-INTENSITY TRAINING IN FOOTBALL PLAYERS.  
EFFECTS ON PHYSICAL AND TECHNICAL PERFORMANCE 
396. Kari Hanne Gjeilo:  HEALTH-RELATED QUALITY OF LIFE AND CHRONIC PAIN IN 
PATIENTS UNDERGOING CARDIAC SURGERY 
397. Øyvind Hauso:  NEUROENDOCRINE ASPECTS OF PHYSIOLOGY AND DISEASE 
398. Ingvild Bjellmo Johnsen:  INTRACELLULAR SIGNALING MECHANISMS IN THE INNATE 
IMMUNE RESPONSE TO VIRAL INFECTIONS 
399. Linda Tømmerdal Roten:  GENETIC PREDISPOSITION FOR DEVELOPMENT OF 
PREEMCLAMPSIA – CANDIDATE GENE STUDIES IN THE HUNT (NORD-TRØNDELAG 
HEALTH STUDY) POPULATION 
400. Trude Teoline Nausthaug Rakvåg:  PHARMACOGENETICS OF MORPHINE IN CANCER 
PAIN 
401. Hanne Lehn:  MEMORY FUNCTIONS OF THE HUMAN MEDIAL TEMPORAL LOBE 
STUDIED WITH fMRI 
402. Randi Utne Holt:  ADHESION AND MIGRATION OF MYELOMA CELLS – IN VITRO 
STUDIES – 
403. Trygve Solstad: NEURAL REPRESENTATIONS OF EUCLIDEAN SPACE 
404. Unn-Merete Fagerli:  MULTIPLE MYELOMA CELLS AND CYTOKINES FROM THE 
BONE MARROW ENVIRONMENT; ASPECTS OF GROWTH REGULATION AND 
MIGRATION 
405. Sigrid Bjørnelv:  EATING– AND WEIGHT PROBLEMS IN ADOLESCENTS, THE YOUNG 
HUNT-STUDY 
406. Mari Hoff:  CORTICAL HAND BONE LOSS IN RHEUMATOID ARTHRITIS.  
EVALUATING DIGITAL X-RAY RADIOGRAMMETRY AS OUTCOME MEASURE OF 
DISEASE ACTIVITY, RESPONSE VARIABLE TO TREATMENT AND PREDICTOR OF 
BONE DAMAGE  
407. Siri Bjørgen:  AEROBIC HIGH INTENSITY INTERVAL TRAINING IS AN EFFECTIVE 
TREATMENT FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
408. Susanne Lindqvist:  VISION AND BRAIN IN ADOLESCENTS WITH LOW BIRTH WEIGHT 
409. Torbjørn Hergum:  3D ULTRASOUND FOR QUANTITATIVE ECHOCARDIOGRAPHY 
410. Jørgen Urnes:  PATIENT EDUCATION IN GASTRO-OESOPHAGEAL REFLUX DISEASE. 
VALIDATION OF A DIGESTIVE SYMPTOMS AND IMPACT QUESTIONNAIRE AND A 
RANDOMISED CONTROLLED TRIAL OF PATIENT EDUCATION 
411. Elvar Eyjolfsson:  13C NMRS OF ANIMAL MODELS OF SCHIZOPHRENIA 
412. Marius Steiro Fimland: CHRONIC AND ACUTE NEURAL ADAPTATIONS TO STRENGTH 
TRAINING 
413. Øyvind Støren: RUNNING AND CYCLING ECONOMY IN ATHLETES; DETERMINING 
FACTORS, TRAINING INTERVENTIONS AND TESTING 
414. Håkon Hov:  HEPATOCYTE GROWTH FACTOR AND ITS RECEPTOR C-MET.  
AUTOCRINE GROWTH AND SIGNALING IN MULTIPLE MYELOMA CELLS 
415. Maria Radtke: ROLE OF AUTOIMMUNITY AND OVERSTIMULATION FOR BETA-CELL 
DEFICIENCY. EPIDEMIOLOGICAL AND THERAPEUTIC PERSPECTIVES 
416. Liv Bente Romundstad:  ASSISTED FERTILIZATION IN NORWAY:  SAFETY OF THE 
REPRODUCTIVE TECHNOLOGY 
417. Erik Magnus Berntsen: PREOPERATIV PLANNING AND FUNCTIONAL 
NEURONAVIGATION – WITH FUNCTIONAL MRI AND DIFFUSION TENSOR 
TRACTOGRAPHY IN PATIENTS WITH BRAIN LESIONS 
418. Tonje Strømmen Steigedal:  MOLECULAR MECHANISMS OF THE PROLIFERATIVE 
RESPONSE TO THE HORMONE GASTRIN 
419. Vidar Rao:  EXTRACORPOREAL PHOTOCHEMOTHERAPY IN PATIENTS WITH 
CUTANEOUS T CELL LYMPHOMA OR GRAFT-vs-HOST DISEASE 
420. Torkild Visnes:  DNA EXCISION REPAIR OF URACIL AND 5-FLUOROURACIL IN 
HUMAN CANCER CELL LINES 
 
2010 
 
421. John Munkhaugen:  BLOOD PRESSURE, BODY WEIGHT, AND KIDNEY FUNCTION IN 
THE NEAR-NORMAL RANGE: NORMALITY, RISK FACTOR OR MORBIDITY ? 
422. Ingrid Castberg:  PHARMACOKINETICS, DRUG INTERACTIONS AND ADHERENCE TO 
TREATMENT WITH ANTIPSYCHOTICS: STUDIES IN A NATURALISTIC SETTING 
423. Jian Xu: BLOOD-OXYGEN-LEVEL-DEPENDENT-FUNCTIONAL MAGNETIC 
RESONANCE IMAGING AND DIFFUSION TENSOR IMAGING IN TRAUMATIC BRAIN 
INJURY RESEARCH 
424. Sigmund Simonsen: ACCEPTABLE RISK AND THE REQUIREMENT OF 
PROPORTIONALITY IN EUROPEAN BIOMEDICAL RESEARCH LAW. WHAT DOES 
THE REQUIREMENT THAT BIOMEDICAL RESEARCH SHALL NOT INVOLVE RISKS 
AND BURDENS DISPROPORTIONATE TO ITS POTENTIAL BENEFITS MEAN?  
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427. Trine Moholdt:  AEROBIC EXERCISE IN CORONARY HEART DISEASE 
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INJURED RAT CENTRAL NERVOUS SYSTEM  
 
 
 
     
 
 
 
 
 
